Erik Magnus Ohman | Scholars@Duke

Erik Magnus Ohman
Professor of Medicine

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices.

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology. He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology.

Current Appointments & Affiliations

Professor of Medicine, Medicine, Cardiology, Medicine 2006
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 1991

Contact Information

8678A Hafs Bldg, Durham, NC 27710
Duke Box 3126, Durham, NC 27710
ohman001@mc.duke.edu (919) 681-2069

Background
Education, Training, & Certifications
- M.B.B.S., Royal College of Surgeons (Ireland) 1981
Previous Appointments & Affiliations
- Associate Consulting Professor of Medicine, Medicine, Cardiology, Medicine 2001 - 2006
- Associate Professor of Medicine with Tenure, Medicine, Cardiology, Medicine 1999 - 2001
- Associate Professor of Medicine, Medicine, Cardiology, Medicine 1997 - 1999
- Assistant Professor of Medicine, Medicine, Cardiology, Medicine 1993 - 1997
- Associate in the Department of Medicine, Medicine, Clinical Science Departments 1991 - 1993
Recognition
In the News
- NOV 19, 2019
  
  Global List of Highly Cited Puts Duke in Top Ten
- NOV 27, 2018
  
  Duke Faculty Plentiful On ‘Highly Cited’ List
- MAY 3, 2015
  
  Frailty Among Older Heart Patients Helps Predicts Severe Outcomes
- JUL 8, 2014 The Wall Street Journal
  
  Side effects: Ways to tell the real from the imagined
- AUG 16, 2013
  
  Study: Drug Dosing for Older Heart Patients Should Differ
Research
Selected Grants
- cVAD and QI Registries Manuscripts awarded by Abiomed 2019 - 2022
- CRISP-AMI Data Analysis awarded by Abiomed 2018 - 2019
- DCRI CERT for Cardiovascular Therapies awarded by National Institutes of Health 1999 - 2002
- Bypass Angioplasty Revascularization Investigation awarded by National Institutes of Health 1987 - 1997
- Bypass Angioplasty Investigation awarded by National Institutes of Health 1993 - 1994
External Relationships
- Abiomed, Inc.
- American College of Cardiology Foundation
- Chiesi USA
- Cytokinetics, Inc.
- Faculty Connection
- Milestone Pharmaceuticals
- Neurocrine Biosciences, Inc.
- Otsuka Pharmaceuticals
- Oxford University
- Pfizer Inc.
- XyloCor
- cara therapeutics
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Figtree, Gemma A., Bjorn Redfors, Rebecca Kozor, Stephen T. Vernon, Stuart M. Grieve, Jawad Mazhar, Holger Thiele, et al. “Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors.” Jacc Cardiovasc Interv 15, no. 11 (June 13, 2022): 1167–75. https://doi.org/10.1016/j.jcin.2022.03.036.
    Full Text Link to Item
  - Han, Yaling, Bimmer E. Claessen, Shao-Liang Chen, Qiu Chunguang, Yujie Zhou, Yawei Xu, Lin Hailong, et al. “Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.” Circ Cardiovasc Interv 15, no. 4 (April 2022): e009495. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009495.
    Full Text Link to Item
  - Dangas, George, Usman Baber, Samin Sharma, Gennaro Giustino, Samantha Sartori, Johny Nicolas, Ridhima Goel, et al. “Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study.” Eurointervention 17, no. 16 (March 18, 2022): 1330–39. https://doi.org/10.4244/EIJ-D-21-00721.
    Full Text Link to Item
  - Januzzi, James L., and E Magnus Ohman. “Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.” J Am Coll Cardiol 79, no. 9 (March 8, 2022): 861–63. https://doi.org/10.1016/j.jacc.2022.01.003.
    Full Text Link to Item
  - Gibson, C Michael, Michael J. Mack, Victoria T. Lee, David J. Schneider, Frank W. Sellke, E Magnus Ohman, Vinod H. Thourani, et al. “Rationale and design of the safe and timely antithrombotic removal - ticagrelor (STAR-T) trial: A prospective, multi-center, double-blind, randomized controlled trial evaluating reductions in postoperative bleeding with intraoperative removal of ticagrelor by the drugsorb™-ATR device in patients undergoing cardiothoracic surgery within 48 hours from last ticagrelor dose.” Am Heart J 245 (March 2022): 19–28. https://doi.org/10.1016/j.ahj.2021.10.188.
    Full Text Link to Item
  - Chiarito, Mauro, Usman Baber, Davide Cao, Samin K. Sharma, George Dangas, Dominick J. Angiolillo, Carlo Briguori, et al. “Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy.” Jacc Cardiovasc Interv 15, no. 3 (February 14, 2022): 282–93. https://doi.org/10.1016/j.jcin.2021.11.005.
    Full Text Link to Item
  - Mac Grory, Brian, E Magnus Ohman, Wuwei Feng, Ying Xian, Shadi Yaghi, Hooman Kamel, and Michael E. Reznik. “Advances in the management of cardioembolic stroke associated with patent foramen ovale.” Bmj 376 (February 9, 2022): e063161. https://doi.org/10.1136/bmj-2020-063161.
    Full Text Link to Item
  - Escaned, Javier, Davide Cao, Usman Baber, Johny Nicolas, Samantha Sartori, Zhongjie Zhang, George Dangas, et al. “Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.” Eur Heart J 42, no. 45 (December 1, 2021): 4624–34. https://doi.org/10.1093/eurheartj/ehab702.
    Full Text Link to Item
  - Stefanini, Giulio G., Carlo Briguori, Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, et al. “Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.” Eur Heart J 42, no. 45 (December 1, 2021): 4683–93. https://doi.org/10.1093/eurheartj/ehab533.
    Full Text Link to Item
  - Napp, L Christian, Ralf Westenfeld, Jacob E. Møller, Federico Pappalardo, Karim Ibrahim, Laurent Bonello, Charles Wilkins, et al. “Impella mechanical circulatory support for Takotsubo syndrome with shock: A retrospective multicenter analysis.” Cardiovasc Revasc Med, November 19, 2021. https://doi.org/10.1016/j.carrev.2021.11.018.
    Full Text Link to Item
  - Povsic, Thomas J., Timothy D. Henry, E Magnus Ohman, Carl J. Pepine, Ronald G. Crystal, Todd K. Rosengart, Rickey R. Reinhardt, et al. “Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.” Am Heart J 241 (November 2021): 38–49. https://doi.org/10.1016/j.ahj.2021.06.013.
    Full Text Link to Item
  - Ohman, E Magnus. “The Evolving Post-PCI Antithrombotic Therapies.” N Engl J Med 385, no. 18 (October 28, 2021): 1712–14. https://doi.org/10.1056/NEJMe2112747.
    Full Text Link to Item
  - Sullivan, Alexander E., Michael G. Nanna, Tracy Y. Wang, Deepak L. Bhatt, Dominick J. Angiolillo, Roxana Mehran, Subhash Banerjee, et al. “Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.” J Am Coll Cardiol 78, no. 15 (October 12, 2021): 1550–63. https://doi.org/10.1016/j.jacc.2021.08.013.
    Full Text Link to Item
  - O’Neill, Brian P., Cindy Grines, Jeffrey W. Moses, E Magnus Ohman, Alexandra Lansky, Jeffery Popma, Navin K. Kapur, et al. “Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.” Catheter Cardiovasc Interv 98, no. 4 (October 2021): E501–12. https://doi.org/10.1002/ccd.29758.
    Full Text Link to Item
  - Picard, Fabien, Deepak L. Bhatt, Grégory Ducrocq, E Magnus Ohman, Shinya Goto, Kim A. Eagle, Peter W. F. Wilson, Sidney C. Smith, Yedid Elbez, and Philippe Gabriel Steg. “Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry.” Int J Cardiol 340 (October 1, 2021): 96–104. https://doi.org/10.1016/j.ijcard.2021.08.031.
    Full Text Link to Item
  - Vogel, Birgit, Usman Baber, David J. Cohen, Samantha Sartori, Samin K. Sharma, Dominick J. Angiolillo, Serdar Farhan, et al. “Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical Trial.” Jama Cardiol 6, no. 9 (September 1, 2021): 1032–41. https://doi.org/10.1001/jamacardio.2021.1720.
    Full Text Link to Item
  - Madhavan, Mahesh V., Behnood Bikdeli, Björn Redfors, Giuseppe Biondi-Zoccai, Nicholas J. Varunok, John R. Burton, Aaron Crowley, et al. “Antiplatelet strategies in acute coronary syndromes: design and methodology of an international collaborative network meta-analysis of randomized controlled trials.” Minerva Cardiol Angiol 69, no. 4 (August 2021): 398–407. https://doi.org/10.23736/S2724-5683.20.05353-0.
    Full Text Link to Item
  - Angiolillo, Dominick J., Davide Cao, Usman Baber, Samantha Sartori, Zhongjie Zhang, George Dangas, Shamir Mehta, et al. “Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI.” Jacc Cardiovasc Interv 14, no. 13 (July 12, 2021): 1434–46. https://doi.org/10.1016/j.jcin.2021.04.043.
    Full Text Link to Item
  - Ohman, E Magnus, Brittany A. Zwischenberger, and Holger Thiele. “Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better.” Jacc Cardiovasc Interv 14, no. 10 (May 24, 2021): 1120–22. https://doi.org/10.1016/j.jcin.2021.04.016.
    Full Text Link to Item
  - Harrington, Robert A., and E Magnus Ohman. “Risk Stratification Science Goes to a New Level.” Jama Cardiol 6, no. 3 (March 1, 2021): 314–15. https://doi.org/10.1001/jamacardio.2020.6325.
    Full Text Link to Item
  - Povsic, Thomas J., Timothy D. Henry, and E Magnus Ohman. “Therapeutic Approaches for the No-Option Refractory Angina Patient.” Circ Cardiovasc Interv 14, no. 2 (February 2021): e009002. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009002.
    Full Text Link to Item
  - Redfors, Björn, Reza Mohebi, Gennaro Giustino, Shmuel Chen, Harry P. Selker, Holger Thiele, Manesh R. Patel, et al. “Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction.” Circ Cardiovasc Interv 14, no. 2 (February 2021): e009879. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009879.
    Full Text Link to Item
  - Ohman, E Magnus, and Michael G. Nanna. “Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?” J Am Coll Cardiol 77, no. 3 (January 26, 2021): 268–70. https://doi.org/10.1016/j.jacc.2020.11.036.
    Full Text Link to Item
  - Samsky, Marc D., Mitchell W. Krucoff, David A. Morrow, William T. Abraham, Fernando Aguel, Andrew D. Althouse, Eric Chen, et al. “Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.” Am Heart J 230 (December 2020): 93–97. https://doi.org/10.1016/j.ahj.2020.09.015.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, and E Magnus Ohman. “Towards a better standard for defining high bleeding risk patients: can we now translate this into a better practice?” Eur Heart J 41, no. 38 (October 7, 2020): 3750–52. https://doi.org/10.1093/eurheartj/ehaa699.
    Full Text Link to Item
  - Baber, Usman, George Dangas, Dominick Joseph Angiolillo, David Joel Cohen, Samin Kumar Sharma, Johny Nicolas, Carlo Briguori, et al. “Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.” Eur Heart J 41, no. 37 (October 1, 2020): 3533–45. https://doi.org/10.1093/eurheartj/ehaa670.
    Full Text Link to Item
  - Russo, Juan J., Megha Prasad, Darshan Doshi, Dimitrios Karmpaliotis, Manish A. Parikh, Ziad A. Ali, Jeffrey J. Popma, et al. “Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.” Catheter Cardiovasc Interv 96, no. 4 (October 1, 2020): 764–70. https://doi.org/10.1002/ccd.28557.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, Megan L. Neely, Marco Valgimigli, Francesco Costa, David Van Klaveren, Rituparna Altner, Deepak L. Bhatt, et al. “Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.” Circ Cardiovasc Qual Outcomes 13, no. 9 (September 2020): e006582. https://doi.org/10.1161/CIRCOUTCOMES.120.006582.
    Full Text Link to Item
  - Yip, Christina, Aruni Seneviratna, Sock-Hwee Tan, Thet Khaing, Siew-Pang Chan, Joshua Loh, Chi-Hang Lee, et al. “Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation.” J Thromb Thrombolysis 50, no. 2 (August 2020): 421–29. https://doi.org/10.1007/s11239-020-02066-y.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, Frederik Dalgaard, Aaron D. Jones, Yuliya Lokhnygina, Stefan K. James, Robert A. Harrington, Lars Wallentin, et al. “Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.” J Am Coll Cardiol 76, no. 2 (July 14, 2020): 162–71. https://doi.org/10.1016/j.jacc.2020.05.031.
    Full Text Link to Item
  - Navarese, Eliano P., Safi U. Khan, Michalina Kołodziejczak, Jacek Kubica, Sergio Buccheri, Christopher P. Cannon, Paul A. Gurbel, et al. “Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials.” Circulation 142, no. 2 (July 14, 2020): 150–60. https://doi.org/10.1161/CIRCULATIONAHA.120.046786.
    Full Text Link to Item
  - Smilowitz, Nathaniel R., Aubrey C. Galloway, E Magnus Ohman, Sunil V. Rao, Sripal Bangalore, Stuart D. Katz, and Judith S. Hochman. “Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey.” Am Heart J 225 (July 2020): 55–59. https://doi.org/10.1016/j.ahj.2020.04.011.
    Full Text Link to Item
  - Mall, Anna, T Andrew Girton, Kevin Yardley, Paige Rossman, E Magnus Ohman, William Schuyler Jones, and Bradi B. Granger. “Understanding the patient experience of pain and discomfort during cardiac catheterization.” Catheter Cardiovasc Interv 95, no. 7 (June 1, 2020): E196–200. https://doi.org/10.1002/ccd.28403.
    Full Text Link to Item
  - Redfors, Björn, Ariel Furer, Harry P. Selker, Holger Thiele, Manesh R. Patel, Shmuel Chen, James E. Udelson, et al. “Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.” J Am Coll Cardiol 75, no. 15 (April 21, 2020): 1743–54. https://doi.org/10.1016/j.jacc.2020.02.045.
    Full Text Link to Item
  - Becker, Kristian C., Lydia Coulter Kwee, Megan L. Neely, Elizabeth Grass, Joseph A. Jakubowski, Keith A. A. Fox, Harvey D. White, et al. “Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements.” Sci Rep 10, no. 1 (April 10, 2020): 6169. https://doi.org/10.1038/s41598-020-63263-6.
    Full Text Open Access Copy Link to Item
  - Marquis-Gravel, Guillaume, Michel Zeitouni, Ajar Kochar, W Schuyler Jones, Michael H. Sketch, Sunil V. Rao, Manesh R. Patel, and E Magnus Ohman. “Technical consideration in acute myocardial infarction with cardiogenic shock: A review of antithrombotic and PCI therapies.” Catheter Cardiovasc Interv 95, no. 5 (April 1, 2020): 924–31. https://doi.org/10.1002/ccd.28455.
    Full Text Link to Item
  - Samsky, Marc, Mitchell Krucoff, Andrew D. Althouse, William T. Abraham, Philip Adamson, Fernando Aguel, Seth Bilazarian, et al. “Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.” Am Heart J 219 (January 2020): 1–8. https://doi.org/10.1016/j.ahj.2019.10.006.
    Full Text Link to Item
  - Whitehead, Evan H., Katherine L. Thayer, Daniel Burkhoff, Nir Uriel, E Magnus Ohman, William O’Neill, and Navin K. Kapur. “Central Venous Pressure and Clinical Outcomes During Left-Sided Mechanical Support for Acute Myocardial Infarction and Cardiogenic Shock.” Front Cardiovasc Med 7 (2020): 155. https://doi.org/10.3389/fcvm.2020.00155.
    Full Text Open Access Copy Link to Item
  - Povsic, Thomas J., E Magnus Ohman, and C Michael Gibson. “Logistical Challenges Associated With Implementing Precision Medicine-Reply.” Jama Cardiol 4, no. 12 (December 1, 2019): 1301. https://doi.org/10.1001/jamacardio.2019.4175.
    Full Text Link to Item
  - DeVore, Adam D., Eric Yow, Mitchell W. Krucoff, Matthew W. Sherwood, Linda K. Shaw, Karen Chiswell, Christopher M. O’Connor, Erik Magnus Ohman, and Eric J. Velazquez. “Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.” Esc Heart Fail 6, no. 6 (December 2019): 1233–42. https://doi.org/10.1002/ehf2.12510.
    Full Text Open Access Copy Link to Item
  - Mehran, Roxana, Usman Baber, Samin K. Sharma, David J. Cohen, Dominick J. Angiolillo, Carlo Briguori, Jin Y. Cha, et al. “Ticagrelor with or without Aspirin in High-Risk Patients after PCI.” N Engl J Med 381, no. 21 (November 21, 2019): 2032–42. https://doi.org/10.1056/NEJMoa1908419.
    Full Text Link to Item
  - Burke, David A., Harun Kundi, Alexandra Almonacid, William O’Neill, Jeffrey Moses, Neal Kleiman, Simon Dixon, et al. “The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.” Jacc Cardiovasc Interv 12, no. 19 (October 14, 2019): 1985–87. https://doi.org/10.1016/j.jcin.2019.07.050.
    Full Text Link to Item
  - Kwee, Lydia Coulter, Megan L. Neely, Elizabeth Grass, Simon G. Gregory, Matthew T. Roe, E Magnus Ohman, Keith A. A. Fox, et al. “Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome.” Physiol Genomics 51, no. 10 (October 1, 2019): 506–15. https://doi.org/10.1152/physiolgenomics.00033.2019.
    Full Text Link to Item
  - Ohman, E Magnus, and Ajar Kochar. “Advancing Procedural Success in Cardiogenic Shock Among Elderly Patients: How Can We Improve?” Jacc Cardiovasc Interv 12, no. 18 (September 23, 2019): 1860–62. https://doi.org/10.1016/j.jcin.2019.06.018.
    Full Text Link to Item
  - Nicolau, Jose C., Susanna R. Stevens, Hussein R. Al-Khalidi, Fabio B. Jatene, Remo H. M. Furtado, Luis A. O. Dallan, Luiz A. F. Lisboa, et al. “Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial.” Int J Cardiol 291 (September 15, 2019): 36–41. https://doi.org/10.1016/j.ijcard.2019.03.029.
    Full Text Link to Item
  - O’Neill, William W., and E Magnus Ohman. “Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".” Circulation 140, no. 11 (September 10, 2019): e557–58. https://doi.org/10.1161/CIRCULATIONAHA.119.040831.
    Full Text Link to Item
  - Thiele, Holger, E Magnus Ohman, Suzanne de Waha-Thiele, Uwe Zeymer, and Steffen Desch. “Management of cardiogenic shock complicating myocardial infarction: an update 2019.” Eur Heart J 40, no. 32 (August 21, 2019): 2671–83. https://doi.org/10.1093/eurheartj/ehz363.
    Full Text Link to Item
  - Darmon, Arthur, Emmanuel Sorbets, Gregory Ducrocq, Yedid Elbez, Jeremie Abtan, Batric Popovic, E Magnus Ohman, et al. “Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients.” J Am Coll Cardiol 73, no. 25 (July 2, 2019): 3281–91. https://doi.org/10.1016/j.jacc.2019.04.046.
    Full Text Link to Item
  - Fanaroff, Alexander C., Kristi Prather, Amanda Brucker, Daniel Wojdyla, Linda Davidson-Ray, Daniel B. Mark, Redford B. Williams, et al. “Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.” Am J Cardiol 123, no. 9 (May 1, 2019): 1399–1405. https://doi.org/10.1016/j.amjcard.2019.01.036.
    Full Text Link to Item
  - O’Neill, Brian P., Mauricio G. Cohen, Mir Babar Basir, Theodore Schreiber, Navin K. Kapur, Simon Dixon, Akshay K. Khandelwal, Cindy Grines, Erik Magnus Ohman, and William W. O’Neill. “Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry.” Am J Cardiol 123, no. 8 (April 15, 2019): 1214–19. https://doi.org/10.1016/j.amjcard.2019.01.029.
    Full Text Link to Item
  - Kaul, Padma, Karen P. Alexander, E Magnus Ohman, Anamaria Savu, Matthew T. Roe, Shaun G. Goodman, Keith A. Fox, et al. “Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.” Can J Cardiol 35, no. 4 (April 2019): 430–37. https://doi.org/10.1016/j.cjca.2018.12.035.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, Holger Thiele, W Schuyler Jones, Richard W. Smalling, Marc Cohen, Divaka Perera, Nico Pijls, et al. “Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial).” Am J Cardiol 123, no. 7 (April 1, 2019): 1026–34. https://doi.org/10.1016/j.amjcard.2018.12.027.
    Full Text Link to Item
  - Fanaroff, Alexander C., and E Magnus Ohman. “Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation.” Annu Rev Med 70 (January 27, 2019): 61–75. https://doi.org/10.1146/annurev-med-042617-092334.
    Full Text Link to Item
  - Fanaroff, Alexander C., Derek Cyr, Megan L. Neely, Jeffery Bakal, Harvey D. White, Keith A. A. Fox, Paul W. Armstrong, Renato D. Lopes, E Magnus Ohman, and Matthew T. Roe. “Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes.” Circ Cardiovasc Qual Outcomes 11, no. 12 (December 2018): e004755. https://doi.org/10.1161/CIRCOUTCOMES.118.004755.
    Full Text Link to Item
  - Collins, Megan E., Steven Rum, Jane Wheeler, Karen Antman, Henry Brem, Joseph Carrese, Michelle Glennon, et al. “Ethical Issues and Recommendations in Grateful Patient Fundraising and Philanthropy.” Acad Med 93, no. 11 (November 2018): 1631–37. https://doi.org/10.1097/ACM.0000000000002365.
    Full Text Open Access Copy Link to Item
  - Hinohara, Tomoya T., Matthew T. Roe, Harvey D. White, Keith A. A. Fox, Deepak L. Bhatt, Christian Hamm, Paul A. Gurbel, et al. “Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).” Am J Cardiol 122, no. 8 (October 15, 2018): 1322–29. https://doi.org/10.1016/j.amjcard.2018.06.052.
    Full Text Link to Item
  - Goldstein, James A., Simon R. Dixon, Pamela S. Douglas, E Magnus Ohman, Jeffrey Moses, Jeffrey J. Popma, and William W. O’Neill. “Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study.” Catheter Cardiovasc Interv 92, no. 4 (October 1, 2018): 813–17. https://doi.org/10.1002/ccd.27242.
    Full Text Link to Item
  - Marquis-Gravel, Guillaume, and E Magnus Ohman. “Left Ventricular Support.” Circ Cardiovasc Interv 11, no. 9 (September 2018): e007214. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007214.
    Full Text Link to Item
  - Yan, Andrew T., Matthew T. Roe, Megan Neely, Derek D. Cyr, Harvey White, Keith A. A. Fox, Dorairaj Prabhakaran, Paul W. Armstrong, Erik M. Ohman, and Shaun G. Goodman. “Early discontinuation of prasugrel or clopidogrel in acute coronary syndromes: insights from the TRILOGY ACS trial.” Coron Artery Dis 29, no. 6 (September 2018): 469–76. https://doi.org/10.1097/MCA.0000000000000623.
    Full Text Link to Item
  - O’Neill, William W., Cindy Grines, Theodore Schreiber, Jeffrey Moses, Brijeshwar Maini, Simon R. Dixon, and E Magnus Ohman. “Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.” Am Heart J 202 (August 2018): 33–38. https://doi.org/10.1016/j.ahj.2018.03.024.
    Full Text Link to Item
  - Bravo, Claudio A., Sameer A. Hirji, Deepak L. Bhatt, Christian Gluud, David P. Faxon, E Magnus Ohman, Tsuyoshi Kaneko, Thomas Engstrøm, Dan Eik Høfsten, and J Matthew Brennan. “Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.” Heart 104, no. 14 (July 2018): 1144–47. https://doi.org/10.1136/heartjnl-2017-312857.
    Full Text Link to Item
  - Inohara, Taku, Karen Pieper, Daniel M. Wojdyla, Manesh R. Patel, William Schuyler Jones, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.” Am Heart J 201 (July 2018): 25–32. https://doi.org/10.1016/j.ahj.2018.03.013.
    Full Text Link to Item
  - Ohman, E Magnus, and Eric J. Velazquez. “Revascularization for Heart Failure: Can We Do Better?” Jacc Heart Fail 6, no. 6 (June 2018): 527–29. https://doi.org/10.1016/j.jchf.2018.05.002.
    Full Text Link to Item
  - Ohman, E Magnus, and Manesh R. Patel. “Should a Meta-Analysis Guide Our Practice?” Jacc Cardiovasc Interv 11, no. 9 (May 14, 2018): 844–46. https://doi.org/10.1016/j.jcin.2018.03.033.
    Full Text Link to Item
  - Vetrovec, George W., Mark Anderson, Theodore Schreiber, Jeffrey Popma, William Lombardi, Brijeshwar Maini, Jacob Eifer Moller, et al. “The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure.” Am Heart J 199 (May 2018): 115–21. https://doi.org/10.1016/j.ahj.2017.09.007.
    Full Text Link to Item
  - Ohman, E Magnus. “Secondary prevention shifts into second gear.” Lancet 391, no. 10117 (January 20, 2018): 181–82. https://doi.org/10.1016/S0140-6736(17)32816-7.
    Full Text Link to Item
  - Zuhone, J. A., K. Kowalik, E. Öhman, E. Lau, and D. Nagai. “The Galaxy Cluster Merger Catalog: An Online Repository of Mock Observations from Simulated Galaxy Cluster Mergers.” Astrophysical Journal, Supplement Series 234, no. 1 (January 1, 2018). https://doi.org/10.3847/1538-4365/aa99db.
    Full Text
  - Waha, Suzanne de, Manesh R. Patel, Christopher B. Granger, E Magnus Ohman, Akiko Maehara, Ingo Eitel, Ori Ben-Yehuda, Paul Jenkins, Holger Thiele, and Gregg W. Stone. “Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.” Eur Heart J 38, no. 47 (December 14, 2017): 3502–10. https://doi.org/10.1093/eurheartj/ehx414.
    Full Text Link to Item
  - Hirji, Sameer A., Susanna R. Stevens, Linda K. Shaw, Erin C. Campbell, Christopher B. Granger, Manesh R. Patel, Michael H. Sketch, et al. “Predicting risk of cardiac events among ST-segment elevation myocardial infarction patients with conservatively managed non-infarct-related artery coronary artery disease: An analysis of the Duke Databank for Cardiovascular Disease.” Am Heart J 194 (December 2017): 116–24. https://doi.org/10.1016/j.ahj.2017.08.023.
    Full Text Link to Item
  - Diepen, Sean van, Jason N. Katz, Nancy M. Albert, Timothy D. Henry, Alice K. Jacobs, Navin K. Kapur, Ahmet Kilic, et al. “Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association.” Circulation 136, no. 16 (October 17, 2017): e232–68. https://doi.org/10.1161/CIR.0000000000000525.
    Full Text Link to Item
  - Fanaroff, Alexander C., Vic Hasselblad, Matthew T. Roe, Deepak L. Bhatt, Stefan K. James, Ph Gabriel Steg, C Michael Gibson, and E Magnus Ohman. “Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis.” Int J Cardiol 241 (August 15, 2017): 87–96. https://doi.org/10.1016/j.ijcard.2017.03.046.
    Full Text Link to Item
  - Alfredsson, Joakim, Benjamin Neely, Megan L. Neely, Deepak L. Bhatt, Shaun G. Goodman, Pierluigi Tricoci, Kenneth W. Mahaffey, et al. “Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.” Heart 103, no. 15 (August 2017): 1168–76. https://doi.org/10.1136/heartjnl-2016-310090.
    Full Text Link to Item
  - Chan, Mark Y., Megan L. Neely, Matthew T. Roe, Shaun G. Goodman, David Erlinge, Jan H. Cornel, Kenneth J. Winters, et al. “Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.” Clin Chem 63, no. 7 (July 2017): 1214–26. https://doi.org/10.1373/clinchem.2016.265272.
    Full Text Link to Item
  - Posenau, J Trevor, Daniel M. Wojdyla, Linda K. Shaw, Karen P. Alexander, E Magnus Ohman, Manesh R. Patel, Peter K. Smith, and Sunil V. Rao. “Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease.” Ann Thorac Surg 104, no. 1 (July 2017): 107–15. https://doi.org/10.1016/j.athoracsur.2016.10.053.
    Full Text Link to Item
  - Brener, Sorin J., Roxana Mehran, George D. Dangas, Edwin Magnus Ohman, Bernhard Witzenbichler, Yiran Zhang, Rupa Parvataneni, and Gregg W. Stone. “Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).” Am J Cardiol 119, no. 11 (June 1, 2017): 1710–16. https://doi.org/10.1016/j.amjcard.2017.02.052.
    Full Text Link to Item
  - Dalby, Anthony J., Shmuel Gottlieb, Derek D. Cyr, Erik Magnus Ohman, Darren K. McGuire, Witold Ruzyllo, Deepak L. Bhatt, et al. “Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.” Am Heart J 188 (June 2017): 156–66. https://doi.org/10.1016/j.ahj.2017.03.015.
    Full Text Link to Item
  - Selker, Harry P., James E. Udelson, Robin Ruthazer, Ralph B. D’Agostino, Melissa Nichols, Ori Ben-Yehuda, Ingo Eitel, et al. “Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trials.” Am Heart J 188 (June 2017): 18–25. https://doi.org/10.1016/j.ahj.2017.02.028.
    Full Text Link to Item
  - Wang, Alice, Lydia Coulter Kwee, Elizabeth Grass, Megan L. Neely, Simon G. Gregory, Keith A. A. Fox, Paul W. Armstrong, et al. “Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.” Atherosclerosis 261 (June 2017): 19–25. https://doi.org/10.1016/j.atherosclerosis.2017.03.041.
    Full Text Link to Item
  - Kosmidou, Ioanna, Björn Redfors, Harry P. Selker, Holger Thiele, Manesh R. Patel, James E. Udelson, E. Magnus Ohman, et al. “Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.” Eur Heart J 38, no. 21 (June 1, 2017): 1656–63. https://doi.org/10.1093/eurheartj/ehx159.
    Full Text Link to Item
  - Fanaroff, Alexander C., Stefan K. James, Giora Weisz, Kristi Prather, Kevin J. Anstrom, Daniel B. Mark, Ori Ben-Yehuda, Karen P. Alexander, Gregg W. Stone, and E Magnus Ohman. “Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.” J Am Coll Cardiol 69, no. 18 (May 9, 2017): 2304–13. https://doi.org/10.1016/j.jacc.2017.02.056.
    Full Text Link to Item
  - Ohman, E Magnus, Matthew T. Roe, P Gabriel Steg, Stefan K. James, Thomas J. Povsic, Jennifer White, Frank Rockhold, et al. “Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.” Lancet 389, no. 10081 (May 6, 2017): 1799–1808. https://doi.org/10.1016/S0140-6736(17)30751-1.
    Full Text Open Access Copy Link to Item
  - Bravo, Claudio A., Sameer A. Hirji, Deepak L. Bhatt, Rachna Kataria, David P. Faxon, E Magnus Ohman, Kevin L. Anderson, et al. “Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.” Cochrane Database Syst Rev 5 (May 3, 2017): CD011986. https://doi.org/10.1002/14651858.CD011986.pub2.
    Full Text Link to Item
  - Hess, Connie N., Robert M. Clare, Megan L. Neely, Pierluigi Tricoci, Kenneth W. Mahaffey, Stefan K. James, John H. Alexander, et al. “Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome.” Am Heart J 187 (May 2017): 194–203. https://doi.org/10.1016/j.ahj.2017.01.016.
    Full Text Link to Item
  - Lau, Emily S., Eugene Braunwald, Sabina A. Murphy, Stephen D. Wiviott, Marc P. Bonaca, Steen Husted, Stefan K. James, et al. “Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials.” J Am Coll Cardiol 69, no. 12 (March 28, 2017): 1549–59. https://doi.org/10.1016/j.jacc.2017.01.028.
    Full Text Link to Item
  - Basir, Mir B., Theodore L. Schreiber, Cindy L. Grines, Simon R. Dixon, Jeffrey W. Moses, Brijeshwar S. Maini, Akshay K. Khandelwal, E Magnus Ohman, and William W. O’Neill. “Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock.” The American Journal of Cardiology 119, no. 6 (March 2017): 845–51. https://doi.org/10.1016/j.amjcard.2016.11.037.
    Full Text
  - Welsh, Robert C., Matthew T. Roe, Philippe Gabriel Steg, Stefan James, Thomas J. Povsic, Christoph Bode, Charles Michael Gibson, and Erik Magnus Ohman. “Corrigendum to "A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease" [Am Heart J 181 (2016) 92-100].” Am Heart J 184 (February 2017): 156. https://doi.org/10.1016/j.ahj.2017.01.004.
    Full Text Link to Item
  - Ohman, E Magnus. “Redefining the Gold Standard of Myocardial Infarction Using Troponin T.” Clin Chem 63, no. 1 (January 2017): 429–30. https://doi.org/10.1373/clinchem.2016.267047.
    Full Text Link to Item
  - Baber, Usman, George Dangas, David J. Cohen, C Michael Gibson, Shamir R. Mehta, Dominick J. Angiolillo, Stuart J. Pocock, et al. “Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.” Am Heart J 182 (December 2016): 125–34. https://doi.org/10.1016/j.ahj.2016.09.006.
    Full Text Link to Item
  - Schoos, Mikkel M., Roxana Mehran, George D. Dangas, Jennifer Yu, Usman Baber, Peter Clemmensen, Frederick Feit, et al. “Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes.” Am J Cardiol 118, no. 11 (December 1, 2016): 1661–68. https://doi.org/10.1016/j.amjcard.2016.08.046.
    Full Text Link to Item
  - Shah, Rohan, Robert M. Clare, Karen Chiswell, W Schuyler Jones, A Sreenivas Kumar, Holger Thiele, Richard W. Smalling, et al. “Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).” Am J Med 129, no. 12 (December 2016): 1307–15. https://doi.org/10.1016/j.amjmed.2016.07.011.
    Full Text Link to Item
  - Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Joseph A. Jakubowski, Deepak L. Bhatt, Harvey D. White, Diego Ardissino, et al. “Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.” J Am Heart Assoc 5, no. 11 (November 4, 2016). https://doi.org/10.1161/JAHA.116.003977.
    Full Text Open Access Copy Link to Item
  - Granger, Christopher B., and E Magnus Ohman. “Enhancing the value of clinical trials: the role of data sharing.” Nat Rev Cardiol 13, no. 11 (November 2016): 629–30. https://doi.org/10.1038/nrcardio.2016.146.
    Full Text Link to Item
  - Kosmidou, Ioanna, Bjorn Redfors, Rushad Dordi, Ulrich Schaefer, Holger Thiele, Manesh Patel, James Udelson, et al. “TCT-2 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B1. https://doi.org/10.1016/j.jacc.2016.09.008.
    Full Text Link to Item
  - Maini, Brijeshwar, Jeffrey Moses, Simon Dixon, Mark Anderson, William Lombardi, Jacob Eifer Møller, Jose Henriques, et al. “TCT-24 Global cVAD Registry: A global initiative in percutaneous circulatory support From the cVAD Steering Committee on behalf of all cVAD Investigators.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B10. https://doi.org/10.1016/j.jacc.2016.09.900.
    Full Text Link to Item
  - Redfors, Bjorn, Ioanna Kosmidou, Rushad Dordi, Ulrich Schaefer, Holger Thiele, Manesh Patel, James Udelson, et al. “TCT-168 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Left Ventricular Morphology and Cardiac Function: A Collaborative Patient-Level Pooled Analysis from 9 Randomized Trials.” J Am Coll Cardiol 68, no. 18S (November 1, 2016): B69. https://doi.org/10.1016/j.jacc.2016.09.310.
    Full Text Link to Item
  - Welsh, Robert C., Matthew T. Roe, Philippe Gabriel Steg, Stefan James, Thomas J. Povsic, Christoph Bode, Charles Michael Gibson, and Erik Magnus Ohman. “A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.” Am Heart J 181 (November 2016): 92–100. https://doi.org/10.1016/j.ahj.2016.08.008.
    Full Text Link to Item
  - Ohman, E Magnus, Pamela S. Douglas, L Blue Dean, and Geoffrey S. Ginsburg. “Philanthropy for Science: Is It a Viable Option?” Circ Res 119, no. 10 (October 28, 2016): 1057–59. https://doi.org/10.1161/CIRCRESAHA.116.309657.
    Full Text Link to Item
  - Eisen, Alon, Deepak L. Bhatt, P Gabriel Steg, Kim A. Eagle, Shinya Goto, Jianping Guo, Sidney C. Smith, E Magnus Ohman, Benjamin M. Scirica, and Benjamin M. REACH Registry Investigators. “Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.” J Am Heart Assoc 5, no. 10 (September 28, 2016). https://doi.org/10.1161/JAHA.116.004080.
    Full Text Open Access Copy Link to Item
  - Doll, Jacob A., E Magnus Ohman, Manesh R. Patel, Carmelo A. Milano, Joseph G. Rogers, David H. Wohns, Navin K. Kapur, and Sunil V. Rao. “A team-based approach to patients in cardiogenic shock.” Catheter Cardiovasc Interv 88, no. 3 (September 2016): 424–33. https://doi.org/10.1002/ccd.26297.
    Full Text Link to Item
  - Jackson, Larry R., Jonathan P. Piccini, Derek D. Cyr, Matthew T. Roe, Megan L. Neely, Felipe Martinez, Thomas F. Lüscher, et al. “Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial.” Clin Cardiol 39, no. 9 (September 2016): 497–506. https://doi.org/10.1002/clc.22562.
    Full Text Link to Item
  - Atkinson, Tamara M., E Magnus Ohman, William W. O’Neill, Tanveer Rab, and Joaquin E. Cigarroa. “Reply: High-Risk Percutaneous Coronary Interventions: First, Do No Harm.” Jacc Cardiovasc Interv 9, no. 16 (August 22, 2016): 1753–54. https://doi.org/10.1016/j.jcin.2016.06.039.
    Full Text Link to Item
  - Selvaraj, Senthil, Ph Gabriel Steg, Yedid Elbez, Emmanuel Sorbets, Laurent J. Feldman, Kim A. Eagle, E Magnus Ohman, Jacques Blacher, and Deepak L. Bhatt. “Reply: Mean Arterial Pressure Estimation by a Non-Traditional Formula and Fractional Pulse Pressure.” J Am Coll Cardiol 68, no. 6 (August 9, 2016): 669. https://doi.org/10.1016/j.jacc.2016.05.051.
    Full Text Link to Item
  - Kong, David F., and E Magnus Ohman. “Chronic Total Coronary Occlusions, Percutaneous Coronary Intervention, and Mortality: A "Hybrid Approach" to Interpretation.” Jacc Cardiovasc Interv 9, no. 15 (August 8, 2016): 1545–47. https://doi.org/10.1016/j.jcin.2016.06.009.
    Full Text Link to Item
  - Kirtane, Ajay J., Darshan Doshi, Martin B. Leon, John M. Lasala, E Magnus Ohman, William W. O’Neill, Adhir Shroff, et al. “Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.” Circulation 134, no. 5 (August 2, 2016): 422–31. https://doi.org/10.1161/CIRCULATIONAHA.116.022061.
    Full Text Link to Item
  - Chin, Chee Tang, William E. Boden, Matthew T. Roe, Benjamin Neely, Megan L. Neely, Jose L. Leiva-Pons, Ramón Corbalán, et al. “Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients.” Heart 102, no. 15 (August 1, 2016): 1221–29. https://doi.org/10.1136/heartjnl-2015-308840.
    Full Text Link to Item
  - Kaul, Padma, E Magnus Ohman, J David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, et al. “Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Am Heart J 178 (August 2016): 55–64. https://doi.org/10.1016/j.ahj.2016.03.017.
    Full Text Link to Item
  - Ohman, E Magnus. “Chronic Stable Angina.” N Engl J Med 375, no. 3 (July 21, 2016): 293. https://doi.org/10.1056/NEJMc1605394.
    Full Text Link to Item
  - Selvaraj, Senthil, P Gabriel Steg, Yedid Elbez, Emmanuel Sorbets, Laurent J. Feldman, Kim A. Eagle, E Magnus Ohman, Jacques Blacher, and Deepak L. Bhatt. “Reply: Pulse Pressure and Cardiovascular Death.” J Am Coll Cardiol 68, no. 1 (July 5, 2016): 132–33. https://doi.org/10.1016/j.jacc.2016.04.020.
    Full Text Link to Item
  - Hagström, Emil, Matthew T. Roe, Gail Hafley, Megan L. Neely, Mandeep S. Sidhu, Kenneth J. Winters, Dorairaj Prabhakaran, et al. “Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.” Clin Cardiol 39, no. 6 (June 2016): 329–37. https://doi.org/10.1002/clc.22533.
    Full Text Link to Item
  - White, Harvey D., Cynthia M. Westerhout, Karen P. Alexander, Matthew T. Roe, Kenneth J. Winters, Derek D. Cyr, Keith Aa Fox, et al. “Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Eur Heart J Acute Cardiovasc Care 5, no. 3 (June 2016): 231–42. https://doi.org/10.1177/2048872615581502.
    Full Text Link to Item
  - Atkinson, Tamara M., E Magnus Ohman, William W. O’Neill, Tanveer Rab, Joaquin E. Cigarroa, and Joaquin E. Interventional Scientific Council of the American College of Cardiology. “A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective.” Jacc Cardiovasc Interv 9, no. 9 (May 9, 2016): 871–83. https://doi.org/10.1016/j.jcin.2016.02.046.
    Full Text Link to Item
  - Cohen, Mauricio G., and E Magnus Ohman. “Should the Benefit of Transradial Access Still Be Questioned?” Jacc Cardiovasc Interv 9, no. 9 (May 9, 2016): 908–10. https://doi.org/10.1016/j.jcin.2016.03.020.
    Full Text Link to Item
  - Alexander, Karen P., Olena Stadnyuk, Suzanne V. Arnold, Daniel B. Mark, E Magnus Ohman, and Kevin J. Anstrom. “Assessing Quality of Life and Medical Care in Chronic Angina: An Internet Survey.” Interact J Med Res 5, no. 2 (April 28, 2016): e12. https://doi.org/10.2196/ijmr.4971.
    Full Text Link to Item
  - Stone, Gregg W., Harry P. Selker, Holger Thiele, Manesh R. Patel, James E. Udelson, E Magnus Ohman, Akiko Maehara, et al. “Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.” J Am Coll Cardiol 67, no. 14 (April 12, 2016): 1674–83. https://doi.org/10.1016/j.jacc.2016.01.069.
    Full Text Link to Item
  - Chin, Chee Tang, Benjamin Neely, E. Magnus Ohman, Paul W. Armstrong, Ramón Corbalán, Harvey D. White, Dorairaj Prabhakaran, et al. “Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.” Stroke 47, no. 4 (April 2016): 1135–39. https://doi.org/10.1161/STROKEAHA.115.012454.
    Full Text Link to Item
  - Hess, Paul L., Daniel M. Wojdyla, Sana M. Al-Khatib, Yuliya Lokhnygina, Lars Wallentin, Paul W. Armstrong, Matthew T. Roe, et al. “Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome.” Jama Cardiol 1, no. 1 (April 1, 2016): 73–79. https://doi.org/10.1001/jamacardio.2015.0359.
    Full Text Link to Item
  - Povsic, Thomas J., Matthew T. Roe, Erik Magnus Ohman, Philippe Gabriel Steg, Stefan James, Alexei Plotnikov, Hardi Mundl, Robert Welsh, Christoph Bode, and Charles Michael Gibson. “A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study.” Am Heart J 174 (April 2016): 120–28. https://doi.org/10.1016/j.ahj.2016.01.004.
    Full Text Link to Item
  - Zimerman, André, Renato D. Lopes, Amanda L. Stebbins, Patrícia O. Guimarães, Ghazala Haque, Chiara Melloni, Kathleen Trollinger, et al. “Pooled analysis of adverse event collection from 4 acute coronary syndrome trials.” Am Heart J 174 (April 2016): 60–67. https://doi.org/10.1016/j.ahj.2016.01.003.
    Full Text Link to Item
  - Kohl, Louis P., Jeffrey D. Leimberger, Karen Chiswell, W Schuyler Jones, Holger Thiele, Richard W. Smalling, Praveen Chandra, et al. “Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.” Am Heart J 174 (April 2016): 7–13. https://doi.org/10.1016/j.ahj.2015.12.004.
    Full Text Link to Item
  - Ohman, E Magnus. “CLINICAL PRACTICE. Chronic Stable Angina.” N Engl J Med 374, no. 12 (March 24, 2016): 1167–76. https://doi.org/10.1056/NEJMcp1502240.
    Full Text Link to Item
  - Lopes, Renato D., Sergio Leonardi, Benjamin Neely, Megan L. Neely, E Magnus Ohman, Diego Ardissino, Christian W. Hamm, et al. “Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial.” J Am Coll Cardiol 67, no. 11 (March 22, 2016): 1289–97. https://doi.org/10.1016/j.jacc.2016.01.034.
    Full Text Link to Item
  - Levine, Glenn N., Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, et al. “2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.” Circulation 133, no. 11 (March 15, 2016): 1135–47. https://doi.org/10.1161/CIR.0000000000000336.
    Full Text Link to Item
  - Doll, Jacob A., Megan L. Neely, Matthew T. Roe, Paul W. Armstrong, Harvey D. White, Dorairaj Prabhakaran, Kenneth J. Winters, et al. “Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.” J Am Coll Cardiol 67, no. 8 (March 1, 2016): 936–47. https://doi.org/10.1016/j.jacc.2015.12.036.
    Full Text Link to Item
  - 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH THORACIC AORTIC DISEASE REPRESENTATIVE MEMBERS*, Duminda N., Loren F. Hiratzka, Mark A. Creager, Eric M. Isselbacher, Lars G. Svensson, Lars G. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Representative Members*, Rick A. Nishimura, et al. “Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” Circulation 133, no. 7 (February 16, 2016): 680–86. https://doi.org/10.1161/CIR.0000000000000331.
    Full Text Link to Item
  - Selvaraj, Senthil, Ph Gabriel Steg, Yedid Elbez, Emmanuel Sorbets, Laurent J. Feldman, Kim A. Eagle, E Magnus Ohman, Jacques Blacher, Deepak L. Bhatt, and Deepak L. REACH Registry Investigators. “Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry.” J Am Coll Cardiol 67, no. 4 (February 2, 2016): 392–403. https://doi.org/10.1016/j.jacc.2015.10.084.
    Full Text Link to Item
  - Roe, Matthew T., Derek D. Cyr, Debra Eckart, Phillip J. Schulte, Michael A. Morse, Kimberly L. Blackwell, Neal E. Ready, et al. “Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.” Eur Heart J 37, no. 4 (January 21, 2016): 412–22. https://doi.org/10.1093/eurheartj/ehv611.
    Full Text Link to Item
  - Weisz, Giora, Philippe Généreux, Andres Iñiguez, Aleksander Zurakowski, Michael Shechter, Karen P. Alexander, Ovidiu Dressler, et al. “Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.” Lancet 387, no. 10014 (January 9, 2016): 136–45. https://doi.org/10.1016/S0140-6736(15)00459-6.
    Full Text Link to Item
  - Alexander, Karen P., Giora Weisz, Kristi Prather, Stefan James, Daniel B. Mark, Kevin J. Anstrom, Linda Davidson-Ray, et al. “Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.” Circulation 133, no. 1 (January 5, 2016): 39–47. https://doi.org/10.1161/CIRCULATIONAHA.115.019768.
    Full Text Link to Item
  - Ohman, E Magnus, and Matthew T. Roe. “Excess of Solid Cancers After Prasugrel: The Food and Drug Administration Outlook.” Am J Ther 23, no. 1 (January 2016): e243–44. https://doi.org/10.1097/MJT.0b013e31824ea5f9.
    Full Text Link to Item
  - Hirji, S. A., C. A. Bravo, R. E. Pachon, D. P. Faxon, E. M. Ohman, K. L. Anderson, A. I. Sidi, M. H. Sketch, S. W. Zarich, and J. M. Brennan. “Early invasive versus conservative strategy for non-infarct related artery lesions in ST elevation myocardial infarction with multi-vessel disease.” Cochrane Database of Systematic Reviews 2015, no. 12 (December 17, 2015). https://doi.org/10.1002/14651858.CD011986.
    Full Text
  - Cohen, Mauricio G., Ray Matthews, Brij Maini, Simon Dixon, George Vetrovec, David Wohns, Igor Palacios, et al. “Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.” Am Heart J 170, no. 5 (November 2015): 872–79. https://doi.org/10.1016/j.ahj.2015.08.009.
    Full Text Link to Item
  - Newby, L Kristin, and E Magnus Ohman. “Biomarkers: Troponin testing--risk stratification to stratified medicine.” Nat Rev Cardiol 12, no. 11 (November 2015): 625–26. https://doi.org/10.1038/nrcardio.2015.157.
    Full Text Link to Item
  - Mennuni, Marco G., George D. Dangas, Roxana Mehran, Yanai Ben-Gal, Ke Xu, Philippe Généreux, Sorin J. Brener, et al. “Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial.” J Invasive Cardiol 27, no. 10 (October 2015): 468–73.
    Link to Item
  - Clemmensen, Peter, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire, Jan H. Cornel, et al. “Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.” Am Heart J 170, no. 4 (October 2015): 695-705.e5. https://doi.org/10.1016/j.ahj.2015.06.011.
    Full Text Link to Item
  - Nicolau, Jose Carlos, Deepak L. Bhatt, Matthew T. Roe, Yuliya Lokhnygina, Benjamin Neely, Ramón Corbalán, José L. Leiva-Pons, et al. “Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.” American Heart Journal 170, no. 4 (October 2015): 683-694.e3. https://doi.org/10.1016/j.ahj.2015.05.017.
    Full Text
  - Cavender, Matthew A., Ph Gabriel Steg, Sidney C. Smith, Kim Eagle, E Magnus Ohman, Shinya Goto, Julia Kuder, et al. “Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.” Circulation 132, no. 10 (September 8, 2015): 923–31. https://doi.org/10.1161/CIRCULATIONAHA.114.014796.
    Full Text Link to Item
  - Daubert, Melissa A., Joseph Massaro, Lawrence Liao, Ashish Pershad, Suresh Mulukutla, Erik Magnus Ohman, Jeffrey Popma, William W. O’Neill, and Pamela S. Douglas. “High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.” Am Heart J 170, no. 3 (September 2015): 550–58. https://doi.org/10.1016/j.ahj.2015.06.013.
    Full Text Link to Item
  - Husted, Steen E., and E Magnus Ohman. “Pharmacological and emerging therapies in the treatment of chronic angina.” Lancet 386, no. 9994 (August 15, 2015): 691–701. https://doi.org/10.1016/S0140-6736(15)61283-1.
    Full Text Link to Item
  - Patel, Manesh R., and E Magnus Ohman. “The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited?” J Am Coll Cardiol 66, no. 5 (August 4, 2015): 521–23. https://doi.org/10.1016/j.jacc.2015.06.024.
    Full Text Link to Item
  - Kragholm, Kristian, Sharif A. Halim, Qinghong Yang, Phillip J. Schulte, Judith S. Hochman, Chiara Melloni, Kenneth W. Mahaffey, et al. “Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.” Circ Cardiovasc Qual Outcomes 8, no. 4 (July 2015): 357–67. https://doi.org/10.1161/CIRCOUTCOMES.114.001615.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Rebecca Hager, Daniel Wojdyla, Harvey D. White, Paul W. Armstrong, John H. Alexander, Pierluigi Tricoci, et al. “Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes.” J Am Heart Assoc 4, no. 6 (June 18, 2015): e001512. https://doi.org/10.1161/JAHA.114.001512.
    Full Text Link to Item
  - Ben-Gal, Yanai, Rephael Mohr, Frederick Feit, E Magnus Ohman, Ajay Kirtane, Ke Xu, Roxana Mehran, and Gregg W. Stone. “Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial.” Circ Cardiovasc Interv 8, no. 6 (June 2015). https://doi.org/10.1161/CIRCINTERVENTIONS.114.002032.
    Full Text Link to Item
  - Thiele, Holger, E Magnus Ohman, Steffen Desch, Ingo Eitel, and Suzanne de Waha. “Management of cardiogenic shock.” Eur Heart J 36, no. 20 (May 21, 2015): 1223–30. https://doi.org/10.1093/eurheartj/ehv051.
    Full Text Link to Item
  - Mehta, Rajendra H., Anita Y. Chen, Karen P. Alexander, E Magnus Ohman, Matthew T. Roe, and Eric D. Peterson. “Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome.” Circulation 131, no. 11 (March 17, 2015): 980–87. https://doi.org/10.1161/CIRCULATIONAHA.114.013451.
    Full Text Link to Item
  - Fihn, Stephan D., James C. Blankenship, Karen P. Alexander, John A. Bittl, John G. Byrne, Barbara J. Fletcher, Gregg C. Fonarow, et al. “2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.” J Thorac Cardiovasc Surg 149, no. 3 (March 2015): e5-23. https://doi.org/10.1016/j.jtcvs.2014.11.002.
    Full Text Link to Item
  - Warren, Josephine, Roxana Mehran, Jennifer Yu, Ke Xu, Michel E. Bertrand, David A. Cox, A Michael Lincoff, et al. “Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction.” Am J Cardiol 115, no. 4 (February 15, 2015): 428–33. https://doi.org/10.1016/j.amjcard.2014.11.023.
    Full Text Link to Item
  - Bakal, Jeffrey A., Matthew T. Roe, E Magnus Ohman, Shaun G. Goodman, Keith A. A. Fox, Yinggan Zheng, Cynthia M. Westerhout, et al. “Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial.” Eur Heart J 36, no. 6 (February 7, 2015): 385-92a. https://doi.org/10.1093/eurheartj/ehu262.
    Full Text Link to Item
  - Roy, Ambuj, Matthew T. Roe, Megan L. Neely, Derek D. Cyr, Dmitry Zamoryakhin, Keith A. A. Fox, Harvey D. White, Paul W. Armstrong, E Magnus Ohman, and Dorairaj Prabhakaran. “Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome.” Heart 101, no. 4 (February 2015): 279–86. https://doi.org/10.1136/heartjnl-2014-306389.
    Full Text Link to Item
  - Povsic, Thomas J., Samuel Broderick, Kevin J. Anstrom, Linda K. Shaw, E Magnus Ohman, Eric L. Eisenstein, Peter K. Smith, and John H. Alexander. “Predictors of long-term clinical endpoints in patients with refractory angina.” J Am Heart Assoc 4, no. 2 (January 30, 2015). https://doi.org/10.1161/JAHA.114.001287.
    Full Text Link to Item
  - Henriques, José P. S., Bimmer E. Claessen, George D. Dangas, Ajay J. Kirtane, Jeffrey J. Popma, Joseph M. Massaro, Barry M. Cohen, E Magnus Ohman, Jeffrey W. Moses, and William W. O’Neill. “Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial.” Int J Cardiol 189 (2015): 272–78. https://doi.org/10.1016/j.ijcard.2015.04.084.
    Full Text Link to Item
  - Jones, W Schuyler, Robert M. Clare, Karen Chiswell, Divaka Perera, John K. French, A Sreenivas Kumar, Jonathan Blaxill, et al. “The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial.” Clin Cardiol 38, no. 1 (January 2015): 25–31. https://doi.org/10.1002/clc.22349.
    Full Text Link to Item
  - Amsterdam, Ezra A., Nanette K. Wenger, Ralph G. Brindis, Donald E. Casey, Theodore G. Ganiats, David R. Holmes, Allan S. Jaffe, et al. “2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 130, no. 25 (December 23, 2014): e344–426. https://doi.org/10.1161/CIR.0000000000000134.
    Full Text Link to Item
  - Amsterdam, Ezra A., Nanette K. Wenger, Ralph G. Brindis, Donald E. Casey, Theodore G. Ganiats, David R. Holmes, Allan S. Jaffe, et al. “2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 130, no. 25 (December 23, 2014): 2354–94. https://doi.org/10.1161/CIR.0000000000000133.
    Full Text Link to Item
  - Wijeysundera, Duminda N., Dallas Duncan, Chileshe Nkonde-Price, Salim S. Virani, Jeffrey B. Washam, Kirsten E. Fleischmann, Lee A. Fleisher, and Lee A. ACC/AHA Task Force Members. “Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 130, no. 24 (December 9, 2014): 2246–64. https://doi.org/10.1161/CIR.0000000000000104.
    Full Text Link to Item
  - Fleisher, Lee A., Kirsten E. Fleischmann, Andrew D. Auerbach, Susan A. Barnason, Joshua A. Beckman, Biykem Bozkurt, Victor G. Davila-Roman, et al. “2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 130, no. 24 (December 9, 2014): e278–333. https://doi.org/10.1161/CIR.0000000000000106.
    Full Text Link to Item
  - Fleisher, Lee A., Kirsten E. Fleischmann, Andrew D. Auerbach, Susan A. Barnason, Joshua A. Beckman, Biykem Bozkurt, Victor G. Davila-Roman, et al. “2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 130, no. 24 (December 9, 2014): 2215–45. https://doi.org/10.1161/CIR.0000000000000105.
    Full Text Link to Item
  - January, Craig T., L Samuel Wann, Joseph S. Alpert, Hugh Calkins, Joaquin E. Cigarroa, Joseph C. Cleveland, Jamie B. Conti, et al. “2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.” Circulation 130, no. 23 (December 2, 2014): e199–267. https://doi.org/10.1161/CIR.0000000000000041.
    Full Text Link to Item
  - January, Craig T., L Samuel Wann, Joseph S. Alpert, Hugh Calkins, Joaquin E. Cigarroa, Joseph C. Cleveland, Jamie B. Conti, et al. “2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.” Circulation 130, no. 23 (December 2, 2014): 2071–2104. https://doi.org/10.1161/CIR.0000000000000040.
    Full Text Link to Item
  - Goto, Kenji, Alexandra J. Lansky, Vivian G. Ng, Cody Pietras, Erol Nargileci, Roxana Mehran, Helen Parise, et al. “Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial).” Am J Cardiol 114, no. 11 (December 1, 2014): 1638–45. https://doi.org/10.1016/j.amjcard.2014.09.003.
    Full Text Link to Item
  - Udell, Jacob A., Ph Gabriel Steg, Benjamin M. Scirica, Kim A. Eagle, E Magnus Ohman, Shinya Goto, Alawi A. Alsheikh-Ali, et al. “Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.” Eur J Prev Cardiol 21, no. 12 (December 2014): 1531–40. https://doi.org/10.1177/2047487313500541.
    Full Text Link to Item
  - Park, Duk-Woo, Robert M. Clare, Phillip J. Schulte, Karen S. Pieper, Linda K. Shaw, Robert M. Califf, E Magnus Ohman, et al. “Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction.” Jama 312, no. 19 (November 19, 2014): 2019–27. https://doi.org/10.1001/jama.2014.15095.
    Full Text Link to Item
  - Fihn, Stephan D., James C. Blankenship, Karen P. Alexander, John A. Bittl, John G. Byrne, Barbara J. Fletcher, Gregg C. Fonarow, et al. “2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.” J Am Coll Cardiol 64, no. 18 (November 4, 2014): 1929–49. https://doi.org/10.1016/j.jacc.2014.07.017.
    Full Text Link to Item
  - Fihn, Stephan D., James C. Blankenship, Karen P. Alexander, John A. Bittl, John G. Byrne, Barbara J. Fletcher, Gregg C. Fonarow, et al. “2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.” Circulation 130, no. 19 (November 4, 2014): 1749–67. https://doi.org/10.1161/CIR.0000000000000095.
    Full Text Link to Item
  - Huber, Kurt, Eric R. Bates, Marco Valgimigli, Lars Wallentin, Steen Dalby Kristensen, Jeffrey L. Anderson, Jose Luis Lopez Sendon, et al. “Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?” Am Heart J 168, no. 5 (November 2014): 611–21. https://doi.org/10.1016/j.ahj.2014.06.014.
    Full Text Link to Item
  - Kumbhani, Dharam J., Ph Gabriel Steg, Christopher P. Cannon, Kim A. Eagle, Sidney C. Smith, Shinya Goto, E Magnus Ohman, et al. “Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.” Eur Heart J 35, no. 41 (November 1, 2014): 2864–72. https://doi.org/10.1093/eurheartj/ehu080.
    Full Text Link to Item
  - Wallentin, Lars, Steen Dalby Kristensen, Jeffrey L. Anderson, Marco Tubaro, José Luis Lopez Sendon, Christopher B. Granger, Christoph Bode, et al. “How can we optimize the processes of care for acute coronary syndromes to improve outcomes?” Am Heart J 168, no. 5 (November 2014): 622–31. https://doi.org/10.1016/j.ahj.2014.07.006.
    Full Text Link to Item
  - Magnus Ohman, E. “My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices.” Trends Cardiovasc Med 24, no. 7 (October 2014): 316–17. https://doi.org/10.1016/j.tcm.2014.06.007.
    Full Text Link to Item
  - Jacobs, Alice K., Jeffrey L. Anderson, Jonathan L. Halperin, Jonathan L. ACC/AHA TASK FORCE MEMBERS, Nancy M. Albert, Biykem Bozkurt, Ralph G. Brindis, et al. “The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.” Circulation 130, no. 14 (September 30, 2014): 1208–17. https://doi.org/10.1161/CIR.0000000000000090.
    Full Text Link to Item
  - Ohman, E Magnus, and Karen P. Alexander. “The challenges with chronic angina.” N Engl J Med 371, no. 12 (September 18, 2014): 1152–53. https://doi.org/10.1056/NEJMe1409369.
    Full Text Link to Item
  - McDonough, Ryan, and E Magnus Ohman. “The use of aortic counterpulsation in United States: what can we learn from administrative databases?” Am Heart J 168, no. 3 (September 2014): 237–38. https://doi.org/10.1016/j.ahj.2014.05.013.
    Full Text Link to Item
  - Pershad, Ashish, Ghassan Fraij, Joseph M. Massaro, Shukri W. David, Neal S. Kleiman, Ali E. Denktas, B Hadley Wilson, et al. “Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study).” Am J Cardiol 114, no. 5 (September 1, 2014): 657–64. https://doi.org/10.1016/j.amjcard.2014.05.055.
    Full Text Link to Item
  - Nishimura, Rick A., Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Robert A. Guyton, Patrick T. O’Gara, et al. “2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” J Thorac Cardiovasc Surg 148, no. 1 (July 2014): e1–132. https://doi.org/10.1016/j.jtcvs.2014.05.014.
    Full Text Link to Item
  - Nishimura, Rick A., Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Robert A. Guyton, Patrick T. O’Gara, et al. “2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 129, no. 23 (June 10, 2014): e521–643. https://doi.org/10.1161/CIR.0000000000000031.
    Full Text Link to Item
  - Nishimura, Rick A., Catherine M. Otto, Robert O. Bonow, Blase A. Carabello, John P. Erwin, Robert A. Guyton, Patrick T. O’Gara, et al. “2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” Circulation 129, no. 23 (June 10, 2014): 2440–92. https://doi.org/10.1161/CIR.0000000000000029.
    Full Text Link to Item
  - Ohman, E Magnus, and Ralf E. Harskamp. “We need to do better for patients with non-ST-segment elevation acute coronary syndrome who are managed without revascularization.” J Am Coll Cardiol 63, no. 21 (June 3, 2014): 2258–60. https://doi.org/10.1016/j.jacc.2014.03.009.
    Full Text Link to Item
  - Anderson, Jeffrey L., Paul A. Heidenreich, Paul G. Barnett, Mark A. Creager, Gregg C. Fonarow, Raymond J. Gibbons, Jonathan L. Halperin, et al. “ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.” Circulation 129, no. 22 (June 3, 2014): 2329–45. https://doi.org/10.1161/CIR.0000000000000042.
    Full Text Link to Item
  - Cohen, Mauricio G., Abhijit Ghatak, Neal S. Kleiman, Srihari S. Naidu, Joseph M. Massaro, Ajay J. Kirtane, Jeffrey Moses, et al. “Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study.” Catheter Cardiovasc Interv 83, no. 7 (June 1, 2014): 1057–64. https://doi.org/10.1002/ccd.25277.
    Full Text Link to Item
  - Planer, David, Roxana Mehran, E Magnus Ohman, Harvey D. White, Jonathan D. Newman, Ke Xu, and Gregg W. Stone. “Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.” Circ Cardiovasc Interv 7, no. 3 (June 2014): 285–93. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000606.
    Full Text Link to Item
  - Henriques, José P. S., Dagmar M. Ouweneel, Srihari S. Naidu, Igor F. Palacios, Jeffrey Popma, E Magnus Ohman, and William W. O’Neill. “Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study.” Am Heart J 167, no. 4 (April 2014): 472-479.e5. https://doi.org/10.1016/j.ahj.2013.12.018.
    Full Text Link to Item
  - Lansky, Alexandra J., Vivian G. Ng, Stephanie Meller, Ke Xu, Martin Fahy, Frederick Feit, E Magnus Ohman, et al. “Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).” Jacc Cardiovasc Interv 7, no. 3 (March 2014): 266–75. https://doi.org/10.1016/j.jcin.2013.08.016.
    Full Text Link to Item
  - Diepen, Sean van, Harmony R. Reynolds, Amanda Stebbins, Renato D. Lopes, Vladimír Džavík, Witold Ruzyllo, Alexander Geppert, et al. “Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.” Crit Care Med 42, no. 2 (February 2014): 281–88. https://doi.org/10.1097/CCM.0b013e31829f6242.
    Full Text Link to Item
  - O’Neill, William W., Theodore Schreiber, David H. W. Wohns, Charanjit Rihal, Srihari S. Naidu, Andrew B. Civitello, Simon R. Dixon, Joseph M. Massaro, Brijeshwar Maini, and E Magnus Ohman. “The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.” J Interv Cardiol 27, no. 1 (February 2014): 1–11. https://doi.org/10.1111/joic.12080.
    Full Text Link to Item
  - Dangas, George D., Annapoorna S. Kini, Samin K. Sharma, Jose P. S. Henriques, Bimmer E. Claessen, Simon R. Dixon, Joseph M. Massaro, et al. “Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).” Am J Cardiol 113, no. 2 (January 15, 2014): 222–28. https://doi.org/10.1016/j.amjcard.2013.09.008.
    Full Text Link to Item
  - Kohli, Payal, Ph Gabriel Steg, Christopher P. Cannon, Sidney C. Smith, Kim A. Eagle, E Magnus Ohman, Mark J. Alberts, et al. “NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.” Am J Med 127, no. 1 (January 2014): 53-60.e1. https://doi.org/10.1016/j.amjmed.2013.08.017.
    Full Text Link to Item
  - Ruff, Christian T., Deepak L. Bhatt, Ph Gabriel Steg, Bernard J. Gersh, Mark J. Alberts, Elaine B. Hoffman, E Magnus Ohman, et al. “Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry.” Int J Cardiol 170, no. 3 (January 1, 2014): 413–18. https://doi.org/10.1016/j.ijcard.2013.11.030.
    Full Text Link to Item
  - Rodés-Cabau, Josep, Harold L. Dauerman, Mauricio G. Cohen, Roxana Mehran, Eric M. Small, Susan S. Smyth, Marco A. Costa, et al. “Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.” J Am Coll Cardiol 62, no. 25 (December 24, 2013): 2349–59. https://doi.org/10.1016/j.jacc.2013.03.029.
    Full Text Link to Item
  - Weisz, Giora, Ramin Farzaneh-Far, Ori Ben-Yehuda, Bernard Debruyne, Gilles Montalescot, Amir Lerman, Ehtisham Mahmud, et al. “Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.” Am Heart J 166, no. 6 (December 2013): 953-959.e3. https://doi.org/10.1016/j.ahj.2013.08.004.
    Full Text Link to Item
  - Rodriguez, Fátima, Christopher P. Cannon, Ph Gabriel Steg, Dharam J. Kumbhani, Shinya Goto, Sidney C. Smith, Kim A. Eagle, et al. “Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.” Clin Cardiol 36, no. 12 (December 2013): 721–27. https://doi.org/10.1002/clc.22217.
    Full Text Link to Item
  - Anderson, Monique L., Eric D. Peterson, S Andrew Peng, Tracy Y. Wang, E Magnus Ohman, Deepak L. Bhatt, Jorge F. Saucedo, and Matthew T. Roe. “Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR.” Circ Cardiovasc Qual Outcomes 6, no. 6 (November 2013): 708–15. https://doi.org/10.1161/CIRCOUTCOMES.113.000262.
    Full Text Link to Item
  - Lopes, Renato D., Jennifer A. White, Dan Atar, Matyas Keltai, Neal S. Kleiman, Harvey D. White, Petr Widimsky, et al. “Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes.” Int J Cardiol 168, no. 3 (October 3, 2013): 2510–17. https://doi.org/10.1016/j.ijcard.2013.03.037.
    Full Text Link to Item
  - Vemulapalli, Sreekanth, Yi Zhou, Matthias Gutberlet, Arramraj Sreenivas Kumar, James S. Mills, Jonathan Blaxill, Richard Smalling, Erik Magnus Ohman, and Manesh R. Patel. “Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial).” Am J Cardiol 112, no. 7 (October 1, 2013): 911–17. https://doi.org/10.1016/j.amjcard.2013.05.021.
    Full Text Link to Item
  - Roe, Matthew T., Shaun G. Goodman, E Magnus Ohman, Susanna R. Stevens, Judith S. Hochman, Shmuel Gottlieb, Felipe Martinez, et al. “Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.” Circulation 128, no. 8 (August 20, 2013): 823–33. https://doi.org/10.1161/CIRCULATIONAHA.113.002303.
    Full Text Link to Item
  - Wiviott, Stephen D., Harvey D. White, E Magnus Ohman, Keith A. A. Fox, Paul W. Armstrong, Dorairaj Prabhakaran, Gail Hafley, et al. “Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.” Lancet 382, no. 9892 (August 17, 2013): 605–13. https://doi.org/10.1016/S0140-6736(13)61451-8.
    Full Text Link to Item
  - Bagai, Akshay, Anita Y. Chen, Tracy Y. Wang, Karen P. Alexander, Laine Thomas, E Magnus Ohman, Judith S. Hochman, Eric D. Peterson, and Matthew T. Roe. “Long-term outcomes among older patients with non-ST-segment elevation myocardial infarction complicated by cardiogenic shock.” Am Heart J 166, no. 2 (August 2013): 298–305. https://doi.org/10.1016/j.ahj.2013.05.003.
    Full Text Link to Item
  - Kumbhani, Dharam J., Ph Gabriel Steg, Christopher P. Cannon, Kim A. Eagle, Sidney C. Smith, Elaine Hoffman, Shinya Goto, E Magnus Ohman, Deepak L. Bhatt, and Deepak L. REduction of Atherothrombosis for Continued Health Registry Investigators. “Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.” Am J Med 126, no. 8 (August 2013): 693-700.e1. https://doi.org/10.1016/j.amjmed.2013.01.033.
    Full Text Link to Item
  - Chan, Mark Y., Jie-Lena Sun, L Kristin Newby, Yuliya Lokhnygina, Harvey D. White, David J. Moliterno, Pierre Théroux, et al. “Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years.” Int J Cardiol 167, no. 2 (July 31, 2013): 548–54. https://doi.org/10.1016/j.ijcard.2012.01.065.
    Full Text Link to Item
  - Kern, Morton, Robert Applegate, Richard G. Bach, Steven R. Bailey, Thomas M. Bashore, Theodore A. Bass, Malcolm Bell, et al. “Conversation in cardiology: should FFR and IVUS be counted as PCI?” Catheter Cardiovasc Interv 82, no. 1 (July 1, 2013): 110–15. https://doi.org/10.1002/ccd.24854.
    Full Text Link to Item
  - Anderson, Jeffrey L., Cynthia D. Adams, Elliott M. Antman, Charles R. Bridges, Robert M. Califf, Donald E. Casey, William E. Chavey, et al. “2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Am Coll Cardiol 61, no. 23 (June 11, 2013): e179–347. https://doi.org/10.1016/j.jacc.2013.01.014.
    Full Text Link to Item
  - Bahit, Maria Cecilia, Renato D. Lopes, Robert M. Clare, L Kristin Newby, Karen S. Pieper, Frans Van de Werf, Paul W. Armstrong, et al. “Heart failure complicating non-ST-segment elevation acute coronary syndrome: timing, predictors, and clinical outcomes.” Jacc Heart Fail 1, no. 3 (June 2013): 223–29. https://doi.org/10.1016/j.jchf.2013.02.007.
    Full Text Link to Item
  - Barakat, R. R., A. Berchuck, M. Markman, and M. E. Randall. “Preface.” Principles and Practice of Gynecologic Oncology: Sixth Edition, May 8, 2013, xi–xii.
  - American College of Cardiology Foundation, L Samuel, L Samuel American Heart Association, L Samuel European Society of Cardiology, L Samuel Heart Rhythm Society, L Samuel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, et al. “Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.” Circulation 127, no. 18 (May 7, 2013): 1916–26. https://doi.org/10.1161/CIR.0b013e318290826d.
    Full Text Link to Item
  - Anderson, Jeffrey L., Jonathan L. Halperin, Nancy M. Albert, Biykem Bozkurt, Ralph G. Brindis, Lesley H. Curtis, David DeMets, et al. “Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.” J Am Coll Cardiol 61, no. 18 (May 7, 2013): 1935–44. https://doi.org/10.1016/j.jacc.2013.02.001.
    Full Text Link to Item
  - Doenst, Torsten, John G. F. Cleland, Jean L. Rouleau, Lilin She, Stanislaw Wos, E Magnus Ohman, Maria Krzeminska-Pakula, et al. “Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease.” Circ Heart Fail 6, no. 3 (May 2013): 443–50. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000130.
    Full Text Link to Item
  - Roe, Matthew T., Shuang Li, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, E Magnus Ohman, and Eric D. Peterson. “Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction.” Circ Cardiovasc Qual Outcomes 6, no. 3 (May 1, 2013): 323–32. https://doi.org/10.1161/CIRCOUTCOMES.113.000120.
    Full Text Link to Item
  - Subherwal, Sumeet, E Magnus Ohman, Kenneth W. Mahaffey, Sunil V. Rao, John H. Alexander, Tracy Y. Wang, Karen P. Alexander, Vic Hasselblad, and Matthew T. Roe. “Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches.” Am Heart J 165, no. 5 (May 2013): 644-654.e1. https://doi.org/10.1016/j.ahj.2012.11.012.
    Full Text Link to Item
  - Rooke, Thom W., Alan T. Hirsch, Sanjay Misra, Anton N. Sidawy, Joshua A. Beckman, Laura Findeiss, Jafar Golzarian, et al. “Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Am Coll Cardiol 61, no. 14 (April 9, 2013): 1555–70. https://doi.org/10.1016/j.jacc.2013.01.004.
    Full Text Link to Item
  - Anderson, Jeffrey L., Jonathan L. Halperin, Nancy M. Albert, Biykem Bozkurt, Ralph G. Brindis, Lesley H. Curtis, David DeMets, et al. “Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 127, no. 13 (April 2, 2013): 1425–43. https://doi.org/10.1161/CIR.0b013e31828b82aa.
    Full Text Link to Item
  - Rose, Jason J., L Kristin Newby, Samuel Broderick, Karen Chiswell, Frans Van de Werf, Paul W. Armstrong, Kenneth W. Mahaffey, et al. “Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes.” J Am Coll Cardiol 61, no. 13 (April 2, 2013): 1461–63. https://doi.org/10.1016/j.jacc.2012.12.032.
    Full Text Link to Item
  - Kumbhani, Dharam J., P Gabriel Steg, Christopher P. Cannon, Kim A. Eagle, Sidney C. Smith, Kevin Crowley, Shinya Goto, et al. “Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.” Eur Heart J 34, no. 16 (April 2013): 1204–14. https://doi.org/10.1093/eurheartj/ehs368.
    Full Text Link to Item
  - Leonardi, Sergio, Paul W. Armstrong, Phillip J. Schulte, E Magnus Ohman, and L Kristin Newby. “Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.” Eur Heart J 34, no. 12 (March 2013): 894-902d. https://doi.org/10.1093/eurheartj/eht003.
    Full Text Link to Item
  - Ducrocq, Gregory, Pierre Amarenco, Julien Labreuche, Mark J. Alberts, Jean-Louis Mas, E Magnus Ohman, Shinya Goto, Philippa Lavallée, Deepak L. Bhatt, and Ph Gabriel Steg. “A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease.” Circulation 127, no. 6 (February 12, 2013): 730–38. https://doi.org/10.1161/CIRCULATIONAHA.112.141572.
    Full Text Link to Item
  - Epstein, Andrew E., John P. DiMarco, Kenneth A. Ellenbogen, NA Mark Estes, Roger A. Freedman, Leonard S. Gettes, A Marc Gillinov, et al. “2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.” Circulation 127, no. 3 (January 22, 2013): e283–352. https://doi.org/10.1161/CIR.0b013e318276ce9b.
    Full Text Link to Item
  - Jacobs, Alice K., Frederick G. Kushner, Steven M. Ettinger, Robert A. Guyton, Jeffrey L. Anderson, E Magnus Ohman, Nancy M. Albert, et al. “ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 127, no. 2 (January 15, 2013): 268–310. https://doi.org/10.1161/CIR.0b013e31827e8e5f.
    Full Text Link to Item
  - Vavalle, John P., and E Magnus Ohman. “Left ventricular support systems for high-risk percutaneous coronary interventions: how can we improve outcomes for rare procedures?” Circulation 127, no. 2 (January 15, 2013): 162–64. https://doi.org/10.1161/CIRCULATIONAHA.112.152785.
    Full Text Link to Item
  - Jacobs, Alice K., Frederick G. Kushner, Steven M. Ettinger, Robert A. Guyton, Jeffrey L. Anderson, E Magnus Ohman, Nancy M. Albert, et al. “ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Am Coll Cardiol 61, no. 2 (January 15, 2013): 213–65. https://doi.org/10.1016/j.jacc.2012.09.025.
    Full Text Link to Item
  - Roe, Matthew T., E Magnus Ohman, and E Magnus TRILOGY ACS Investigators. “Prasugrel versus clopidogrel for acute coronary syndromes.” N Engl J Med 368, no. 2 (January 10, 2013): 188–89. https://doi.org/10.1056/NEJMc1213509.
    Full Text Link to Item
  - Brott, Thomas G., Jonathan L. Halperin, Suhny Abbara, J Michael Bacharach, John D. Barr, Ruth L. Bush, Christopher U. Cates, et al. “2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography.” Catheter Cardiovasc Interv 81, no. 1 (January 1, 2013): E76-123. https://doi.org/10.1002/ccd.22983.
    Full Text Link to Item
  - Wiviott, S. D., H. D. White, and E. M. Ohman. “Erratum: Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: A secondary, prespecifi ed analysis of the TRILOGY\ ACS trial (The Lancet (2013) 382 (605-613).” The Lancet 382, no. 9894 (January 1, 2013): 768.
  - Williams, Eric S., Vivian P. Thompson, Karen E. Chiswell, John H. Alexander, Harvey D. White, E Magnus Ohman, and Sana M. Al-Khatib. “Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.” Cardiol J 20, no. 4 (2013): 439–46. https://doi.org/10.5603/CJ.2013.0104.
    Full Text Link to Item
  - 2012 Writing Group Members, Clyde W., Cynthia M. Tracy, Andrew E. Epstein, Dawood Darbar, John P. DiMarco, Sandra B. Dunbar, NA Mark Estes, et al. “2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Thorac Cardiovasc Surg 144, no. 6 (December 2012): e127–45. https://doi.org/10.1016/j.jtcvs.2012.08.032.
    Full Text Link to Item
  - Alhejily, Wesam A., and E Magnus Ohman. “Repeat revascularization after PCI: are we reinventing the wheel or redefining Achilles' heel?” Circ Cardiovasc Interv 5, no. 6 (December 2012): 746–47. https://doi.org/10.1161/CIRCINTERVENTIONS.112.974956.
    Full Text Link to Item
  - Wang, Tracy Y., Emily F. Honeycutt, Victor F. Tapson, Stephan Moll, Christopher B. Granger, and E Magnus Ohman. “Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.” Am J Med 125, no. 12 (December 2012): 1214–21. https://doi.org/10.1016/j.amjmed.2012.05.021.
    Full Text Link to Item
  - Gurbel, P. A., D. Erlinge, E. M. Ohman, B. Neely, M. Neely, S. G. Goodman, K. Huber, et al. “Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy.” Jama, November 4, 2012, 1–10. https://doi.org/10.1001/jama.2012.17312.
    Full Text Link to Item
  - Dangas, George D., Bimmer E. Claessen, Roxana Mehran, Ke Xu, Martin Fahy, Helen Parise, José P. S. Henriques, E Magnus Ohman, Harvey D. White, and Gregg W. Stone. “Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.” Jacc Cardiovasc Interv 5, no. 11 (November 2012): 1097–1105. https://doi.org/10.1016/j.jcin.2012.07.012.
    Full Text Link to Item
  - Thygesen, Kristian, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman, Harvey D. White, Harvey D. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, et al. “Third universal definition of myocardial infarction.” Circulation 126, no. 16 (October 16, 2012): 2020–35. https://doi.org/10.1161/CIR.0b013e31826e1058.
    Full Text Link to Item
  - Roe, Matthew T., Paul W. Armstrong, Keith A. A. Fox, Harvey D. White, Dorairaj Prabhakaran, Shaun G. Goodman, Jan H. Cornel, et al. “Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.” N Engl J Med 367, no. 14 (October 4, 2012): 1297–1309. https://doi.org/10.1056/NEJMoa1205512.
    Full Text Link to Item
  - Bangalore, Sripal, Gabriel Steg, Prakash Deedwania, Kevin Crowley, Kim A. Eagle, Shinya Goto, E Magnus Ohman, et al. “β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.” Jama 308, no. 13 (October 3, 2012): 1340–49. https://doi.org/10.1001/jama.2012.12559.
    Full Text Link to Item
  - Rao, S. V., and E. M. Ohman. “Antithrombotic Strategies in Patients Undergoing Elective Percutaneous Coronary Intervention,” October 3, 2012, 236–45. https://doi.org/10.1002/9781118410875.ch16.
    Full Text
  - O’Neill, William W., Neal S. Kleiman, Jeffrey Moses, Jose P. S. Henriques, Simon Dixon, Joseph Massaro, Igor Palacios, et al. “A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.” Circulation 126, no. 14 (October 2, 2012): 1717–27. https://doi.org/10.1161/CIRCULATIONAHA.112.098194.
    Full Text Link to Item
  - Thygesen, Kristian, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman, Harvey D. White, Harvey D. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, et al. “Third universal definition of myocardial infarction.” Eur Heart J 33, no. 20 (October 2012): 2551–67. https://doi.org/10.1093/eurheartj/ehs184.
    Full Text Link to Item
  - Lopes, Renato D., Sumeet Subherwal, Dajuanicia N. Holmes, Laine Thomas, Tracy Y. Wang, Sunil V. Rao, Erik Magnus Ohman, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction.” Eur Heart J 33, no. 16 (August 2012): 2044–53. https://doi.org/10.1093/eurheartj/ehs012.
    Full Text Link to Item
  - Udell, Jacob A., Philippe Gabriel Steg, Benjamin M. Scirica, Sidney C. Smith, E Magnus Ohman, Kim A. Eagle, Shinya Goto, Jang Ik Cho, Deepak L. Bhatt, and Deepak L. REduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. “Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis.” Arch Intern Med 172, no. 14 (July 23, 2012): 1086–95. https://doi.org/10.1001/archinternmed.2012.2782.
    Full Text Link to Item
  - Gurbel, Paul A., Matthew T. Roe, Joseph A. Jakubowski, Svathi Shah, David Erlinge, Shaun G. Goodman, Kurt Huber, et al. “Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps?” Thromb Haemost 108, no. 1 (July 2012): 12–20. https://doi.org/10.1160/TH12-01-0039.
    Full Text Link to Item
  - Subherwal, Sumeet, Deepak L. Bhatt, Shuang Li, Tracy Y. Wang, Laine Thomas, Karen P. Alexander, Manesh R. Patel, et al. “Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.” Circ Cardiovasc Qual Outcomes 5, no. 4 (July 1, 2012): 541–49. https://doi.org/10.1161/CIRCOUTCOMES.111.964379.
    Full Text Link to Item
  - Wilson, Peter W. F., Ralph D’Agostino, Deepak L. Bhatt, Kim Eagle, Michael J. Pencina, Sidney C. Smith, Mark J. Alberts, et al. “An international model to predict recurrent cardiovascular disease.” Am J Med 125, no. 7 (July 2012): 695-703.e1. https://doi.org/10.1016/j.amjmed.2012.01.014.
    Full Text Link to Item
  - Gurbel, Paul A., E Magnus Ohman, Young-Hoon Jeong, and Udaya S. Tantry. “Toward a therapeutic window for antiplatelet therapy in the elderly.” Eur Heart J 33, no. 10 (May 2012): 1187–89. https://doi.org/10.1093/eurheartj/ehr458.
    Full Text Link to Item
  - Venkitachalam, Lakshmi, Kaijun Wang, Avi Porath, Ramon Corbalan, Alan T. Hirsch, David J. Cohen, Sidney C. Smith, et al. “Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance.” Circulation 125, no. 15 (April 17, 2012): 1858–69. https://doi.org/10.1161/CIRCULATIONAHA.111.064378.
    Full Text Link to Item
  - Hamm, Christian W., Jean-Pierre Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Hector Bueno, Pio Caso, et al. “[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)].” G Ital Cardiol (Rome) 13, no. 3 (March 2012): 171–228. https://doi.org/10.1714/1038.11322.
    Full Text Link to Item
  - Rooke, Thom W., Alan T. Hirsch, Sanjay Misra, Anton N. Sidawy, Joshua A. Beckman, Laura K. Findeiss, Jafar Golzarian, et al. “2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.” Catheter Cardiovasc Interv 79, no. 4 (March 1, 2012): 501–31. https://doi.org/10.1002/ccd.23373.
    Full Text Link to Item
  - Roe, Matthew T., Jennifer A. White, Padma Kaul, Pierluigi Tricoci, Yuliya Lokhnygina, Chadwick D. Miller, Arnoud W. van’t Hof, et al. “Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.” Circ Cardiovasc Qual Outcomes 5, no. 2 (March 1, 2012): 205–13. https://doi.org/10.1161/CIRCOUTCOMES.111.962332.
    Full Text Link to Item
  - Levine, Glenn N., Elaine E. Steinke, Faisal G. Bakaeen, Biykem Bozkurt, Melvin D. Cheitlin, Jamie Beth Conti, Elyse Foster, et al. “Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association.” Circulation 125, no. 8 (February 28, 2012): 1058–72. https://doi.org/10.1161/CIR.0b013e3182447787.
    Full Text Link to Item
  - Levine, Glenn N., Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, et al. “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.” Catheter Cardiovasc Interv 79, no. 3 (February 15, 2012): 453–95. https://doi.org/10.1002/ccd.23438.
    Full Text Link to Item
  - Stegman, Brian M., L Kristin Newby, Judith S. Hochman, and E Magnus Ohman. “Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility?” J Am Coll Cardiol 59, no. 7 (February 14, 2012): 644–47. https://doi.org/10.1016/j.jacc.2011.11.010.
    Full Text Link to Item
  - Hamm, C. W., J. P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, et al. “ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.” Revista Espanola De Cardiologia 65, no. 2 (February 1, 2012). https://doi.org/10.1016/j.recesp.2011.11.006.
    Full Text
  - Patel, M. R., R. W. Smalling, and E. M. Ohman. “Thromboaspiration before intra-aortic balloon counterpulsation - Reply.” Jama Journal of the American Medical Association 307, no. 2 (January 11, 2012): 147. https://doi.org/10.1001/jama.2011.1987.
    Full Text
  - Roe, Matthew T., and E Magnus Ohman. “A new era in secondary prevention after acute coronary syndrome.” N Engl J Med 366, no. 1 (January 5, 2012): 85–87. https://doi.org/10.1056/NEJMe1112770.
    Full Text Link to Item
  - Halim, Sharif A., L Kristin Newby, and E Magnus Ohman. “Biomarkers in cardiovascular clinical trials: past, present, future.” Clin Chem 58, no. 1 (January 2012): 45–53. https://doi.org/10.1373/clinchem.2011.165787.
    Full Text Link to Item
  - Hillis, L David, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, et al. “2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Thorac Cardiovasc Surg 143, no. 1 (January 2012): 4–34. https://doi.org/10.1016/j.jtcvs.2011.10.015.
    Full Text Link to Item
  - Hamm, C. W., J. P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, et al. “Wytyczne dotycza̧ce diagnostyki i leczenia ostrych zespołów wieńcowych bez przetrwałego uniesienia odcinka ST.” Kardiologia Polska 69, no. SUPPL. 5 (December 28, 2011).
  - Hillis, L. D., P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, et al. “2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary.” Journal of the American College of Cardiology 58, no. 24 (December 6, 2011): 2584–2614. https://doi.org/10.1016/j.jacc.2011.08.008.
    Full Text
  - Levine, Glenn N., Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, et al. “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.” J Am Coll Cardiol 58, no. 24 (December 6, 2011): e44-122. https://doi.org/10.1016/j.jacc.2011.08.007.
    Full Text Link to Item
  - Levine, Glenn N., Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, et al. “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.” Circulation 124, no. 23 (December 6, 2011): 2574–2609. https://doi.org/10.1161/CIR.0b013e31823a5596.
    Full Text Link to Item
  - Levine, Glenn N., Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, et al. “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.” Circulation 124, no. 23 (December 6, 2011): e574–651. https://doi.org/10.1161/CIR.0b013e31823ba622.
    Full Text Link to Item
  - Hillis, L David, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, et al. “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 124, no. 23 (December 6, 2011): 2610–42. https://doi.org/10.1161/CIR.0b013e31823b5fee.
    Full Text Link to Item
  - Hillis, L David, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, et al. “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Circulation 124, no. 23 (December 6, 2011): e652–735. https://doi.org/10.1161/CIR.0b013e31823c074e.
    Full Text Link to Item
  - Hillis, L David, Peter K. Smith, Jeffrey L. Anderson, John A. Bittl, Charles R. Bridges, John G. Byrne, Joaquin E. Cigarroa, et al. “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons.” J Am Coll Cardiol 58, no. 24 (December 6, 2011): e123–210. https://doi.org/10.1016/j.jacc.2011.08.009.
    Full Text Link to Item
  - American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Clyde W., Clyde W. American Association for Thoracic Surgery, Clyde W. American Society of Echocardiography, Clyde W. American Society of Nuclear Cardiology, Clyde W. Heart Failure Society of America, Clyde W. Heart Rhythm Society, Clyde W. Society for Cardiovascular Angiography and Interventions, et al. “2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Thorac Cardiovasc Surg 142, no. 6 (December 2011): 1303–38. https://doi.org/10.1016/j.jtcvs.2011.10.019.
    Full Text Link to Item
  - American College of Cardiology Foundation/American Heart Association Task Force on Practice, Clyde W., Clyde W. American Association for Thoracic Surgery, Clyde W. American Society of Echocardiography, Clyde W. American Society of Nuclear Cardiology, Clyde W. Heart Failure Society of America, Clyde W. Heart Rhythm Society, Clyde W. Society for Cardiovascular Angiography and Interventions, et al. “2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” J Thorac Cardiovasc Surg 142, no. 6 (December 2011): e153–203. https://doi.org/10.1016/j.jtcvs.2011.10.020.
    Full Text Link to Item
  - Chenier, Michael, Douglas Johnson, Magnus Ohman, and Elizabeth Pavlisko. “Cardiac angiosarcoma presenting as progressive dyspnea on exertion.” J Cardiovasc Med (Hagerstown) 12, no. 12 (December 2011): 904–7. https://doi.org/10.2459/JCM.0b013e32834036cf.
    Full Text Link to Item
  - Hamm, C. W., J. P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, et al. “Israrci ST-segment yükselmesi belirtileri göstermeyen hastalarda Akut KoronerSendromlarin (AKS) tedavi kilavuzlari.” Turk Kardiyoloji Dernegi Arsivi 39, no. SUPP-3 (December 1, 2011): 73–128.
  - Hamm, Christian W., Jean-Pierre Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Hector Bueno, Pio Caso, et al. “ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).” Eur Heart J 32, no. 23 (December 2011): 2999–3054. https://doi.org/10.1093/eurheartj/ehr236.
    Full Text Link to Item
  - Levine, G. N., E. R. Bates, J. C. Blankenship, S. R. Bailey, J. A. Bittl, B. Cercek, C. E. Chambers, et al. “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions (Accepted).” Catheterization and Cardiovascular Interventions 45, no. 4 (November 8, 2011). https://doi.org/10.1002/ccd.23390.
    Full Text
  - Roe, Matthew T., Anita Y. Chen, Laine Thomas, Tracy Y. Wang, Karen P. Alexander, Bradley G. Hammill, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction: the CRUSADE long-term mortality model and risk score.” Am Heart J 162, no. 5 (November 2011): 875-883.e1. https://doi.org/10.1016/j.ahj.2011.08.010.
    Full Text Link to Item
  - Patel, Manesh R., Richard W. Smalling, Holger Thiele, Huiman X. Barnhart, Yi Zhou, Praveen Chandra, Derek Chew, et al. “Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.” Jama 306, no. 12 (September 28, 2011): 1329–37. https://doi.org/10.1001/jama.2011.1280.
    Full Text Link to Item
  - Stone, Gregg W., and E Magnus Ohman. “Antithrombin alternatives in STEMI.” Lancet 378, no. 9792 (August 20, 2011): 643–45. https://doi.org/10.1016/S0140-6736(11)61059-3.
    Full Text Link to Item
  - Unverzagt, Susanne, Maria-Theresia Machemer, Alexander Solms, Holger Thiele, Daniel Burkhoff, Melchior Seyfarth, Antoinette de Waha, et al. “Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.” Cochrane Database Syst Rev, no. 7 (July 6, 2011): CD007398. https://doi.org/10.1002/14651858.CD007398.pub2.
    Full Text Link to Item
  - Goto, Kenji, Alexandra J. Lansky, Eugenia Nikolsky, Martin Fahy, Frederick Feit, E Magnus Ohman, Harvey D. White, et al. “Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.” Jacc Cardiovasc Interv 4, no. 7 (July 2011): 769–77. https://doi.org/10.1016/j.jcin.2011.02.019.
    Full Text Link to Item
  - Patel, Manesh R., Holger Thiele, Richard W. Smalling, Praveen Chandra, Yi Zhou, Marc Cohen, Divaka Perera, and Erik Magnus Ohman. “A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial.” Am Heart J 162, no. 1 (July 2011): 47-55.e1. https://doi.org/10.1016/j.ahj.2011.03.037.
    Full Text Link to Item
  - Mehran, Roxana, Sunil V. Rao, Deepak L. Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, et al. “Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.” Circulation 123, no. 23 (June 14, 2011): 2736–47. https://doi.org/10.1161/CIRCULATIONAHA.110.009449.
    Full Text Link to Item
  - Mehran, Roxana, Stuart Pocock, Eugenia Nikolsky, George D. Dangas, Tim Clayton, Bimmer E. Claessen, Adriano Caixeta, et al. “Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.” Jacc Cardiovasc Interv 4, no. 6 (June 2011): 654–64. https://doi.org/10.1016/j.jcin.2011.02.011.
    Full Text Link to Item
  - Goyal, A., D. L. Bhatt, P. G. Steg, B. J. Gersh, M. J. Alberts, E. M. Ohman, R. M. Califf, et al. “Response to letter regarding article, "attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries".” Circulation 123, no. 20 (May 24, 2011). https://doi.org/10.1161/CIRCULATIONAHA.111.025189.
    Full Text
  - Ohman, E. M., and M. T. Roe. “Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5).” Thromb Haemost 105, no. 5 (May 2011): 763–65. https://doi.org/10.1160/TH11-03-0159.
    Full Text Link to Item
  - Lansky, Alexandra, Kenji Goto, Martin Fahy, Ecatarina Cristea, Roxana Mehran, Gregg W. Stone, Frederick Feit, et al. “Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy”.” Circulation 123, no. 15 (April 19, 2011): e410–11. https://doi.org/10.1161/circulationaha.110.010306.
    Full Text Link to Item
  - Hess, Connie Ng, E Magnus Ohman, and Manesh R. Patel. “Amplatzer vascular plug closure of a subclavian arteriovenous fistula associated with implantable cardioverter-defibrillator implantation.” Catheter Cardiovasc Interv 77, no. 5 (April 1, 2011): 761–63. https://doi.org/10.1002/ccd.22792.
    Full Text Link to Item
  - Wann, L Samuel, Anne B. Curtis, Kenneth A. Ellenbogen, NA Mark Estes, Michael D. Ezekowitz, Warren M. Jackman, Craig T. January, et al. “2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Heart Rhythm 8, no. 3 (March 2011): e1–8. https://doi.org/10.1016/j.hrthm.2011.01.032.
    Full Text Link to Item
  - Ambrosio, Giuseppe, Steven Steinhubl, Paolo Gresele, Isabella Tritto, Cinzia Zuchi, Michel E. Bertrand, A Michael Lincoff, et al. “Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial.” Eur J Cardiovasc Prev Rehabil 18, no. 1 (February 2011): 121–28. https://doi.org/10.1097/HJR.0b013e32833bc070.
    Full Text Link to Item
  - Caixeta, Adriano, George D. Dangas, Roxana Mehran, Frederick Feit, Eugenia Nikolsky, Alexandra J. Lansky, Jiro Aoki, et al. “Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.” Am Heart J 161, no. 2 (February 2011): 298-306.e1. https://doi.org/10.1016/j.ahj.2010.10.035.
    Full Text Link to Item
  - Caixeta, Adriano, Gregg W. Stone, Roxana Mehran, Edwin A. Lee, Brent T. McLaurin, David A. Cox, Michel E. Bertrand, et al. “Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.” J Thromb Thrombolysis 31, no. 2 (February 2011): 154–64. https://doi.org/10.1007/s11239-010-0516-y.
    Full Text Link to Item
  - Hakim, Diaa A., George D. Dangas, Adriano Caixeta, Eugenia Nikolsky, Alexandra J. Lansky, Jeffrey W. Moses, Bimmer Claessen, et al. “Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.” Am Heart J 161, no. 2 (February 2011): 391–96. https://doi.org/10.1016/j.ahj.2010.11.001.
    Full Text Link to Item
  - Mehta, Rajendra H., J Conor O’Shea, Amanda L. Stebbins, Christopher B. Granger, Paul W. Armstrong, Harvey D. White, Eric J. Topol, Robert M. Califf, and E Magnus Ohman. “Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.” J Am Coll Cardiol 57, no. 2 (January 11, 2011): 138–46. https://doi.org/10.1016/j.jacc.2010.09.021.
    Full Text Link to Item
  - Wann, L Samuel, Anne B. Curtis, Craig T. January, Kenneth A. Ellenbogen, James E. Lowe, NA Mark Estes, Richard L. Page, et al. “2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.” Heart Rhythm 8, no. 1 (January 2011): 157–76. https://doi.org/10.1016/j.hrthm.2010.11.047.
    Full Text Link to Item
  - Piccini, Jonathan P., Phillip J. Schulte, Karen S. Pieper, Rajendra H. Mehta, Harvey D. White, Frans Van de Werf, Diego Ardissino, et al. “Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.” Crit Care Med 39, no. 1 (January 2011): 78–83. https://doi.org/10.1097/CCM.0b013e3181fd6ad7.
    Full Text Link to Item
  - Cavender, M. A., and E. M. Ohman. “Heart Disease in the Elderly,” December 1, 2010, 424–27. https://doi.org/10.1016/B978-032304525-4.00066-6.
    Full Text
  - Melloni, Chiara, Bimal R. Shah, Fang-Shu Ou, Matthew T. Roe, Sidney C. Smith, Charles V. Pollack, Magnus Ohman, W Brian Gibler, Eric D. Peterson, and Karen P. Alexander. “Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry.” Am Heart J 160, no. 6 (December 2010): 1121-1129.e1. https://doi.org/10.1016/j.ahj.2010.09.008.
    Full Text Link to Item
  - Mudrick, Daniel W., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, W Brian Gibler, E Magnus Ohman, Eric D. Peterson, and Karen P. Alexander. “Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative.” Am Heart J 160, no. 6 (December 2010): 1072–78. https://doi.org/10.1016/j.ahj.2010.08.008.
    Full Text Link to Item
  - Van De Car, David A., Sunil V. Rao, and E Magnus Ohman. “Bivalirudin: a review of the pharmacology and clinical application.” Expert Rev Cardiovasc Ther 8, no. 12 (December 2010): 1673–81. https://doi.org/10.1586/erc.10.158.
    Full Text Link to Item
  - Tackett, Andrea H., Alison L. Bailey, Joanne Micale Foody, Julie M. Miller, Carolyn Apperson-Hansen, E Magnus Ohman, Judith S. Hochman, et al. “Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.” Am Heart J 160, no. 4 (October 2010): 678–84. https://doi.org/10.1016/j.ahj.2010.06.030.
    Full Text Link to Item
  - Bhatt, Deepak L., Kim A. Eagle, E Magnus Ohman, Alan T. Hirsch, Shinya Goto, Elizabeth M. Mahoney, Peter W. F. Wilson, et al. “Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.” Jama 304, no. 12 (September 22, 2010): 1350–57. https://doi.org/10.1001/jama.2010.1322.
    Full Text Link to Item
  - Stone, G. W., R. Mehran, E. Nikolsky, H. Parise, M. Fahy, A. J. Lansky, J. W. Moses, et al. “Response to letter regarding article, "prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: Assessment from the acute catheterization and Urgent intervention triage strategy trial".” Circulation 122, no. 12 (September 21, 2010). https://doi.org/10.1161/CIRCULATIONAHA.110.951897.
    Full Text
  - Goyal, Abhinav, Deepak L. Bhatt, P Gabriel Steg, Bernard J. Gersh, Mark J. Alberts, E Magnus Ohman, Ramón Corbalán, et al. “Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries.” Circulation 122, no. 12 (September 21, 2010): 1167–75. https://doi.org/10.1161/CIRCULATIONAHA.109.919274.
    Full Text Link to Item
  - Mehta, Rajendra H., Anita Y. Chen, E Magnus Ohman, W Brian Gibler, Eric D. Peterson, Matthew T. Roe, and Matthew T. CRUSADE National Quality Improvement Initiative Investigators. “Influence of transfer-in rates on quality of care and outcomes at receiving hospitals in patients with non-ST-segment elevation myocardial infarction.” Am Heart J 160, no. 3 (September 2010): 405–11. https://doi.org/10.1016/j.ahj.2010.06.025.
    Full Text Link to Item
  - Lansky, Alexandra J., Kenji Goto, Ecaterina Cristea, Martin Fahy, Helen Parise, Frederick Feit, E Magnus Ohman, et al. “Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.” Circ Cardiovasc Interv 3, no. 4 (August 2010): 308–16. https://doi.org/10.1161/CIRCINTERVENTIONS.109.887604.
    Full Text Link to Item
  - Kirtane, Ajay J., Helen Parise, Roxana Mehran, Jeffrey W. Moses, Martin Fahy, Michel E. Bertrand, E Magnus Ohman, et al. “Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).” Am J Cardiol 106, no. 2 (July 15, 2010): 180–86. https://doi.org/10.1016/j.amjcard.2010.03.015.
    Full Text Link to Item
  - Chin, Chee Tang, Matthew T. Roe, Keith A. A. Fox, Dorairaj Prabhakaran, Debra A. Marshall, Helene Petitjean, Yuliya Lokhnygina, et al. “Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.” Am Heart J 160, no. 1 (July 2010): 16-22.e1. https://doi.org/10.1016/j.ahj.2010.04.022.
    Full Text Link to Item
  - Mehran, Roxana, Stuart J. Pocock, Eugenia Nikolsky, Tim Clayton, George D. Dangas, Ajay J. Kirtane, Helen Parise, et al. “A risk score to predict bleeding in patients with acute coronary syndromes.” J Am Coll Cardiol 55, no. 23 (June 8, 2010): 2556–66. https://doi.org/10.1016/j.jacc.2009.09.076.
    Full Text Link to Item
  - Eisenstein, Eric L., Emily F. Honeycutt, Kevin J. Anstrom, Richard C. Becker, Christopher B. Granger, Sunil V. Rao, Marc E. Jolicoeur, E Magnus Ohman, and E Magnus CATCH Investigators. “Economic assessment of thrombocytopenia: CATCH Registry.” J Med Syst 34, no. 3 (June 2010): 379–86. https://doi.org/10.1007/s10916-008-9250-9.
    Full Text Link to Item
  - Lopes, Renato D., Eric D. Peterson, Anita Y. Chen, Matthew T. Roe, Tracy Y. Wang, E Magnus Ohman, David J. Magid, et al. “Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry.” Jacc Cardiovasc Interv 3, no. 6 (June 2010): 669–77. https://doi.org/10.1016/j.jcin.2010.03.015.
    Full Text Link to Item
  - Mechtouff, L., E. Touzé, P. G. Steg, E. M. Ohman, S. Goto, A. T. Hirsch, J. Röther, et al. “Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease.” J Intern Med 267, no. 6 (June 2010): 621–33. https://doi.org/10.1111/j.1365-2796.2009.02198.x.
    Full Text Link to Item
  - Ohman, E Magnus, Matthew T. Roe, Paul W. Armstrong, Keith A. Fox, Dorairaj Prabhakaran, and Harvey D. White. “Public sensationalism and clinical trials: how to address the challenges of science?” Am J Med 123, no. 6 (June 2010): 481–83. https://doi.org/10.1016/j.amjmed.2009.12.012.
    Full Text Link to Item
  - Cohen, Mauricio G., Mario Pascual, Benjamin M. Scirica, and E. Magnus Ohman. “Therapeutic goals in patients with refractory chronic angina.” Rev Esp Cardiol 63, no. 5 (May 2010): 571–82. https://doi.org/10.1016/s1885-5857(10)70119-5.
    Full Text Link to Item
  - Ducrocq, Gregory, Joshua S. Wallace, Gabriel Baron, Philippe Ravaud, Mark J. Alberts, Peter W. F. Wilson, Erik Magnus Ohman, et al. “Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis.” Eur Heart J 31, no. 10 (May 2010): 1257–65. https://doi.org/10.1093/eurheartj/ehq021.
    Full Text Link to Item
  - Gharacholou, Shahyar Michael, Karen P. Alexander, Anita Y. Chen, Tracy Y. Wang, Chiara Melloni, W Brian Gibler, Charles V. Pollack, E Magnus Ohman, Eric D. Peterson, and Matthew T. Roe. “Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative.” Am Heart J 159, no. 5 (May 2010): 757–63. https://doi.org/10.1016/j.ahj.2010.02.009.
    Full Text Link to Item
  - Michaels, Andrew D., Sarah A. Spinler, Barbara Leeper, E Magnus Ohman, Karen P. Alexander, L Kristin Newby, Hakan Ay, et al. “Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association.” Circulation 121, no. 14 (April 13, 2010): 1664–82. https://doi.org/10.1161/CIR.0b013e3181d4b43e.
    Full Text Link to Item
  - Parikh, Shailja V., James A. de Lemos, Michael E. Jessen, Emmanouil S. Brilakis, E Magnus Ohman, Anita Y. Chen, Tracy Y. Wang, et al. “Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).” Jacc Cardiovasc Interv 3, no. 4 (April 2010): 419–27. https://doi.org/10.1016/j.jcin.2010.01.012.
    Full Text Link to Item
  - Glickman, Seth W., William Boulding, Matthew Manary, Richard Staelin, Matthew T. Roe, Robert J. Wolosin, E Magnus Ohman, Eric D. Peterson, and Kevin A. Schulman. “Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction.” Circ Cardiovasc Qual Outcomes 3, no. 2 (March 2010): 188–95. https://doi.org/10.1161/CIRCOUTCOMES.109.900597.
    Full Text Link to Item
  - Hudson, Michael, Adam Greenbaum, Laura Brenton, C Michael Gibson, Robert Siegel, Lisa R. Reeves, Miguel Fiol Sala, et al. “Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial.” Jacc Cardiovasc Interv 3, no. 3 (March 2010): 352–59. https://doi.org/10.1016/j.jcin.2009.11.020.
    Full Text Link to Item
  - Krempf, Michel, Klaus G. Parhofer, Ph Gabriel Steg, Deepak L. Bhatt, E Magnus Ohman, Joachim Röther, Shinya Goto, Blandine Pasquet, Peter W. F. Wilson, and Peter W. F. Reach Registry Investigators. “Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).” Am J Cardiol 105, no. 5 (March 1, 2010): 667–71. https://doi.org/10.1016/j.amjcard.2009.10.048.
    Full Text Link to Item
  - Shah, Bimal R., Eric D. Peterson, Anita Y. Chen, Kenneth W. Mahaffey, Elizabeth R. DeLong, E Magnus Ohman, Charles V. Pollack, W Brian Gibler, and Matthew T. Roe. “Influence of clinical trial participation on subsequent antithrombin use.” Clin Cardiol 33, no. 3 (March 2010): E49–55. https://doi.org/10.1002/clc.20581.
    Full Text Link to Item
  - Goto, Kenji, Alexandra J. Lansky, Martin Fahy, Ecatarina Cristea, Frederick Feit, E Magnus Ohman, Harvey D. White, et al. “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.” Circulation 121, no. 7 (February 23, 2010): 853–62. https://doi.org/10.1161/CIRCULATIONAHA.109.877944.
    Full Text Link to Item
  - Cannon, Christopher P., Karen E. Rhee, Robert M. Califf, William E. Boden, Alan T. Hirsch, Mark J. Alberts, Greg Cable, et al. “Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).” Am J Cardiol 105, no. 4 (February 15, 2010): 445–52. https://doi.org/10.1016/j.amjcard.2009.10.014.
    Full Text Link to Item
  - Ohman, E Magnus, and Robert M. Califf. “When can noninferior be superior? The multidimensional nature of clinical decision-making calls for innovative approaches to clinical trials.” J Am Coll Cardiol 55, no. 6 (February 9, 2010): 555–57. https://doi.org/10.1016/j.jacc.2009.10.027.
    Full Text Link to Item
  - Rao, Sunil V., and E Magnus Ohman. “Anticoagulant therapy for percutaneous coronary intervention.” Circ Cardiovasc Interv 3, no. 1 (February 1, 2010): 80–88. https://doi.org/10.1161/CIRCINTERVENTIONS.109.884478.
    Full Text Link to Item
  - Pocock, Stuart J., Roxana Mehran, Tim C. Clayton, Eugenia Nikolsky, Helen Parise, Martin Fahy, Alexandra J. Lansky, et al. “Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.” Circulation 121, no. 1 (January 5, 2010): 43–51. https://doi.org/10.1161/CIRCULATIONAHA.109.878017.
    Full Text Link to Item
  - Cavender, Matthew A., Karen P. Alexander, Samuel Broderick, Linda K. Shaw, Charles B. McCants, Judith Kempf, and E Magnus Ohman. “Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease.” Am Heart J 158, no. 6 (December 2009): 933–40. https://doi.org/10.1016/j.ahj.2009.10.013.
    Full Text Link to Item
  - Meadows, Telly A., Deepak L. Bhatt, Alan T. Hirsch, Mark A. Creager, Robert M. Califf, E Magnus Ohman, Christopher P. Cannon, et al. “Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.” Am Heart J 158, no. 6 (December 2009): 1038–45. https://doi.org/10.1016/j.ahj.2009.09.014.
    Full Text Link to Item
  - Allen LaPointe, Nancy M., Anita Y. Chen, Matthew T. Roe, David J. Cohen, Deborah B. Diercks, James W. Hoekstra, Francis M. Fesmire, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.” Am J Cardiol 104, no. 10 (November 15, 2009): 1324–29. https://doi.org/10.1016/j.amjcard.2009.06.054.
    Full Text Link to Item
  - Ali, Robin C., Chiara Melloni, Fang-Shu Ou, Kenneth Schmader, E Magnus Ohman, Matthew T. Roe, Eric D. Peterson, and Karen P. Alexander. “Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time.” J Am Geriatr Soc 57, no. 11 (November 2009): 1990–96. https://doi.org/10.1111/j.1532-5415.2009.02483.x.
    Full Text Link to Item
  - Amsterdam, Ezra A., Eric D. Peterson, Fang-Shu Ou, L Kristin Newby, Charles V. Pollack, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative.” Am Heart J 158, no. 5 (November 2009): 748-754.e1. https://doi.org/10.1016/j.ahj.2009.09.008.
    Full Text Link to Item
  - Lopes, Renato D., E Magnus Ohman, Christopher B. Granger, Emily F. Honeycutt, Kevin J. Anstrom, Peter B. Berger, Eric M. Crespo, et al. “Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).” Am J Cardiol 104, no. 9 (November 1, 2009): 1285–91. https://doi.org/10.1016/j.amjcard.2009.06.045.
    Full Text Link to Item
  - Diamantouros, P., and E. M. Ohman. “Cardiogenic Shock,” October 30, 2009, 179–89. https://doi.org/10.1002/9781444306347.ch23.
    Full Text
  - Alberts, Mark J., Deepak L. Bhatt, Jean-Louis Mas, E Magnus Ohman, Alan T. Hirsch, Joachim Röther, Geneviève Salette, et al. “Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.” Eur Heart J 30, no. 19 (October 2009): 2318–26. https://doi.org/10.1093/eurheartj/ehp355.
    Full Text Link to Item
  - Gehrie, Erika R., Harmony R. Reynolds, Anita Y. Chen, Brian H. Neelon, Matthew T. Roe, W Brian Gibler, E Magnus Ohman, L Kristin Newby, Eric D. Peterson, and Judith S. Hochman. “Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.” Am Heart J 158, no. 4 (October 2009): 688–94. https://doi.org/10.1016/j.ahj.2009.08.004.
    Full Text Link to Item
  - Nikolsky, Eugenia, Gregg W. Stone, Ajay J. Kirtane, George D. Dangas, Alexandra J. Lansky, Brent McLaurin, A Michael Lincoff, et al. “Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.” J Am Coll Cardiol 54, no. 14 (September 29, 2009): 1293–1302. https://doi.org/10.1016/j.jacc.2009.07.019.
    Full Text Link to Item
  - Fermann, Gregory J., Ali S. Raja, Eric D. Peterson, Matthew T. Roe, James W. Hoekstra, Sarah Milford-Beland, Deborah B. Diercks, et al. “Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.” Clin Cardiol 32, no. 9 (September 2009): 519–25. https://doi.org/10.1002/clc.20629.
    Full Text Link to Item
  - Roe, Matthew T., Anita Y. Chen, Christopher P. Cannon, Sunil Rao, John Rumsfeld, David J. Magid, Ralph Brindis, et al. “Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.” Circ Cardiovasc Qual Outcomes 2, no. 5 (September 2009): 414–20. https://doi.org/10.1161/CIRCOUTCOMES.109.850248.
    Full Text Link to Item
  - Takakuwa, Kevin M., Fang-Shu Ou, Eric D. Peterson, Charles V. Pollack, W Frank Peacock, James W. Hoekstra, E Magnus Ohman, W Brian Gibler, Andra L. Blomkalns, and Matthew T. Roe. “The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.” Clin Cardiol 32, no. 9 (September 2009): 498–505. https://doi.org/10.1002/clc.20626.
    Full Text Link to Item
  - Wang, Tracy Y., L Kristin Newby, Anita Y. Chen, Jyotsna Mulgund, Matthew T. Roe, Ali F. Sonel, Deepak L. Bhatt, et al. “Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome.” Clin Cardiol 32, no. 9 (September 2009): E22–28. https://doi.org/10.1002/clc.20518.
    Full Text Link to Item
  - Cohen, Mauricio G., Steven J. Filby, Matthew T. Roe, Anita Y. Chen, Venu Menon, George A. Stouffer, W Brian Gibler, et al. “The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.” Am Heart J 158, no. 2 (August 2009): 263–70. https://doi.org/10.1016/j.ahj.2009.05.016.
    Full Text Link to Item
  - Mehran, Roxana, Eugenia Nikolsky, Alexandra J. Lansky, Ajay J. Kirtane, Young-Hak Kim, Frederick Feit, Steven Manoukian, et al. “Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.” Jacc Cardiovasc Interv 2, no. 8 (August 2009): 748–57. https://doi.org/10.1016/j.jcin.2009.05.018.
    Full Text Link to Item
  - Prasad, Abhiram, Bernard J. Gersh, Michel E. Bertrand, A Michael Lincoff, Jeffrey W. Moses, E Magnus Ohman, Harvey D. White, et al. “Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.” J Am Coll Cardiol 54, no. 5 (July 28, 2009): 477–86. https://doi.org/10.1016/j.jacc.2009.03.063.
    Full Text Link to Item
  - Jolicoeur, E Marc, E Magnus Ohman, Emily Honeycutt, Richard C. Becker, Eric M. Crespo, Gustavo B. F. Oliveira, David J. Moliterno, Kevin J. Anstrom, and Christopher B. Granger. “Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin.” Am J Cardiol 104, no. 2 (July 15, 2009): 292–97. https://doi.org/10.1016/j.amjcard.2009.03.034.
    Full Text Link to Item
  - Chandra, Abhinav, Seth W. Glickman, Fang-Shu Ou, W Frank Peacock, James K. McCord, Charles B. Cairns, Eric D. Peterson, E Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.” Ann Emerg Med 54, no. 1 (July 2009): 17–25. https://doi.org/10.1016/j.annemergmed.2009.01.025.
    Full Text Link to Item
  - Dumaine, Raphaelle L., Gilles Montalescot, Ph Gabriel Steg, E Magnus Ohman, Kim Eagle, Deepak L. Bhatt, and Deepak L. REACH Registry Investigators. “Renal function, atherothrombosis extent, and outcomes in high-risk patients.” Am Heart J 158, no. 1 (July 2009): 141-148.e1. https://doi.org/10.1016/j.ahj.2009.05.011.
    Full Text Link to Item
  - Mehran, Roxana, Stuart J. Pocock, Gregg W. Stone, Tim C. Clayton, George D. Dangas, Frederick Feit, Steven V. Manoukian, et al. “Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.” Eur Heart J 30, no. 12 (June 2009): 1457–66. https://doi.org/10.1093/eurheartj/ehp110.
    Full Text Link to Item
  - Spinler, Sarah A., Fang-Shu Ou, Matthew T. Roe, W Brian Gibler, E Magnus Ohman, Charles V. Pollack, Karen P. Alexander, and Eric D. Peterson. “Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.” Pharmacotherapy 29, no. 6 (June 2009): 631–38. https://doi.org/10.1592/phco.29.6.631.
    Full Text Link to Item
  - Ebrahimi, Ramin, Cornelius Dyke, Roxana Mehran, Steven V. Manoukian, Frederick Feit, David A. Cox, Bernard J. Gersh, et al. “Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.” J Am Coll Cardiol 53, no. 21 (May 26, 2009): 1965–72. https://doi.org/10.1016/j.jacc.2009.03.006.
    Full Text Link to Item
  - Wang, Tracy Y., Fang-Shu Ou, Matthew T. Roe, Robert A. Harrington, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.” Circulation 119, no. 18 (May 12, 2009): 2454–62. https://doi.org/10.1161/CIRCULATIONAHA.108.827162.
    Full Text Link to Item
  - Bhatt, Deepak L., Eric D. Peterson, Robert A. Harrington, Fang-Shu Ou, Christopher P. Cannon, C Michael Gibson, Neal S. Kleiman, et al. “Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.” Eur Heart J 30, no. 10 (May 2009): 1195–1202. https://doi.org/10.1093/eurheartj/ehp099.
    Full Text Link to Item
  - Halim, Sharif A., Jyotsna Mulgund, Anita Y. Chen, Matthew T. Roe, Eric D. Peterson, W Brian Gibler, E Magnus Ohman, and L Kristin Newby. “Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE.” Circ Cardiovasc Qual Outcomes 2, no. 3 (May 2009): 199–206. https://doi.org/10.1161/CIRCOUTCOMES.108.810127.
    Full Text Link to Item
  - Lansky, Alexandra J., Roxana Mehran, Ecatarina Cristea, Helen Parise, Frederick Feit, E Magnus Ohman, Harvey D. White, et al. “Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).” Am J Cardiol 103, no. 9 (May 1, 2009): 1196–1203. https://doi.org/10.1016/j.amjcard.2009.01.030.
    Full Text Link to Item
  - Subherwal, Sumeet, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, L Kristin Newby, Tracy Y. Wang, et al. “Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.” Circulation 119, no. 14 (April 14, 2009): 1873–82. https://doi.org/10.1161/CIRCULATIONAHA.108.828541.
    Full Text Link to Item
  - Crespo, Eric M., Gustavo B. F. Oliveira, Emily F. Honeycutt, Richard C. Becker, Peter B. Berger, David J. Moliterno, Kevin J. Anstrom, et al. “Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry.” Am Heart J 157, no. 4 (April 2009): 651–57. https://doi.org/10.1016/j.ahj.2009.01.005.
    Full Text Link to Item
  - Lopes, Renato D., Karen P. Alexander, Steven V. Manoukian, Michel E. Bertrand, Frederick Feit, Harvey D. White, Charles V. Pollack, et al. “Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.” J Am Coll Cardiol 53, no. 12 (March 24, 2009): 1021–30. https://doi.org/10.1016/j.jacc.2008.12.021.
    Full Text Link to Item
  - Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, Tracy Y. Wang, Erik M. Ohman, David J. Magid, Michael P. Ho, Stephen D. Wiviott, Benjamin M. Scirica, and Eric D. Peterson. “Antithrombotic Strategy During Percutaneous Coronary Iintervention in NSTEMI: Update From ACTION Registry-GWTG.” Journal of the American College of Cardiology 53, no. 10 (March 10, 2009): A398–A398.
    Link to Item
  - Alexander, Karen P., Michael A. Blazing, Robert S. Rosenson, Elisabeth Hazard, Wilbert S. Aronow, Sidney C. Smith, and E Magnus Ohman. “Management of hyperlipidemia in older adults.” J Cardiovasc Pharmacol Ther 14, no. 1 (March 2009): 49–58. https://doi.org/10.1177/1074248408328927.
    Full Text Link to Item
  - Patel, Uptal D., Fang-Shu Ou, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Eric D. Peterson, and Matthew T. Roe. “Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation acute coronary syndromes.” Am J Kidney Dis 53, no. 3 (March 2009): 426–37. https://doi.org/10.1053/j.ajkd.2008.09.024.
    Full Text Link to Item
  - Pollack, Charles V., Judd E. Hollander, Anita Y. Chen, Eric D. Peterson, Sripal Bangalore, Frank W. Peacock, Christopher P. Cannon, et al. “Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative.” Crit Pathw Cardiol 8, no. 1 (March 2009): 29–33. https://doi.org/10.1097/HPC.0b013e3181980f9f.
    Full Text Link to Item
  - Aoki, Jiro, Alexandra J. Lansky, Roxana Mehran, Jeffery Moses, Michel E. Bertrand, Brent T. McLaurin, David A. Cox, et al. “Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.” Circulation 119, no. 5 (February 10, 2009): 687–98. https://doi.org/10.1161/CIRCULATIONAHA.108.804203.
    Full Text Link to Item
  - Piccini, Jonathan P., and E Magnus Ohman. “ECG interpretation in ST-elevation myocardial infarction: pattern recognition or caliper measurements?” Heart 95, no. 4 (February 2009): 267–68. https://doi.org/10.1136/hrt.2008.153049.
    Full Text Link to Item
  - Lincoff, A Michael, Steven R. Steinhubl, Steven V. Manoukian, Derek Chew, Charles V. Pollack, Frederick Feit, James H. Ware, et al. “Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.” Jacc Cardiovasc Interv 1, no. 6 (December 2008): 639–48. https://doi.org/10.1016/j.jcin.2008.10.004.
    Full Text Link to Item
  - Mehta, Rajendra H., Deepak L. Bhatt, Ph Gabriel Steg, Shinya Goto, Alan T. Hirsch, Chiau-Suong Liau, Joachim Röther, et al. “Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.” Eur Heart J 29, no. 24 (December 2008): 3052–60. https://doi.org/10.1093/eurheartj/ehn478.
    Full Text Link to Item
  - Pinto, Duane S., Gregg W. Stone, Chunxue Shi, Elizabeth S. Dunn, Matthew R. Reynolds, Meghan York, Joshua Walczak, et al. “Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.” J Am Coll Cardiol 52, no. 22 (November 25, 2008): 1758–68. https://doi.org/10.1016/j.jacc.2008.08.021.
    Full Text Link to Item
  - Alexander, Deepu, Noelle Mann, Fang-Shu Ou, Eric D. Peterson, E Magnus Ohman, W Brian Gibler, and Matthew T. Roe. “Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).” Am J Cardiol 102, no. 10 (November 15, 2008): 1335–40. https://doi.org/10.1016/j.amjcard.2008.06.063.
    Full Text Link to Item
  - Goto, Shinya, Deepak L. Bhatt, Joachim Röther, Mark Alberts, Michael D. Hill, Yasuo Ikeda, Shinichiro Uchiyama, et al. “Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.” Am Heart J 156, no. 5 (November 2008): 855-863.e2. https://doi.org/10.1016/j.ahj.2008.06.029.
    Full Text Link to Item
  - Granger, C. B., E. M. Ohman, and R. C. Becker. “Risk factors for thrombocytopenia in patients treated with prolonged heparin therapy - Reply.” Archives of Internal Medicine 168, no. 19 (October 27, 2008): 2171.
  - Kelly, Robert V., Michael J. Gillespie, Mauricio G. Cohen, David P. McLaughlin, E. Magnus Ohman, and George A. Stouffer. “The contrast media iohexol causes vasoconstriction of the proximal left anterior descending coronary artery: implications for appropriate stent sizing.” Angiology 59, no. 5 (October 2008): 574–80. https://doi.org/10.1177/0003319708318375.
    Full Text Link to Item
  - Roe, Matthew T., Fang-Shu Ou, Karen P. Alexander, Laura Kristin Newby, Joanne M. Foody, W Brian Gibler, William E. Boden, Erik Magnus Ohman, Sidney C. Smith, and Eric D. Peterson. “Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.” Eur Heart J 29, no. 20 (October 2008): 2480–88. https://doi.org/10.1093/eurheartj/ehn364.
    Full Text Link to Item
  - Madala, Mohan C., Barry A. Franklin, Anita Y. Chen, Aaron D. Berman, Matthew T. Roe, Eric D. Peterson, E Magnus Ohman, et al. “Obesity and age of first non-ST-segment elevation myocardial infarction.” J Am Coll Cardiol 52, no. 12 (September 16, 2008): 979–85. https://doi.org/10.1016/j.jacc.2008.04.067.
    Full Text Link to Item
  - White, Harvey D., E Magnus Ohman, A Michael Lincoff, Michel E. Bertrand, Antonio Colombo, Brent T. McLaurin, David A. Cox, et al. “Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.” J Am Coll Cardiol 52, no. 10 (September 2, 2008): 807–14. https://doi.org/10.1016/j.jacc.2008.05.036.
    Full Text Link to Item
  - Alexander, Deepu, Fang-Shu Ou, Matthew T. Roe, Charles V. Pollack, E Magnus Ohman, Christopher P. Cannon, W Brian Gibler, et al. “Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).” Am Heart J 156, no. 3 (September 2008): 606–12. https://doi.org/10.1016/j.ahj.2008.05.012.
    Full Text Link to Item
  - Bassand, Jean-Pierre, Christian W. Hamm, Diego Ardissino, Eric Boersma, Andrzej Budaj, Francisco Fernandez-Aviles, Keith A. A. Fox, et al. “[Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].” Rev Port Cardiol 27, no. 9 (September 2008): 1063–1143.
    Link to Item
  - Wang, Tracy Y., Anita Y. Chen, Karen P. Alexander, E Magnus Ohman, W Brian Gibler, Eric D. Peterson, and Matthew T. Roe. “Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.” Am J Med 121, no. 9 (September 2008): 805–10. https://doi.org/10.1016/j.amjmed.2008.04.023.
    Full Text Link to Item
  - Dunlay, Shannon M., Karen P. Alexander, Chiara Melloni, Jennifer L. Kraschnewski, Li Liang, W Brian Gibler, Matthew T. Roe, E Magnus Ohman, and Eric D. Peterson. “Medical records and quality of care in acute coronary syndromes: results from CRUSADE.” Arch Intern Med 168, no. 15 (August 11, 2008): 1692–98. https://doi.org/10.1001/archinte.168.15.1692.
    Full Text Link to Item
  - Cavender, Matthew A., and E Magnus Ohman. “What do you need to know before performing a percutaneous coronary intervention?” Circulation 118, no. 6 (August 5, 2008): 609–11. https://doi.org/10.1161/CIRCULATIONAHA.108.791848.
    Full Text Link to Item
  - Cavender, Matthew A., Sunil V. Rao, and E Magnus Ohman. “Major bleeding: management and risk reduction in acute coronary syndromes.” Expert Opin Pharmacother 9, no. 11 (August 2008): 1869–83. https://doi.org/10.1517/14656566.9.11.1869.
    Full Text Link to Item
  - Melloni, Chiara, Karen P. Alexander, Anita Y. Chen, L Kristin Newby, Matthew T. Roe, Nancy M. Allen LaPointe, Charles V. Pollack, et al. “Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.” Am Heart J 156, no. 2 (August 2008): 209–15. https://doi.org/10.1016/j.ahj.2008.03.023.
    Full Text Link to Item
  - Lopes, R. D., K. S. Pieper, J. R. Horton, S. M. Al-Khatib, L. K. Newby, R. H. Mehta, F. Van de Werf, et al. “Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.” Heart 94, no. 7 (July 2008): 867–73. https://doi.org/10.1136/hrt.2007.134486.
    Full Text Link to Item
  - Mehran, Roxana, Bruce Brodie, David A. Cox, Cindy L. Grines, Barry Rutherford, Deepak L. Bhatt, George Dangas, et al. “The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.” Am Heart J 156, no. 1 (July 2008): 44–56. https://doi.org/10.1016/j.ahj.2008.02.008.
    Full Text Link to Item
  - Roe, Matthew T., Anita Y. Chen, Elizabeth R. Delong, William E. Boden, James E. Calvin, Charles B. Cairns, Sidney C. Smith, et al. “Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.” Am Heart J 156, no. 1 (July 2008): 185–92. https://doi.org/10.1016/j.ahj.2008.01.033.
    Full Text Link to Item
  - Goodman, Shaun G., Venu Menon, Christopher P. Cannon, Gabriel Steg, E Magnus Ohman, and Robert A. Harrington. “Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).” Chest 133, no. 6 Suppl (June 2008): 708S-775S. https://doi.org/10.1378/chest.08-0665.
    Full Text Link to Item
  - Alexander, Karen P., Anita Y. Chen, Tracy Y. Wang, Sunil V. Rao, L Kristin Newby, Nancy M Allen LaPointe, E Magnus Ohman, et al. “Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes.” Am Heart J 155, no. 6 (June 2008): 1047–53. https://doi.org/10.1016/j.ahj.2008.01.009.
    Full Text Link to Item
  - White, Harvey D., Derek P. Chew, James W. Hoekstra, Chadwick D. Miller, Charles V. Pollack, Frederick Feit, A Michael Lincoff, et al. “Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.” J Am Coll Cardiol 51, no. 18 (May 6, 2008): 1734–41. https://doi.org/10.1016/j.jacc.2007.12.052.
    Full Text Link to Item
  - Wang, Tracy Y., Anita Y. Chen, Eric D. Peterson, Richard C. Becker, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.” Eur Heart J 29, no. 9 (May 2008): 1103–9. https://doi.org/10.1093/eurheartj/ehn126.
    Full Text Link to Item
  - Feit, Frederick, Steven V. Manoukian, Ramin Ebrahimi, Charles V. Pollack, E Magnus Ohman, Michael J. Attubato, Roxana Mehran, and Gregg W. Stone. “Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.” J Am Coll Cardiol 51, no. 17 (April 29, 2008): 1645–52. https://doi.org/10.1016/j.jacc.2007.11.081.
    Full Text Link to Item
  - McCord, James, Hani Jneid, Judd E. Hollander, James A. de Lemos, Bojan Cercek, Priscilla Hsue, W Brian Gibler, et al. “Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.” Circulation 117, no. 14 (April 8, 2008): 1897–1907. https://doi.org/10.1161/CIRCULATIONAHA.107.188950.
    Full Text Link to Item
  - Mehta, Rajendra H., Sunil V. Rao, E Magnus Ohman, Eric R. Bates, Gretchen Marcucci, Min Zhang, Karen S. Pieper, et al. “Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.” Eur Heart J 29, no. 7 (April 2008): 880–87. https://doi.org/10.1093/eurheartj/ehn100.
    Full Text Link to Item
  - Melloni, Chiara, Eric D. Peterson, Anita Y. Chen, Lynda A. Szczech, L Kristin Newby, Robert A. Harrington, W Brian Gibler, et al. “Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.” J Am Coll Cardiol 51, no. 10 (March 11, 2008): 991–96. https://doi.org/10.1016/j.jacc.2007.11.045.
    Full Text Link to Item
  - Boden, William E., Prediman K. Shah, Vipul Gupta, and E Magnus Ohman. “Contemporary approach to the diagnosis and management of non-ST-segment elevation acute coronary syndromes.” Prog Cardiovasc Dis 50, no. 5 (March 2008): 311–51. https://doi.org/10.1016/j.pcad.2007.11.003.
    Full Text Link to Item
  - Chan, Mark Y., Richard C. Becker, Robert A. Harrington, Eric D. Peterson, Paul W. Armstrong, Harvey White, Keith A. A. Fox, E Magnus Ohman, and Matthew T. Roe. “Noninvasive, medical management for non-ST-elevation acute coronary syndromes.” Am Heart J 155, no. 3 (March 2008): 397–407. https://doi.org/10.1016/j.ahj.2007.11.014.
    Full Text Link to Item
  - Diercks, Deborah B., and E Magnus Ohman. “Hypertension with acute coronary syndrome and heart failure.” Ann Emerg Med 51, no. 3 Suppl (March 2008): S34–36. https://doi.org/10.1016/j.annemergmed.2007.11.012.
    Full Text Link to Item
  - Jolicoeur, E Marc, Christopher B. Granger, Timothy D. Henry, David J. Holmes, Carl J. Pepine, Daniel Mark, Bernard R. Chaitman, Bernard J. Gersh, E Magnus Ohman, and E Magnus Working Group Members. “Clinical and research issues regarding chronic advanced coronary artery disease: part I: Contemporary and emerging therapies.” Am Heart J 155, no. 3 (March 2008): 418–34. https://doi.org/10.1016/j.ahj.2007.12.004.
    Full Text Link to Item
  - Melloni, Chiara, Karen P. Alexander, Sarah Milford-Beland, L Kristin Newby, Lynda A. Szczech, Charles V. Pollack, J Douglas Kirk, et al. “Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease.” Clin Cardiol 31, no. 3 (March 2008): 125–29. https://doi.org/10.1002/clc.20210.
    Full Text Link to Item
  - Jolicoeur, E Marc, E Magnus Ohman, Robert Temple, Norman Stockbridge, Sidney Smith, Daniel Mark, Robert M. Califf, et al. “Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.” Am Heart J 155, no. 3 (March 2008): 435–44. https://doi.org/10.1016/j.ahj.2007.12.005.
    Full Text Link to Item
  - Wang, Tracy Y., Lee A. Robinson, Fang-Shu Ou, Matthew T. Roe, E Magnus Ohman, W Brian Gibler, Sidney C. Smith, Eric D. Peterson, and Richard C. Becker. “Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.” Am Heart J 155, no. 2 (February 2008): 361–68. https://doi.org/10.1016/j.ahj.2007.09.003.
    Full Text Link to Item
  - Rao, Sunil V., Padma R. Kaul, Lawrence Liao, Paul W. Armstrong, E Magnus Ohman, Christopher B. Granger, Robert M. Califf, Robert A. Harrington, Eric L. Eisenstein, and Daniel B. Mark. “Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes.” Am Heart J 155, no. 2 (February 2008): 369–74. https://doi.org/10.1016/j.ahj.2007.10.014.
    Full Text Link to Item
  - Berger, Jeffrey S., Amanda Stebbins, Christopher B. Granger, Eric M. Ohman, Paul W. Armstrong, Frans Van de Werf, Harvey D. White, et al. “Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.” Circulation 117, no. 2 (January 15, 2008): 192–99. https://doi.org/10.1161/CIRCULATIONAHA.107.729558.
    Full Text Link to Item
  - Oliveira, Gustavo B. F., Eric M. Crespo, Richard C. Becker, Emily F. Honeycutt, Charles S. Abrams, Kevin J. Anstrom, Peter B. Berger, et al. “Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.” Arch Intern Med 168, no. 1 (January 14, 2008): 94–102. https://doi.org/10.1001/archinternmed.2007.65.
    Full Text Link to Item
  - Peacock, W Frank, Deepak L. Bhatt, Deborah Diercks, Ezra Amsterdam, Abhinav Chandra, E Magnus Ohman, David F. M. Brown, and James Januzzi. “Cardiologists' and emergency physicians' perspectives on and knowledge of reperfusion guidelines pertaining to ST-segment-elevation myocardial infarction.” Tex Heart Inst J 35, no. 2 (2008): 152–61.
    Link to Item
  - Röther, Joachim, Mark J. Alberts, Emmanuel Touzé, Jean-Louis Mas, Michael D. Hill, Patrik Michel, Deepak L. Bhatt, et al. “Risk factor profile and management of cerebrovascular patients in the REACH Registry.” Cerebrovasc Dis 25, no. 4 (2008): 366–74. https://doi.org/10.1159/000120687.
    Full Text Link to Item
  - Atwater, Brett D., Sarah Milford-Beland, L Kristin Newby, Adrian F. Hernandez, W Frank Peacock, W Brian Gibler, Robert H. Christenson, E Magnus Ohman, Eric D. Peterson, and Matthew T. Roe. “Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes.” Am J Cardiol 100, no. 12 (December 15, 2007): 1727–33. https://doi.org/10.1016/j.amjcard.2007.07.023.
    Full Text Link to Item
  - Stone, Gregg W., James H. Ware, Michel E. Bertrand, A Michael Lincoff, Jeffrey W. Moses, E Magnus Ohman, Harvey D. White, et al. “Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.” Jama 298, no. 21 (December 5, 2007): 2497–2506. https://doi.org/10.1001/jama.298.21.2497.
    Full Text Link to Item
  - Glickman, Seth W., William Boulding, Richard Staelin, Jyotsna Mulgund, Matthew T. Roe, Barbara L. Lytle, John S. Rumsfeld, et al. “A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.” Am Heart J 154, no. 6 (December 2007): 1206–20. https://doi.org/10.1016/j.ahj.2007.08.001.
    Full Text Link to Item
  - Lytle, Barbara L., Elizabeth S. Fraulo, Jyotsna Mulgund, Vincent A. Miller, Matthew T. Roe, Sidney C. Smith, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “What aspects of hospital culture influence quality?” Crit Pathw Cardiol 6, no. 4 (December 2007): 145–49. https://doi.org/10.1097/HPC.0b013e3181599209.
    Full Text Link to Item
  - Blomkalns, Andra L., Matthew T. Roe, Eric D. Peterson, E Magnus Ohman, Elizabeth S. Fraulo, and W Brian Gibler. “Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative.” Acad Emerg Med 14, no. 11 (November 2007): 949–54. https://doi.org/10.1197/j.aem.2007.06.017.
    Full Text Link to Item
  - Diercks, Deborah B., Matthew T. Roe, Anita Y. Chen, W Franklin Peacock, J Douglas Kirk, Charles V. Pollack, W Brian Gibler, Sidney C. Smith, Magnus Ohman, and Eric D. Peterson. “Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.” Ann Emerg Med 50, no. 5 (November 2007): 489–96. https://doi.org/10.1016/j.annemergmed.2007.03.033.
    Full Text Link to Item
  - Zia, Mohammad I., Shaun G. Goodman, Eric D. Peterson, Jyotsna Mulgund, Anita Y. Chen, Anatoly Langer, Mary Tan, et al. “Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.” Can J Cardiol 23, no. 13 (November 2007): 1073–79. https://doi.org/10.1016/s0828-282x(07)70876-0.
    Full Text Link to Item
  - Shah, Monica R., Vic Hasselblad, Gudaye Tasissa, Robert H. Christenson, Cynthia Binanay, Christopher M. O’Connor, E Magnus Ohman, Lynne W. Stevenson, and Robert M. Califf. “Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).” Am J Cardiol 100, no. 9 (November 1, 2007): 1427–33. https://doi.org/10.1016/j.amjcard.2007.06.035.
    Full Text Link to Item
  - Shah, Bimal R., Seth W. Glickman, Li Liang, W Brian Gibler, E Magnus Ohman, Charles V. Pollack, Matthew T. Roe, and Eric D. Peterson. “The impact of for-profit hospital status on the care and outcomes of patients with non-ST-segment elevation myocardial infarction: results from the CRUSADE Initiative.” J Am Coll Cardiol 50, no. 15 (October 9, 2007): 1462–68. https://doi.org/10.1016/j.jacc.2007.07.012.
    Full Text Link to Item
  - Greenbaum, Adam B., E Magnus Ohman, C Michael Gibson, Steven Borzak, Amanda L. Stebbins, Mei Lu, Michel R. Le May, Jill E. Stankowski, Hakan Emanuelsson, and W Douglas Weaver. “Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.” Am Heart J 154, no. 4 (October 2007): 702–9. https://doi.org/10.1016/j.ahj.2007.06.001.
    Full Text Link to Item
  - Roe, Matthew T., Anita Y. Chen, Rajendra H. Mehta, Yun Li, Ralph G. Brindis, Sidney C. Smith, John S. Rumsfeld, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.” Circulation 116, no. 10 (September 4, 2007): 1153–61. https://doi.org/10.1161/CIRCULATIONAHA.107.697003.
    Full Text Link to Item
  - Jolicoeur, E Marc, Tracy Wang, Renato D. Lopes, and E Magnus Ohman. “Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.” Curr Cardiol Rep 9, no. 5 (September 2007): 396–405. https://doi.org/10.1007/BF02938367.
    Full Text Link to Item
  - Sen, Souvik, Alan Hinderliter, Pranab K. Sen, Jennifer Simmons, James Beck, Steven Offenbacher, E Magnus Ohman, and Stephen M. Oppenheimer. “Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack.” Circulation 116, no. 8 (August 21, 2007): 928–35. https://doi.org/10.1161/CIRCULATIONAHA.106.671727.
    Full Text Link to Item
  - Li, Guohong, Alison C. Keenan, Justin C. Young, Margaret J. Hall, Zehra Pamuklar, E Magnus Ohman, Steven R. Steinhubl, and Susan S. Smyth. “Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils.” Arterioscler Thromb Vasc Biol 27, no. 8 (August 2007): 1850–56. https://doi.org/10.1161/ATVBAHA.107.144576.
    Full Text Link to Item
  - Miller, Chadwick D., Matthew T. Roe, Jyotsna Mulgund, James W. Hoekstra, Renato Santos, Charles V. Pollack, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.” Am J Med 120, no. 8 (August 2007): 685–92. https://doi.org/10.1016/j.amjmed.2007.04.016.
    Full Text Link to Item
  - Wang, Tracy Y., Anita Y. Chen, Matthew T. Roe, Karen P. Alexander, L Kristin Newby, Sidney C. Smith, Sripal Bangalore, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative.” Am J Cardiol 100, no. 3 (August 1, 2007): 391–96. https://doi.org/10.1016/j.amjcard.2007.03.035.
    Full Text Link to Item
  - LaPointe, Nancy M Allen, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Charles V. Pollack, Barbara L. Lytle, Magnus E. Ohman, Brian W. Gibler, and Eric D. Peterson. “Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.” Arch Intern Med 167, no. 14 (July 23, 2007): 1539–44. https://doi.org/10.1001/archinte.167.14.1539.
    Full Text Link to Item
  - Peterson, Eric D., E Magnus Ohman, Ralph G. Brindis, David J. Cohen, and David J. Magid. “Development of systems of care for ST-elevation myocardial infarction patients: evaluation and outcomes.” Circulation 116, no. 2 (July 10, 2007): e64–67. https://doi.org/10.1161/CIRCULATIONAHA.107.184051.
    Full Text Link to Item
  - Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, William, Jean-Pierre Bassand, Christian W. Hamm, Diego Ardissino, Eric Boersma, Andrzej Budaj, Francisco Fernández-Avilés, et al. “Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.” Eur Heart J 28, no. 13 (July 2007): 1598–1660. https://doi.org/10.1093/eurheartj/ehm161.
    Full Text Link to Item
  - Glickman, Seth W., Fang-Shu Ou, Elizabeth R. DeLong, Matthew T. Roe, Barbara L. Lytle, Jyotsna Mulgund, John S. Rumsfeld, et al. “Pay for performance, quality of care, and outcomes in acute myocardial infarction.” Jama 297, no. 21 (June 6, 2007): 2373–80. https://doi.org/10.1001/jama.297.21.2373.
    Full Text Link to Item
  - Ohman, E. M., and A. E. Raizner. “Success of identification and treatment of heparin-induced thrombocytopenia.” Acc Cardiosource Review Journal 16, no. 6 (June 1, 2007): 23–26.
  - Tickoo, Sumit, Matthew T. Roe, Eric D. Peterson, Sarah Milford-Beland, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Christopher P. Cannon, and Christopher P. CRUSADE Investigators. “Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative.” Am J Cardiol 99, no. 11 (June 1, 2007): 1496–99. https://doi.org/10.1016/j.amjcard.2007.01.021.
    Full Text Link to Item
  - Bennett, Kyla M., Adrian F. Hernandez, Anita Y. Chen, Jyotsna Mulgund, L Kristin Newby, John S. Rumsfeld, Judith S. Hochman, et al. “Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.” Am J Cardiol 99, no. 10 (May 15, 2007): 1351–56. https://doi.org/10.1016/j.amjcard.2006.12.057.
    Full Text Link to Item
  - Tricoci, Pierluigi, Eric D. Peterson, Anita Y. Chen, L Kristin Newby, Robert A. Harrington, Adam B. Greenbaum, Chistopher P. Cannon, et al. “Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).” Am J Cardiol 99, no. 10 (May 15, 2007): 1389–93. https://doi.org/10.1016/j.amjcard.2006.12.066.
    Full Text Link to Item
  - Alexander, Karen P., L Kristin Newby, Christopher P. Cannon, Paul W. Armstrong, W Brian Gibler, Michael W. Rich, Frans Van de Werf, et al. “Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.” Circulation 115, no. 19 (May 15, 2007): 2549–69. https://doi.org/10.1161/CIRCULATIONAHA.107.182615.
    Full Text Link to Item
  - Alexander, Karen P., L Kristin Newby, Paul W. Armstrong, Christopher P. Cannon, W Brian Gibler, Michael W. Rich, Frans Van de Werf, et al. “Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.” Circulation 115, no. 19 (May 15, 2007): 2570–89. https://doi.org/10.1161/CIRCULATIONAHA.107.182616.
    Full Text Link to Item
  - Harrington, Robert A., and E Magnus Ohman. “The enigma of drug-eluting stents: hope, hype, humility, and advancing patient care.” Jama 297, no. 18 (May 9, 2007): 2028–30. https://doi.org/10.1001/jama.297.18.2028.
    Full Text Link to Item
  - Dzavík, Vladimir, Gad Cotter, Harmony R. Reynolds, John H. Alexander, Krishnan Ramanathan, Amanda L. Stebbins, David Hathaway, et al. “Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.” Eur Heart J 28, no. 9 (May 2007): 1109–16. https://doi.org/10.1093/eurheartj/ehm075.
    Full Text Link to Item
  - Gogo, Prospero B., Harold L. Dauerman, Jyotsna Mulgund, E Magnus Ohman, Manesh R. Patel, David J. Cohen, Jorge F. Saucedo, et al. “Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).” Am J Cardiol 99, no. 9 (May 1, 2007): 1222–26. https://doi.org/10.1016/j.amjcard.2006.12.037.
    Full Text Link to Item
  - Skolnick, Adam H., Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Charles V. Pollack, E Magnus Ohman, John S. Rumsfeld, W Brian Gibler, Eric D. Peterson, and David J. Cohen. “Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative.” J Am Coll Cardiol 49, no. 17 (May 1, 2007): 1790–97. https://doi.org/10.1016/j.jacc.2007.01.066.
    Full Text Link to Item
  - Roe, Matthew T., Abdul R. Halabi, Rajendra H. Mehta, Anita Y. Chen, L Kristin Newby, Robert A. Harrington, Sidney C. Smith, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction.” Am Heart J 153, no. 4 (April 2007): 507–14. https://doi.org/10.1016/j.ahj.2006.12.018.
    Full Text Link to Item
  - Manoukian, Steven V., Frederick Feit, Roxana Mehran, Michele D. Voeltz, Ramin Ebrahimi, Martial Hamon, George D. Dangas, et al. “Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.” J Am Coll Cardiol 49, no. 12 (March 27, 2007): 1362–68. https://doi.org/10.1016/j.jacc.2007.02.027.
    Full Text Link to Item
  - Steg, Ph Gabriel, Deepak L. Bhatt, Peter W. F. Wilson, Ralph D’Agostino, E Magnus Ohman, Joachim Röther, Chiau-Suong Liau, et al. “One-year cardiovascular event rates in outpatients with atherothrombosis.” Jama 297, no. 11 (March 21, 2007): 1197–1206. https://doi.org/10.1001/jama.297.11.1197.
    Full Text Link to Item
  - Stone, Gregg W., Harvey D. White, E Magnus Ohman, Michel E. Bertrand, A Michael Lincoff, Brent T. McLaurin, David A. Cox, et al. “Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.” Lancet 369, no. 9565 (March 17, 2007): 907–19. https://doi.org/10.1016/S0140-6736(07)60450-4.
    Full Text Link to Item
  - Mehta, Rajendra H., Robert M. Califf, Qinghong Yang, Karen S. Pieper, Harvey D. White, E Magnus Ohman, Robert A. Harrington, and Christopher B. Granger. “Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.” Am J Cardiol 99, no. 6 (March 15, 2007): 793–96. https://doi.org/10.1016/j.amjcard.2006.10.035.
    Full Text Link to Item
  - Mehta, Rajendra H., Sarah Milford-Beland, Eric D. Peterson, Deepak L. Bhatt, Michael E. Farkouh, Gerald X. Brogan, W Brian Gibler, E Magnus Ohman, and Matthew T. Roe. “Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes.” Diabetes Care 30, no. 3 (March 2007): 731–33. https://doi.org/10.2337/dc06-1367.
    Full Text Link to Item
  - Stone, Gregg W., Michel E. Bertrand, Jeffrey W. Moses, E Magnus Ohman, A Michael Lincoff, James H. Ware, Stuart J. Pocock, et al. “Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.” Jama 297, no. 6 (February 14, 2007): 591–602. https://doi.org/10.1001/jama.297.6.591.
    Full Text Link to Item
  - Bassand, J. P., C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernández-Avilés, K. A. A. Fox, et al. “ESC 2007 Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.” Revista Espanola De Cardiologia 60, no. 10 (January 1, 2007). https://doi.org/10.1157/13111518.
    Full Text
  - Patel, Manesh R., Anita Y. Chen, Matthew T. Roe, E Magnus Ohman, L Kristin Newby, Robert A. Harrington, Sydney C. Smith, W Brian Gibler, James E. Calvin, and Eric D. Peterson. “A comparison of acute coronary syndrome care at academic and nonacademic hospitals.” Am J Med 120, no. 1 (January 2007): 40–46. https://doi.org/10.1016/j.amjmed.2006.10.008.
    Full Text Link to Item
  - Touzé, Emmanuel, Jean-Louis Mas, Joachim Röther, Shinya Goto, Alan T. Hirsch, Yasuo Ikeda, Chiau-Suong Liau, et al. “Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry.” Stroke 37, no. 12 (December 2006): 2880–85. https://doi.org/10.1161/01.STR.0000249411.44097.5b.
    Full Text Link to Item
  - Stone, Gregg W., Brent T. McLaurin, David A. Cox, Michel E. Bertrand, A Michael Lincoff, Jeffrey W. Moses, Harvey D. White, et al. “Bivalirudin for patients with acute coronary syndromes.” N Engl J Med 355, no. 21 (November 23, 2006): 2203–16. https://doi.org/10.1056/NEJMoa062437.
    Full Text Link to Item
  - Calvin, James E., Matthew T. Roe, Anita Y. Chen, Rajendra H. Mehta, Gerard X. Brogan, Elizabeth R. Delong, Dan J. Fintel, et al. “Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes.” Ann Intern Med 145, no. 10 (November 21, 2006): 739–48. https://doi.org/10.7326/0003-4819-145-10-200611210-00006.
    Full Text Link to Item
  - Tricoci, Pierluigi, Eric D. Peterson, Jyotsna Mulgund, L Kristin Newby, Jorge F. Saucedo, Neil S. Kleiman, Deepak L. Bhatt, et al. “Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE).” Am J Cardiol 98, no. 9 (November 1, 2006): 1172–76. https://doi.org/10.1016/j.amjcard.2006.05.047.
    Full Text Link to Item
  - Mehta, Rajendra H., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Ralph G. Brindis, Sidney C. Smith, et al. “Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.” Arch Intern Med 166, no. 18 (October 9, 2006): 2027–34. https://doi.org/10.1001/archinte.166.18.2027.
    Full Text Link to Item
  - Mehta, Rajendra H., L Kristin Newby, Yogin Patel, James W. Hoekstra, Chadwick D. Miller, Anita Y. Chen, Barbara L. Lytle, et al. “The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromes.” Am Heart J 152, no. 4 (October 2006): 648–60. https://doi.org/10.1016/j.ahj.2006.04.015.
    Full Text Link to Item
  - Patel, Manesh R., Anita Y. Chen, Eric D. Peterson, L Kristin Newby, Charles V. Pollack, Ralph G. Brindis, C Michael Gibson, et al. “Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.” Am Heart J 152, no. 4 (October 2006): 641–47. https://doi.org/10.1016/j.ahj.2006.02.035.
    Full Text Link to Item
  - Alexander, Karen P., Anita Y. Chen, L Kristin Newby, Janice B. Schwartz, Rita F. Redberg, Judith S. Hochman, Matthew T. Roe, et al. “Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.” Circulation 114, no. 13 (September 26, 2006): 1380–87. https://doi.org/10.1161/CIRCULATIONAHA.106.620815.
    Full Text Link to Item
  - Mehta, Rajendra H., Anita Y. Chen, Charles V. Pollack, Matthew T. Roe, Robert J. Zalenski, Elizabeth A. Clements, W Brian Gibler, E Magnus Ohman, Robert A. Harrington, and Eric D. Peterson. “Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.” Am J Cardiol 98, no. 5 (September 1, 2006): 624–27. https://doi.org/10.1016/j.amjcard.2006.03.040.
    Full Text Link to Item
  - Mehta, Rajendra H., Matthew T. Roe, Jyotsna Mulgund, E Magnus Ohman, Christopher P. Cannon, W Brian Gibler, Charles V. Pollack, Sidney C. Smith, T Bruce Ferguson, and Eric D. Peterson. “Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.” J Am Coll Cardiol 48, no. 2 (July 18, 2006): 281–86. https://doi.org/10.1016/j.jacc.2006.04.029.
    Full Text Link to Item
  - Diercks, Deborah B., Matthew T. Roe, Jyotsna Mulgund, Charles V. Pollack, J Douglas Kirk, W Brian Gibler, E Magnus Ohman, Sidney C. Smith, William E. Boden, and Eric D. Peterson. “The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.” Am Heart J 152, no. 1 (July 2006): 140–48. https://doi.org/10.1016/j.ahj.2005.09.024.
    Full Text Link to Item
  - Menon, Venu, John S. Rumsfeld, Matthew T. Roe, Mauricio G. Cohen, Eric D. Peterson, Ralph G. Brindis, Anita Y. Chen, et al. “Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes.” Am J Med 119, no. 7 (July 2006): 584–90. https://doi.org/10.1016/j.amjmed.2006.01.018.
    Full Text Link to Item
  - Cohen, Mauricio G., Matthew T. Roe, Jyotsna Mulgund, Eric D. Peterson, Ali F. Sonel, Venu Menon, Sidney C. Smith, et al. “Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE).” Am Heart J 152, no. 1 (July 2006): 110–17. https://doi.org/10.1016/j.ahj.2005.09.003.
    Full Text Link to Item
  - Roe, Matthew T., Anita Y. Chen, Arthur L. Riba, Raj Gopal Goswami, W Frank Peacock, Charles V. Pollack, Sean P. Collins, et al. “Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.” Am J Cardiol 97, no. 12 (June 15, 2006): 1707–12. https://doi.org/10.1016/j.amjcard.2005.12.068.
    Full Text Link to Item
  - Singh, Kanwar P., Matthew T. Roe, Eric D. Peterson, Anita Y. Chen, Kenneth W. Mahaffey, Shaun G. Goodman, Robert A. Harrington, et al. “Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative.” J Thromb Thrombolysis 21, no. 3 (June 2006): 211–20. https://doi.org/10.1007/s11239-006-5708-0.
    Full Text Link to Item
  - Roe, Matthew T., Eric D. Peterson, L Kristin Newby, Anita Y. Chen, Charles V. Pollack, Ralph G. Brindis, Robert A. Harrington, et al. “The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.” Am Heart J 151, no. 6 (June 2006): 1205–13. https://doi.org/10.1016/j.ahj.2005.08.006.
    Full Text Link to Item
  - Kaul, Padma, Wei-Ching Chang, A Michael Lincoff, Philip Aylward, Amadeo Betriu, Christoph Bode, Robert M. Califf, et al. “Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial.” Eur Heart J 27, no. 10 (May 2006): 1198–1206. https://doi.org/10.1093/eurheartj/ehi854.
    Full Text Link to Item
  - Peterson, Eric D., Matthew T. Roe, Jyotsna Mulgund, Elizabeth R. DeLong, Barbara L. Lytle, Ralph G. Brindis, Sidney C. Smith, et al. “Association between hospital process performance and outcomes among patients with acute coronary syndromes.” Jama 295, no. 16 (April 26, 2006): 1912–20. https://doi.org/10.1001/jama.295.16.1912.
    Full Text Link to Item
  - Tricoci, Pierluigi, Matthew T. Roe, Jyotsna Mulgund, L Kristin Newby, Sidney C. Smith, Charles V. Pollack, Dan J. Fintel, et al. “Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.” Arch Intern Med 166, no. 7 (April 10, 2006): 806–11. https://doi.org/10.1001/archinte.166.7.806.
    Full Text Link to Item
  - Henry, Timothy D., James M. Atkins, Michael S. Cunningham, Gary S. Francis, William J. Groh, Robert A. Hong, Karl B. Kern, et al. “ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?” J Am Coll Cardiol 47, no. 7 (April 4, 2006): 1339–45. https://doi.org/10.1016/j.jacc.2005.05.101.
    Full Text Link to Item
  - Kupchak, Peter, Alan H. B. Wu, Farooq Ghani, L Kristen Newby, E Magnus Ohman, and Robert H. Christenson. “Influence of imprecision on ROC curve analysis for cardiac markers.” Clin Chem 52, no. 4 (April 2006): 752–53. https://doi.org/10.1373/clinchem.2005.064477.
    Full Text Link to Item
  - Ohman, E Magnus, Deepak L. Bhatt, P Gabriel Steg, Shinya Goto, Alan T. Hirsch, Chiau-Suong Liau, Jean-Louis Mas, et al. “The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.” Am Heart J 151, no. 4 (April 2006): 786.e1-786.10. https://doi.org/10.1016/j.ahj.2005.11.004.
    Full Text Link to Item
  - Han, Jin H., Abhinav Chandra, Jyotsna Mulgund, Matthew T. Roe, Eric D. Peterson, Lynda A. Szczech, Uptal Patel, E Magnus Ohman, Christopher J. Lindsell, and W Brian Gibler. “Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.” Am J Med 119, no. 3 (March 2006): 248–54. https://doi.org/10.1016/j.amjmed.2005.08.057.
    Full Text Link to Item
  - Diercks, Deborah B., W Frank Peacock, Brian C. Hiestand, Anita Y. Chen, Charles V. Pollack, J Douglas Kirk, Sidney C. Smith, et al. “Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative).” Am J Cardiol 97, no. 4 (February 15, 2006): 437–42. https://doi.org/10.1016/j.amjcard.2005.09.073.
    Full Text Link to Item
  - Januzzi, James L., L Kristin Newby, Sabina A. Murphy, Karen Pieper, Elliot M. Antman, David A. Morrow, Marc S. Sabatine, E Magnus Ohman, Christopher P. Cannon, and Eugene Braunwald. “Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.” Am Heart J 151, no. 2 (February 2006): 360–66. https://doi.org/10.1016/j.ahj.2005.04.021.
    Full Text Link to Item
  - Newby, L Kristin, Matthew T. Roe, Anita Y. Chen, E Magnus Ohman, Robert H. Christenson, Charles V. Pollack, James W. Hoekstra, et al. “Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.” J Am Coll Cardiol 47, no. 2 (January 17, 2006): 312–18. https://doi.org/10.1016/j.jacc.2005.08.062.
    Full Text Link to Item
  - Bhatt, Deepak L., P Gabriel Steg, E Magnus Ohman, Alan T. Hirsch, Yasuo Ikeda, Jean-Louis Mas, Shinya Goto, et al. “International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.” Jama 295, no. 2 (January 11, 2006): 180–89. https://doi.org/10.1001/jama.295.2.180.
    Full Text Link to Item
  - Brogan, Gerard X., Eric D. Peterson, Jyotsna Mulgund, Deepak L. Bhatt, E Magnus Ohman, W Brian Gibler, Charles V. Pollack, Michael E. Farkouh, and Matthew T. Roe. “Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.” Diabetes Care 29, no. 1 (January 2006): 9–14.
    Link to Item
  - Santa-Cruz, Richard A., Mauricio G. Cohen, and E Magnus Ohman. “Aortic counterpulsation: a review of the hemodynamic effects and indications for use.” Catheter Cardiovasc Interv 67, no. 1 (January 2006): 68–77. https://doi.org/10.1002/ccd.20552.
    Full Text Link to Item
  - Galla, John M., Kenneth W. Mahaffey, Shelly K. Sapp, John H. Alexander, Matthew T. Roe, E Magnus Ohman, Christopher B. Granger, et al. “Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.” Am Heart J 151, no. 1 (January 2006): 16–24. https://doi.org/10.1016/j.ahj.2005.01.045.
    Full Text Link to Item
  - Mehta, Rajendra H., David Marks, Robert M. Califf, SeeHyang Sohn, Karen S. Pieper, Frans Van de Werf, Eric D. Peterson, et al. “Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction.” Am J Med 119, no. 1 (January 2006): 70.e1-70.e8. https://doi.org/10.1016/j.amjmed.2005.07.043.
    Full Text Link to Item
  - Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, C Michael Gibson, Nancy M. Allen-LaPointe, Charles Pollack, et al. “Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.” Jama 294, no. 24 (December 28, 2005): 3108–16. https://doi.org/10.1001/jama.294.24.3108.
    Full Text Link to Item
  - Ryan, Jason W., Eric D. Peterson, Anita Y. Chen, Matthew T. Roe, E Magnus Ohman, Christopher P. Cannon, Peter B. Berger, et al. “Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.” Circulation 112, no. 20 (November 15, 2005): 3049–57. https://doi.org/10.1161/CIRCULATIONAHA.105.582346.
    Full Text Link to Item
  - Alexander, Karen P., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Joanne M. Foody, William E. Boden, et al. “Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.” J Am Coll Cardiol 46, no. 8 (October 18, 2005): 1479–87. https://doi.org/10.1016/j.jacc.2005.05.084.
    Full Text Link to Item
  - Yang, Xin, Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, Ralph G. Brindis, Sunil V. Rao, W Brian Gibler, E Magnus Ohman, Eric D. Peterson, and Eric D. CRUSADE Investigators. “The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.” J Am Coll Cardiol 46, no. 8 (October 18, 2005): 1490–95. https://doi.org/10.1016/j.jacc.2005.06.072.
    Full Text Link to Item
  - Reddan, Donal N., Lynda Szczech, Manjushri V. Bhapkar, David J. Moliterno, Robert M. Califf, E Magnus Ohman, Peter B. Berger, et al. “Renal function, concomitant medication use and outcomes following acute coronary syndromes.” Nephrol Dial Transplant 20, no. 10 (October 2005): 2105–12. https://doi.org/10.1093/ndt/gfh981.
    Full Text Link to Item
  - Kandzari, David E., Matthew T. Roe, E Magnus Ohman, Sarah Milford-Beland, Anita Y. Chen, Barbara L. Lytle, David J. Cohen, et al. “Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.” Am J Cardiol 96, no. 6 (September 15, 2005): 750–55. https://doi.org/10.1016/j.amjcard.2005.05.015.
    Full Text Link to Item
  - Roe, Matthew T., Eric D. Peterson, Yun Li, Charles V. Pollack, Robert H. Christenson, W Frank Peacock, Francis M. Fesmire, et al. “Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes.” Arch Intern Med 165, no. 16 (September 12, 2005): 1870–76. https://doi.org/10.1001/archinte.165.16.1870.
    Full Text Link to Item
  - Kelly, Robert V., Walter A. Tan, Hyunsoon Cho, Gail Tudor, E Magnus Ohman, and Allan D. Struthers. “Prevalence of symptomatic diastolic heart failure in patients hospitalized with cerebral or peripheral vascular disease.” Congest Heart Fail 11, no. 5 (September 2005): 256–61. https://doi.org/10.1111/j.1527-5299.2005.04337.x.
    Full Text Link to Item
  - Turer, Aslan T., Kenneth W. Mahaffey, Dianne Gallup, W Douglas Weaver, Robert H. Christenson, Nathan R. Every, and E Magnus Ohman. “Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.” Curr Control Trials Cardiovasc Med 6 (August 23, 2005): 12. https://doi.org/10.1186/1468-6708-6-12.
    Full Text Link to Item
  - Gibler, W Brian, Christopher P. Cannon, Andra L. Blomkalns, Douglas M. Char, Barbara J. Drew, Judd E. Hollander, Allan S. Jaffe, et al. “Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency department.” Ann Emerg Med 46, no. 2 (August 2005): 185–97. https://doi.org/10.1016/j.annemergmed.2005.04.022.
    Full Text Link to Item
  - Ohman, E Magnus, and Patricia P. Chang. “Improving quality of life after cardiogenic shock: do more revascularization!.” J Am Coll Cardiol 46, no. 2 (July 19, 2005): 274–76. https://doi.org/10.1016/j.jacc.2005.04.018.
    Full Text Link to Item
  - Kaul, P., L. K. Newby, Y. Fu, D. B. Mark, S. G. Goodman, G. S. Wagner, R. A. Harrington, et al. “Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns.” Heart 91, no. 7 (July 2005): 876–81. https://doi.org/10.1136/hrt.2004.042887.
    Full Text Link to Item
  - Ohman, E Magnus, Frans Van de Werf, Elliott M. Antman, Robert M. Califf, James A. de Lemos, C Michael Gibson, Renee L. Oliverio, et al. “Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial.” Am Heart J 150, no. 1 (July 2005): 79–88. https://doi.org/10.1016/j.ahj.2005.01.007.
    Full Text Link to Item
  - Meine, Trip J., Matthew T. Roe, Anita Y. Chen, Manesh R. Patel, Jeffrey B. Washam, E Magnus Ohman, W Frank Peacock, et al. “Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.” Am Heart J 149, no. 6 (June 2005): 1043–49. https://doi.org/10.1016/j.ahj.2005.02.010.
    Full Text Link to Item
  - Sánchez, Carlos D., L Kristin Newby, Darren K. McGuire, Vic Hasselblad, Mark N. Feinglos, and E Magnus Ohman. “Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes.” Am J Cardiol 95, no. 11 (June 1, 2005): 1290–94. https://doi.org/10.1016/j.amjcard.2005.01.070.
    Full Text Link to Item
  - Mehta, Rajendra H., Robert M. Califf, Jyotsna Garg, Karen S. Pieper, John H. Alexander, David J. Moliterno, Frans Van de Werf, et al. “Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.” Am J Cardiol 95, no. 11 (June 1, 2005): 1371–75. https://doi.org/10.1016/j.amjcard.2005.01.087.
    Full Text Link to Item
  - Gibler, W Brian, Christopher P. Cannon, Andra L. Blomkalns, Douglas M. Char, Barbara J. Drew, Judd E. Hollander, Allan S. Jaffe, et al. “Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers.” Circulation 111, no. 20 (May 24, 2005): 2699–2710. https://doi.org/10.1161/01.CIR.0000165556.44271.BE.
    Full Text Link to Item
  - Cohen, Mauricio G., and E Magnus Ohman. “Drug-eluting stents in acute myocardial infarction: is science catching up with practice?” Jama 293, no. 17 (May 4, 2005): 2154–56. https://doi.org/10.1001/jama.293.17.2154.
    Full Text Link to Item
  - Hoekstra, James W., Matthew T. Roe, Eric D. Peterson, Venu Menon, Jyotsna Mulgund, Charles V. Pollack, Chadwick Miller, et al. “Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns.” Acad Emerg Med 12, no. 5 (May 2005): 431–38. https://doi.org/10.1197/j.aem.2004.11.029.
    Full Text Link to Item
  - Chang, Wei-Ching, William K. Midodzi, Cynthia M. Westerhout, Eric Boersma, Judith Cooper, Elliot S. Barnathan, Maarten L. Simoons, Lars Wallentin, E Magnus Ohman, and Paul W. Armstrong. “Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis.” J Epidemiol Community Health 59, no. 5 (May 2005): 427–33. https://doi.org/10.1136/jech.2004.024984.
    Full Text Link to Item
  - Cohen, Mauricio G., Robert V. Kelly, David F. Kong, Venu Menon, Monica Shah, Jorge Ferreira, Karen S. Pieper, et al. “Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.” Am J Med 118, no. 5 (May 2005): 482–88. https://doi.org/10.1016/j.amjmed.2004.12.018.
    Full Text Link to Item
  - Roe, Matthew T., Eric D. Peterson, Charles V. Pollack, L Kristin Newby, Yun Li, Robert H. Christenson, W Frank Peacock, et al. “Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.” Ann Emerg Med 45, no. 4 (April 2005): 355–62. https://doi.org/10.1016/j.annemergmed.2004.10.016.
    Full Text Link to Item
  - Meine, Trip J., Sana M. Al-Khatib, John H. Alexander, Christopher B. Granger, Harvey D. White, Rakhi Kilaru, Kathryn Williams, E Magnus Ohman, Eric Topol, and Robert M. Califf. “Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy.” Am Heart J 149, no. 4 (April 2005): 670–74. https://doi.org/10.1016/j.ahj.2004.07.035.
    Full Text Link to Item
  - Blomkalns, Andra L., Anita Y. Chen, Judith S. Hochman, Eric D. Peterson, Kelly Trynosky, Deborah B. Diercks, Gerard X. Brogan, et al. “Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.” J Am Coll Cardiol 45, no. 6 (March 15, 2005): 832–37. https://doi.org/10.1016/j.jacc.2004.11.055.
    Full Text Link to Item
  - Sonel, Ali F., Chester B. Good, Jyotsna Mulgund, Matthew T. Roe, W Brian Gibler, Sidney C. Smith, Mauricio G. Cohen, et al. “Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?).” Circulation 111, no. 10 (March 15, 2005): 1225–32. https://doi.org/10.1161/01.CIR.0000157732.03358.64.
    Full Text Link to Item
  - Kandzari, David E., Matthew T. Roe, Anita Y. Chen, Barbara L. Lytle, Charles V. Pollack, Robert A. Harrington, E Magnus Ohman, W Brian Gibler, and Eric D. Peterson. “Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.” Am Heart J 149, no. 3 (March 2005): 474–81. https://doi.org/10.1016/j.ahj.2004.11.014.
    Full Text Link to Item
  - Foody, JoAnne M., Matthew T. Roe, Anita Y. Chen, Sidney C. Smith, Ralph G. Brindis, Eric D. Peterson, W Brian Gibler, E Magnus Ohman, and E Magnus CRUSADE Investigators. “Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE).” Am J Cardiol 95, no. 4 (February 15, 2005): 483–85. https://doi.org/10.1016/j.amjcard.2004.09.060.
    Full Text Link to Item
  - Ly, Hung Q., Ajay J. Kirtane, Jacki Buros, Robert P. Giugliano, Jeffrey J. Popma, Elliot M. Antman, Robert A. Harrington, E Magnus Ohman, C Michael Gibson, and C Michael TIMI Study Group. “Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.” Am J Cardiol 95, no. 3 (February 1, 2005): 383–86. https://doi.org/10.1016/j.amjcard.2004.09.038.
    Full Text Link to Item
  - Ohman, E Magnus, Christopher B. Granger, Lawrence Rice, Charles S. Abrams, Richard C. Becker, Peter B. Berger, Neal S. Kleiman, et al. “Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee.” J Thromb Thrombolysis 19, no. 1 (February 2005): 11–19. https://doi.org/10.1007/s11239-005-0850-7.
    Full Text Link to Item
  - Ohman, E Magnus, John Nanas, Robert J. Stomel, Massoud A. Leesar, Dennis W. T. Nielsen, Daniel O’Dea, Felix J. Rogers, et al. “Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.” J Thromb Thrombolysis 19, no. 1 (February 2005): 33–39. https://doi.org/10.1007/s11239-005-0938-0.
    Full Text Link to Item
  - Kirtane, Ajay J., Pedro Martinezclark, Aref M. Rahman, Kausik K. Ray, Dimitrios Karmpaliotis, Sabina A. Murphy, Robert P. Giugliano, et al. “Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction.” J Am Coll Cardiol 45, no. 2 (January 18, 2005): 321–23. https://doi.org/10.1016/j.jacc.2004.10.018.
    Full Text Link to Item
  - Kirtane, Ajay J., Aaron Weisbord, Dimitrios Karmpaliotis, Sabina A. Murphy, Robert P. Giugliano, Christopher P. Cannon, Elliott M. Antman, et al. “Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.” Am J Cardiol 95, no. 2 (January 15, 2005): 224–27. https://doi.org/10.1016/j.amjcard.2004.09.007.
    Full Text Link to Item
  - Roe, Matthew T., Eric D. Peterson, E Magnus Ohman, Sidney C. Smith, and W Brian Gibler. “Overcoming the challenges facing quality-improvement strategies for non-ST-segment elevation acute coronary syndromes.” Am Fam Physician 70, no. 10 (November 15, 2004): 1868–76.
    Link to Item
  - Bhatt, Deepak L., Matthew T. Roe, Eric D. Peterson, Yun Li, Anita Y. Chen, Robert A. Harrington, Adam B. Greenbaum, et al. “Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.” Jama 292, no. 17 (November 3, 2004): 2096–2104. https://doi.org/10.1001/jama.292.17.2096.
    Full Text Link to Item
  - Ohman, E Magnus, Matthew T. Roe, Sidney C. Smith, Ralph G. Brindis, Robert H. Christenson, Robert A. Harrington, W Brian Gibler, Eric D. Peterson, and Eric D. CRUSADE Investigators. “Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative.” Am Heart J 148, no. 5 Suppl (November 2004): S34–39. https://doi.org/10.1016/j.ahj.2004.09.013.
    Full Text Link to Item
  - Stone, Gregg W., Michel Bertrand, Antonio Colombo, George Dangas, Michael E. Farkouh, Frederick Feit, Alexandra J. Lansky, et al. “Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.” Am Heart J 148, no. 5 (November 2004): 764–75. https://doi.org/10.1016/j.ahj.2004.04.036.
    Full Text Link to Item
  - Barbagelata, Alejandro, Robert M. Califf, Elena B. Sgarbossa, David Knight, Daniel B. Mark, Christopher B. Granger, Paul W. Armstrong, et al. “Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.” Am Heart J 148, no. 5 (November 2004): 795–802. https://doi.org/10.1016/j.ahj.2004.04.046.
    Full Text Link to Item
  - DeMaria, A. N., E. M. Ohman, B. Pitt, and J. T. Willerson. “Task force 2: Investigator participation in clinical research.” Circulation 110, no. 16 (October 19, 2004): 2517–24. https://doi.org/10.1161/circ.110.16.2517.
    Full Text
  - Califf, Robert M., Steven E. Nissen, Anthony N. DeMaria, Erik Magnus Ohman, Bertram Pitt, James T. Willerson, David W. Bilheimer, et al. “Task force 2: Investigator participation in clinical research.” J Am Coll Cardiol 44, no. 8 (October 19, 2004): 1729–36. https://doi.org/10.1016/j.jacc.2004.08.039.
    Full Text Link to Item
  - Popp, Richard J., Sidney C. Smith, Rober J. Adams, Elliot M. Antman, Rae Ellen W. Kavey, Anthony N. DeMaria, Erik Magnus Ohman, et al. “ACCF/AHA consensus conference report on professionalism and ethics.” Circulation 110, no. 16 (October 19, 2004): 2506–49. https://doi.org/10.1161/01.CIR.0000147952.60985.b0.
    Full Text Link to Item
  - Menon, Venu, Robert A. Harrington, Judith S. Hochman, Christopher P. Cannon, Shaun D. Goodman, Robert G. Wilcox, Holger J. Schünemann, and E Magnus Ohman. “Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.” Chest 126, no. 3 Suppl (September 2004): 549S-575S. https://doi.org/10.1378/chest.126.3_suppl.549S.
    Full Text Link to Item
  - Ottervanger, J. P., P. Armstrong, E. S. Barnathan, E. Boersma, J. S. Cooper, E. M. Ohman, S. James, L. Wallentin, M. L. Simoons, and M. L. GUSTO IV-ACS Investigators. “Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS.” Eur Heart J 25, no. 17 (September 2004): 1494–1501. https://doi.org/10.1016/j.ehj.2004.07.004.
    Full Text Link to Item
  - Popma, Jeffrey J., Peter Berger, E Magnus Ohman, Robert A. Harrington, Cindy Grines, and Jeffrey I. Weitz. “Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.” Chest 126, no. 3 Suppl (September 2004): 576S-599S. https://doi.org/10.1378/chest.126.3_suppl.576S.
    Full Text Link to Item
  - Urban, Philip M., Robert J. Freedman, E Magnus Ohman, Gregg W. Stone, Jan T. Christenson, Marc Cohen, Michael F. Miller, et al. “In-hospital mortality associated with the use of intra-aortic balloon counterpulsation.” Am J Cardiol 94, no. 2 (July 15, 2004): 181–85. https://doi.org/10.1016/j.amjcard.2004.03.058.
    Full Text Link to Item
  - Lader, Ellis W., Christopher P. Cannon, E Magnus Ohman, L Kristin Newby, Daniel P. Sulmasy, Robyn J. Barst, Joan M. Fair, et al. “The clinician as investigator: participating in clinical trials in the practice setting.” Circulation 109, no. 21 (June 1, 2004): 2672–79. https://doi.org/10.1161/01.CIR.0000128702.16441.75.
    Full Text Link to Item
  - Lader, Ellis W., Christopher P. Cannon, E Magnus Ohman, L Kristin Newby, Daniel P. Sulmasy, Robyn J. Barst, Joan M. Fair, et al. “The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.” Circulation 109, no. 21 (June 1, 2004): e302–4. https://doi.org/10.1161/01.CIR.0000128807.57602.61.
    Full Text Link to Item
  - Lader, Ellis W., Christopher P. Cannon, E Magnus Ohman, L Kristin Newby, Daniel P. Sulmasy, Robyn J. Barst, Joan M. Fair, et al. “The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.” Circulation 109, no. 21 (June 1, 2004): e305–7. https://doi.org/10.1161/01.CIR.0000129020.43304.A7.
    Full Text Link to Item
  - Stouffer, George A., Alok Pathak, Herbert C. Whinna, and E Magnus Ohman. “Effect of multielement intravascular ultrasound on the anticoagulant potency of enoxaparin.” Am J Cardiol 93, no. 11 (June 1, 2004): 1453-A12. https://doi.org/10.1016/j.amjcard.2004.02.057.
    Full Text Link to Item
  - Agrawal, M., A. M. Wodlinger, C. E. Huggins, G. E. Tudor, J. A. Pieper, K. P. O’Reilly, C. J. Denu-Ciocca, G. A. Stouffer, and E. M. Ohman. “Effect of N-acetylcysteine on serum creatinine concentration in patients with chronic renal insufficiency who are undergoing coronary angiography.” Heartdrug 4, no. 2 (May 24, 2004): 87–91. https://doi.org/10.1159/000077294.
    Full Text
  - Lenderink, Timo, Eric Boersma, Witold Ruzyllo, Petr Widimsky, E Magnus Ohman, Paul W. Armstrong, Lars Wallentin, Maarten L. Simoons, and Maarten L. GUSTO IV-ACS Investigators. “Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.” Am Heart J 147, no. 5 (May 2004): 865–73. https://doi.org/10.1016/j.ahj.2003.11.009.
    Full Text Link to Item
  - Hudson, Michael P., Christopher M. O’Connor, Wendy A. Gattis, Gudaye Tasissa, Vic Hasselblad, Cathy M. Holleman, Laura H. Gaulden, Frank Sedor, and E Magnus Ohman. “Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.” Am Heart J 147, no. 3 (March 2004): 546–52. https://doi.org/10.1016/j.ahj.2003.10.014.
    Full Text Link to Item
  - Kshirsagar, Abhijit V., Charles Poole, Amy Mottl, David Shoham, Nora Franceschini, Gail Tudor, Malay Agrawal, Cindy Denu-Ciocca, E. Magnus Ohman, and William F. Finn. “N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.” J Am Soc Nephrol 15, no. 3 (March 2004): 761–69. https://doi.org/10.1097/01.asn.0000116241.47678.49.
    Full Text Link to Item
  - Stouffer, George A., Jana Hirmerova, Stephan Moll, Bryon Rubery, Mark Napoli, E Magnus Ohman, and Ross Simpson. “Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.” Catheter Cardiovasc Interv 61, no. 3 (March 2004): 364–67. https://doi.org/10.1002/ccd.10799.
    Full Text Link to Item
  - Gurm, Hitinder S., A Michael Lincoff, David Lee, WH Wilson Tang, Gang Jia, Joan E. Booth, Robert M. Califf, et al. “Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.” J Am Coll Cardiol 43, no. 4 (February 18, 2004): 542–48. https://doi.org/10.1016/j.jacc.2003.09.038.
    Full Text Link to Item
  - Roe, M. T., K. W. Mahaffey, R. Kilaru, J. H. Alexander, K. M. Akkerhuis, M. L. Simoons, R. A. Harrington, et al. “Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.” Eur Heart J 25, no. 4 (February 2004): 313–21. https://doi.org/10.1016/j.ehj.2003.12.009.
    Full Text Link to Item
  - Kelly, Robert V., Mauricio G. Cohen, and E Magnus Ohman. “Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!.” Am Heart Hosp J 2, no. 4 (2004): 211–22. https://doi.org/10.1111/j.1541-9215.2004.03548.x.
    Full Text Link to Item
  - Steinhubl, S. R., and E. M. Ohman. “Glycoprotein IIb/IIIa Receptor Inhibitors,” January 1, 2004, 97–108. https://doi.org/10.1016/B978-0-7216-0408-4.50014-7.
    Full Text
  - Roe, Matthew T., Robert H. Christenson, E Magnus Ohman, Raymond Bahr, Francis M. Fesmire, Alan Storrow, Michael Mollod, et al. “A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes.” Am Heart J 146, no. 6 (December 2003): 993–98. https://doi.org/10.1016/S0002-8703(03)00517-9.
    Full Text Link to Item
  - Alexander, John H., Robert A. Harrington, Manju Bhapkar, Kenneth W. Mahaffey, A Michael Lincoff, E Magnus Ohman, Peter Klootwijk, et al. “Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes.” Am J Med 115, no. 8 (December 1, 2003): 613–19. https://doi.org/10.1016/j.amjmed.2003.08.007.
    Full Text Link to Item
  - Mahaffey, Kenneth W., Bruce E. Lewis, Nancy M. Wildermann, Scott D. Berkowitz, Renee M. Oliverio, Mark A. Turco, Yoseph Shalev, et al. “The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.” J Invasive Cardiol 15, no. 11 (November 2003): 611–16.
    Link to Item
  - Cohen, Marc, Philip Urban, Jan T. Christenson, Debra L. Joseph, Robert J. Freedman, Michael F. Miller, E Magnus Ohman, et al. “Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry.” Eur Heart J 24, no. 19 (October 2003): 1763–70. https://doi.org/10.1016/j.ehj.2003.07.002.
    Full Text Link to Item
  - Roe, Matthew T., E Magnus Ohman, Charles V. Pollack, Eric D. Peterson, Ralph G. Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, Robert M. Califf, and W Brian Gibler. “Changing the model of care for patients with acute coronary syndromes.” Am Heart J 146, no. 4 (October 2003): 605–12. https://doi.org/10.1016/S0002-8703(03)00388-0.
    Full Text Link to Item
  - Cohen, Mauricio G., and E Magnus Ohman. “The everlasting effect of primary percutaneous coronary intervention--even after transport?” Can J Cardiol 19, no. 10 (September 2003): 1119–22.
    Link to Item
  - Wong, Cheuk-Kit, Harvey D. White, Robert G. Wilcox, Douglas A. Criger, Robert M. Califf, Eric J. Topol, and E Magnus Ohman. “Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.” Card Electrophysiol Rev 7, no. 3 (September 2003): 201–7. https://doi.org/10.1023/B:CEPR.0000012382.81986.47.
    Full Text Link to Item
  - Chen, Edmond W., John G. Canto, Lori S. Parsons, Eric D. Peterson, Katherine A. Littrell, Nathan R. Every, C Michael Gibson, et al. “Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock.” Circulation 108, no. 8 (August 26, 2003): 951–57. https://doi.org/10.1161/01.CIR.0000085068.59734.E4.
    Full Text Link to Item
  - Khot, Umesh N., Monica B. Khot, Christopher T. Bajzer, Shelly K. Sapp, E Magnus Ohman, Sorin J. Brener, Stephen G. Ellis, A Michael Lincoff, and Eric J. Topol. “Prevalence of conventional risk factors in patients with coronary heart disease.” Jama 290, no. 7 (August 20, 2003): 898–904. https://doi.org/10.1001/jama.290.7.898.
    Full Text Link to Item
  - Tolleson, Thaddeus R., L Kristin Newby, Robert A. Harrington, Manjushri V. Bhapkar, Freek W. A. Verheugt, Peter B. Berger, David J. Moliterno, et al. “Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).” Am J Cardiol 92, no. 3 (August 1, 2003): 330–33. https://doi.org/10.1016/s0002-9149(03)00641-6.
    Full Text Link to Item
  - Ohman, E. M., M. F. Miller, D. L. Joseph, M. Cohen, R. J. Freedman, G. W. Stone, P. M. Urban, R. C. Reddy, J. T. Christenson, and J. J. Ferguson. “Validation of a multicenter registry database of intra-aortic balloon pumping in a variety of clinical settings.” Heartdrug 3, no. 1 (July 21, 2003): 8–13. https://doi.org/10.1159/000070903.
    Full Text
  - Stone, Gregg W., E Magnus Ohman, Michael F. Miller, Debra L. Joseph, Jan T. Christenson, Marc Cohen, Philip M. Urban, et al. “Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry.” J Am Coll Cardiol 41, no. 11 (June 4, 2003): 1940–45. https://doi.org/10.1016/s0735-1097(03)00400-5.
    Full Text Link to Item
  - Gibson, C Michael, Ajay J. Kirtane, Sabina A. Murphy, Juhana Karha, Christopher P. Cannon, Robert P. Giugliano, Mathew T. Roe, Robert A. Harrington, E Magnus Ohman, and Elliott M. Antman. “Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.” J Thromb Thrombolysis 15, no. 3 (June 2003): 189–96. https://doi.org/10.1023/B:THRO.0000011374.60110.bc.
    Full Text Link to Item
  - Sánchez, Carlos D., L Kristin Newby, Vic Hasselblad, Steve E. McNulty, Alan B. Storrow, W Brian Gibler, J Lee Garvey, Donald H. Schreiber, John F. Tucker, and E Magnus Ohman. “Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain units.” Am J Cardiol 91, no. 10 (May 15, 2003): 1228–30. https://doi.org/10.1016/s0002-9149(03)00269-8.
    Full Text Link to Item
  - Ohman, E Magnus. “To the editor.” Am Heart J 145, no. 5 (May 2003): e26. https://doi.org/10.1016/S0002-8703(03)00076-0.
    Full Text Link to Item
  - Rao, Sunil V., E Magnus Ohman, Christopher B. Granger, Paul W. Armstrong, W Brian Gibler, Robert H. Christenson, Vic Hasselblad, Amanda Stebbins, Steven McNulty, and L Kristin Newby. “Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes.” Am J Cardiol 91, no. 8 (April 15, 2003): 936–40. https://doi.org/10.1016/s0002-9149(03)00107-3.
    Full Text Link to Item
  - Staman, Karen L., Matthew T. Roe, Elizabeth S. Fraulo, Barbara L. Lytle, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Quality improvement tools designed to improve adherence to the ACC/AHA Guidelines for the care of patients with non-ST-segment acute coronary syndromes: the CRUSADE quality improvement initiative.” Crit Pathw Cardiol 2, no. 1 (March 2003): 34–40. https://doi.org/10.1097/01.HPC.0000053684.59325.88.
    Full Text Link to Item
  - Al-Khatib, Sana M., Amanda L. Stebbins, Robert M. Califf, Kerry L. Lee, Christopher B. Granger, Harvey D. White, Paul W. Armstrong, Eric J. Topol, E Magnus Ohman, and E Magnus GUSTO-III trial. “Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.” Am Heart J 145, no. 3 (March 2003): 515–21. https://doi.org/10.1067/mhj.2003.170.
    Full Text Link to Item
  - Newby, L Kristin, Britta U. Goldmann, and E Magnus Ohman. “Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes.” J Am Coll Cardiol 41, no. 4 Suppl S (February 19, 2003): 31S-36S. https://doi.org/10.1016/s0735-1097(02)02832-2.
    Full Text Link to Item
  - Kaul, Padma, L Kristin Newby, Yuling Fu, Vic Hasselblad, Kenneth W. Mahaffey, Robert H. Christenson, Robert A. Harrington, et al. “Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.” J Am Coll Cardiol 41, no. 3 (February 5, 2003): 371–80. https://doi.org/10.1016/s0735-1097(02)02824-3.
    Full Text Link to Item
  - Ottervanger, J. P., P. Armstrong, E. S. Barnathan, E. Boersma, J. S. Cooper, E. M. Ohman, S. James, et al. “Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV--Acute Coronary Syndrome) Trial.” Circulation 107, no. 3 (January 28, 2003): 437–42. https://doi.org/10.1161/01.cir.0000046487.06811.5e.
    Full Text Link to Item
  - Hasdai, David, Eric J. Topol, Rakhi Kilaru, Alexander Battler, Robert A. Harrington, Alec Vahanian, E Magnus Ohman, et al. “Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.” Am Heart J 145, no. 1 (January 2003): 73–79. https://doi.org/10.1067/mhj.2003.53.
    Full Text Link to Item
  - O’Shea, J Conor, Robert G. Wilcox, Allan M. Skene, Amanda L. Stebbins, Christopher B. Granger, Paul W. Armstrong, Christoph Bode, et al. “Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.” Am J Cardiol 90, no. 12 (December 15, 2002): 1374–77. https://doi.org/10.1016/s0002-9149(02)02876-x.
    Full Text Link to Item
  - Gurbel, Paul A., Brian Galbut, Kevin P. Bliden, Raymond D. Bahr, Matthew T. Roe, Victor L. Serebruany, W Brian Gibler, Robert H. Christenson, E Magnus Ohman, and E Magnus EARLY Platelet Substudy. “Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).” J Thromb Thrombolysis 14, no. 3 (December 2002): 213–19. https://doi.org/10.1023/a:1025048726396.
    Full Text Link to Item
  - Wong, Brian Y. L., Judy Gnarpe, Koon K. Teo, E Magnus Ohman, Connie Prosser, W Brian Gibler, Anatoly Langer, Wei-Ching Chang, and Paul W. Armstrong. “Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.” Am Heart J 144, no. 6 (December 2002): 987–94. https://doi.org/10.1067/mhj.2002.126734.
    Full Text Link to Item
  - Newby, L Kristin, Joseph S. Alpert, E Magnus Ohman, Kristian Thygesen, and Robert M. Califf. “Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations.” Am Heart J 144, no. 6 (December 2002): 957–80. https://doi.org/10.1067/mhj.2002.129778.
    Full Text Link to Item
  - Hoekstra, James W., Charles V. Pollack, Matthew T. Roe, Eric D. Peterson, Ralph Brindis, Robert A. Harrington, Robert H. Christenson, Sidney C. Smith, E Magnus Ohman, and W Brian Gibler. “Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative.” Acad Emerg Med 9, no. 11 (November 2002): 1146–55. https://doi.org/10.1111/j.1553-2712.2002.tb01569.x.
    Full Text Link to Item
  - Levinsky, Matthew J., and E Magnus Ohman. “Risk stratification in acute coronary syndromes: the need for continued vigilance in "low-risk" patients.” Am Heart J 144, no. 5 (November 2002): 750–52. https://doi.org/10.1067/mhj.2002.126117.
    Full Text Link to Item
  - Christenson, Jan T., Marc Cohen, James J. Ferguson, Robert J. Freedman, Michael F. Miller, E Magnus Ohman, Ramachandra C. Reddy, Gregg W. Stone, and Philip M. Urban. “Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery.” Ann Thorac Surg 74, no. 4 (October 2002): 1086–90. https://doi.org/10.1016/s0003-4975(02)03854-7.
    Full Text Link to Item
  - Wong, C. -. K., H. D. White, R. G. Wilcox, D. A. Criger, R. M. Califf, E. J. Topol, E. M. Ohman, and E. M. GUSTO-III Investigators. “Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.” Heart 88, no. 4 (October 2002): 357–62. https://doi.org/10.1136/heart.88.4.357.
    Full Text Link to Item
  - Batchelor, Wayne B., Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R Michael Mantell, Patricia Dillard, Marie Davidian, et al. “Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.” Circulation 106, no. 12 (September 17, 2002): 1470–76. https://doi.org/10.1161/01.cir.0000029744.01096.1f.
    Full Text Link to Item
  - Al Suwaidi, Jassim, Donal N. Reddan, Kathryn Williams, Karen S. Pieper, Robert A. Harrington, Robert M. Califf, Christopher B. Granger, et al. “Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.” Circulation 106, no. 8 (August 20, 2002): 974–80. https://doi.org/10.1161/01.cir.0000027560.41358.b3.
    Full Text Link to Item
  - Bahit, Maria Cecilia, Douglas A. Criger, E Magnus Ohman, Christopher B. Granger, and Galen S. Wagner. “Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa data).” Am J Cardiol 90, no. 3 (August 1, 2002): 233–37. https://doi.org/10.1016/s0002-9149(02)02460-8.
    Full Text Link to Item
  - Bahr, Raymond D., Paul A. Gurbel, Alex I. Malinin, Charlyn Wentz, Robert H. Christenson, Matthew T. Roe, W Brian Gibler, Michael M. Kitt, E Magnus Ohman, and Victor L. Serebruany. “Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction.” Am J Cardiol 90, no. 3 (August 1, 2002): 310–12. https://doi.org/10.1016/s0002-9149(02)02470-0.
    Full Text Link to Item
  - Cantor, Warren J., Julie M. Miller, Anne S. Hellkamp, Judith M. Kramer, Eric D. Peterson, Vic Hasselblad, James P. Zidar, L Kristin Newby, and E Magnus Ohman. “Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women.” Am Heart J 144, no. 2 (August 2002): 297–302. https://doi.org/10.1067/mhj.2002.123318.
    Full Text Link to Item
  - Anderson, R David, Harvey D. White, E Magnus Ohman, Galen S. Wagner, Mitchell W. Krucoff, Paul W. Armstrong, W Douglas Weaver, et al. “Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.” Am Heart J 144, no. 1 (July 2002): 81–88. https://doi.org/10.1067/mhj.2002.123319.
    Full Text Link to Item
  - Aviles, Ronnier J., Arman T. Askari, Bertil Lindahl, Lars Wallentin, Gang Jia, E Magnus Ohman, Kenneth W. Mahaffey, et al. “Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.” N Engl J Med 346, no. 26 (June 27, 2002): 2047–52. https://doi.org/10.1056/NEJMoa013456.
    Full Text Link to Item
  - Cantor, Warren J., L Kristin Newby, Robert H. Christenson, Robert H. Tuttle, Vic Hasselblad, Paul W. Armstrong, David J. Moliterno, et al. “Prognostic significance of elevated troponin I after percutaneous coronary intervention.” J Am Coll Cardiol 39, no. 11 (June 5, 2002): 1738–44. https://doi.org/10.1016/s0735-1097(02)01877-6.
    Full Text Link to Item
  - Cohen, Marc, James J. Ferguson, Robert J. Freedman, Michael F. Miller, Ramachandra C. Reddy, E Magnus Ohman, Gregg W. Stone, Jan Christenson, and Debra L. Joseph. “Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective Benchmark registry.” Catheter Cardiovasc Interv 56, no. 2 (June 2002): 200–206. https://doi.org/10.1002/ccd.10188.
    Full Text Link to Item
  - Kroll, Christopher R., and E Magnus Ohman. “Should reperfusion strategies in myocardial infarction be modified for the very elderly?” Am Heart J 143, no. 3 (March 2002): 373–76. https://doi.org/10.1067/mhj.2002.120779.
    Full Text Link to Item
  - Brener, Sorin J., Uwe Zeymer, AA Jennifer Adgey, Thomas R. Vrobel, Stephen G. Ellis, Karl Ludwig Neuhaus, Nadine Juran, et al. “Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial.” J Am Coll Cardiol 39, no. 3 (February 6, 2002): 377–86. https://doi.org/10.1016/s0735-1097(01)01758-2.
    Full Text Link to Item
  - Harrington, R. A., and E. Magnus Ohman. “Early invasive strategy for acute coronary syndromes without persistent ST-segment elevation: has the time come for 'drive-through' angiography?” Eur Heart J 23, no. 3 (February 2002): 191–94. https://doi.org/10.1053/euhj.2001.3022.
    Full Text Link to Item
  - Gibler, W Brian, Paul W. Armstrong, E Magnus Ohman, W Douglas Weaver, Amanda L. Stebbins, Joel M. Gore, L Kristin Newby, Robert M. Califf, Eric J. Topol, and Eric J. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) Investigators. “Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.” Ann Emerg Med 39, no. 2 (February 2002): 123–30. https://doi.org/10.1067/mem.2002.121402.
    Full Text Link to Item
  - Savonitto, Stefano, Christopher B. Granger, Diego Ardissino, Laura Gardner, Claudio Cavallini, Marcello Galvani, Filippo Ottani, et al. “The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.” J Am Coll Cardiol 39, no. 1 (January 2, 2002): 22–29. https://doi.org/10.1016/s0735-1097(01)01706-5.
    Full Text Link to Item
  - Ohman, E. M., B. D. MacNeil, and I. K. Jang. “Efegatran sulphate has no advantage over heparin as an adjunct to thrombolytic therapy in acute myocardial infarction.” Evidence Based Cardiovascular Medicine 6, no. 4 (January 1, 2002): 139–40. https://doi.org/10.1054/ebcm.2002.0499.
    Full Text
  - Perlman, A. “Medical clinics of North America: Preface.” Medical Clinics of North America 86, no. 1 (2002): xi–xiii. https://doi.org/10.1016/S0025-7125(03)00067-1.
    Full Text
  - Ohman, J. H. “Erratum: Intravenous thrombolysis in acute myocardial infarction (Chest (2001) 119 (253s-277s)).” Chest 121, no. 1 (January 1, 2002): 310.
  - PRIME Investigators, W. R. “Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial.” Am Heart J 143, no. 1 (January 2002): 95–105. https://doi.org/10.1067/mhj.2002.119896.
    Full Text Link to Item
  - Roe, M. T., C. B. Granger, J. A. Puma, A. S. Hellkamp, J. S. Hochman, E. M. Ohman, H. D. White, et al. “Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.” Am J Cardiol 88, no. 12 (December 15, 2001): 1403-A6. https://doi.org/10.1016/s0002-9149(01)02119-1.
    Full Text Link to Item
  - Cantor, Warren J., and E Magnus Ohman. “'Facilitated' PCI for Acute MI: PCI with Lysis and Platelet Inhibition.” Curr Interv Cardiol Rep 3, no. 4 (November 2001): 321–29.
    Link to Item
  - Ferguson, J. J., M. Cohen, R. J. Freedman, G. W. Stone, M. F. Miller, D. L. Joseph, and E. M. Ohman. “The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry.” J Am Coll Cardiol 38, no. 5 (November 1, 2001): 1456–62. https://doi.org/10.1016/s0735-1097(01)01553-4.
    Full Text Link to Item
  - Ohman, E. M., and E. Peterson. “Implications and challenges using practice guidelines for chronic angina.” Ann Intern Med 135, no. 7 (October 2, 2001): 527–29. https://doi.org/10.7326/0003-4819-135-7-200110020-00013.
    Full Text Link to Item
  - Hudson, M. P., C. B. Granger, E. J. Topol, K. S. Pieper, P. W. Armstrong, G. I. Barbash, A. D. Guerci, A. Vahanian, R. M. Califf, and E. M. Ohman. “Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.” Circulation 104, no. 11 (September 11, 2001): 1229–35. https://doi.org/10.1161/hc3601.095717.
    Full Text Link to Item
  - Singh, M., G. S. Reeder, E. M. Ohman, V. Mathew, W. B. Hillegass, R. D. Anderson, D. S. Gallup, K. N. Garratt, and D. R. Holmes. “Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experience.” J Am Coll Cardiol 38, no. 3 (September 2001): 624–30. https://doi.org/10.1016/s0735-1097(01)01445-0.
    Full Text Link to Item
  - Herrmann, H. C., R. H. Li, and E. M. Ohman. “Facilitated percutaneous coronary intervention: Results from the SPEED trial.” European Heart Journal, Supplement 3, no. A (July 19, 2001). https://doi.org/10.1016/S1520-765X(01)90022-7.
    Full Text
  - Newby, L. K., E. M. Ohman, R. H. Christenson, D. J. Moliterno, R. A. Harrington, H. D. White, P. W. Armstrong, et al. “Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.” Circulation 103, no. 24 (June 19, 2001): 2891–96. https://doi.org/10.1161/01.cir.103.24.2891.
    Full Text Link to Item
  - Ohman, E. M., and J. S. Hochman. “Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit?” Am Heart J 141, no. 6 (June 2001): 889–92. https://doi.org/10.1067/mhj.2001.115296.
    Full Text Link to Item
  - Cantor, W. J., A. S. Hellkamp, E. D. Peterson, J. P. Zidar, P. A. Cowper, M. H. Sketch, J. E. Tcheng, R. M. Califf, and E. M. Ohman. “Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes?” J Am Coll Cardiol 37, no. 7 (June 1, 2001): 1883–90. https://doi.org/10.1016/s0735-1097(01)01244-x.
    Full Text Link to Item
  - Newby, L. K., A. B. Storrow, W. B. Gibler, J. L. Garvey, J. F. Tucker, A. L. Kaplan, D. H. Schreiber, R. H. Tuttle, S. E. McNulty, and E. M. Ohman. “Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study.” Circulation 103, no. 14 (April 10, 2001): 1832–37. https://doi.org/10.1161/01.cir.103.14.1832.
    Full Text Link to Item
  - Aronow, H. D., E. J. Topol, M. T. Roe, P. L. Houghtaling, K. E. Wolski, A. M. Lincoff, R. A. Harrington, et al. “Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.” Lancet 357, no. 9262 (April 7, 2001): 1063–68. https://doi.org/10.1016/S0140-6736(00)04257-4.
    Full Text Link to Item
  - Cantor, W. J., A. L. Kaplan, J. L. Velianou, M. H. Sketch, G. W. Barsness, P. B. Berger, and E. M. Ohman. “Effectiveness and safety of abciximab after failed thrombolytic therapy.” Am J Cardiol 87, no. 4 (February 15, 2001): 439-A4. https://doi.org/10.1016/s0002-9149(00)01398-9.
    Full Text Link to Item
  - Greenbaum, A. B., R. A. Harrington, M. P. Hudson, C. M. MacAulay, R. G. Wilcox, M. L. Simoons, L. G. Berdan, et al. “Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.” J Am Coll Cardiol 37, no. 2 (February 2001): 492–98. https://doi.org/10.1016/s0735-1097(00)01143-8.
    Full Text Link to Item
  - Christenson, R. H., S. H. Duh, M. T. Roe, and E. M. Ohman. “Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies.” Cardiovasc Toxicol 1, no. 2 (2001): 171–76. https://doi.org/10.1385/ct:1:2:171.
    Full Text Link to Item
  - Goldmann, Britta U., Robert H. Christenson, Christian W. Hamm, Thomas Meinertz, and E Magnus Ohman. “Implications of troponin testing in clinical medicine.” Curr Control Trials Cardiovasc Med 2, no. 2 (2001): 75–84. https://doi.org/10.1186/cvm-2-2-075.
    Full Text Open Access Copy Link to Item
  - Hirsh, J., T. E. Warkentin, S. G. Shaughnessy, S. S. Anand, J. L. Halperin, R. Raschke, C. Granger, E. M. Ohman, and J. E. Dalen. “Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.” Chest 119, no. 1 Suppl (January 2001): 64S-94S. https://doi.org/10.1378/chest.119.1_suppl.64s.
    Full Text Link to Item
  - Ohman, E. M., R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J. W. Kennedy. “Intravenous thrombolysis in acute myocardial infarction.” Chest 119, no. 1 Suppl (January 2001): 253S-277S. https://doi.org/10.1378/chest.119.1_suppl.253s.
    Full Text Link to Item
  - Popma, J. J., E. M. Ohman, J. Weitz, A. M. Lincoff, R. A. Harrington, and P. Berger. “Antithrombotic therapy in patients undergoing percutaneous coronary intervention.” Chest 119, no. 1 Suppl (January 2001): 321S-336S. https://doi.org/10.1378/chest.119.1_suppl.321s.
    Full Text Link to Item
  - Roe, M. T., E. M. Ohman, A. C. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff. “Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.” J Am Coll Cardiol 37, no. 1 (January 2001): 9–18. https://doi.org/10.1016/s0735-1097(00)01101-3.
    Full Text Link to Item
  - Saur, C. D., B. B. Granger, L. H. Muhlbaier, L. M. Forman, R. J. McKenzie, M. C. Taylor, and P. K. Smith. “Depressive symptoms and outcome of coronary artery bypass grafting.” Am J Crit Care 10, no. 1 (January 2001): 4–10.
    Link to Item
  - Chang, W. C., Y. Fu, E. M. Ohman, M. Gupta, A. Morris, S. N. Roth, C. B. Granger, et al. “Temporal evolution in the management of acute ST elevation myocardial infarction: The seven-year GUSTO experience from Canada and the United States.” Canadian Journal of Cardiology 16, no. 10 (December 12, 2000): 1231–39.
  - Campbell, K. R., W. Cantor, M. Sketch, and E. M. Ohman. “Glycoprotein IIb/IIIa inhibitors: therapeutic applications in acute ST-segment elevation myocardial infarction.” Am Heart J 140, no. 6 Suppl (December 2000): S115–24. https://doi.org/10.1067/mhj.2000.111612.
    Full Text Link to Item
  - Campbell, K. R., K. W. Mahaffey, B. E. Lewis, J. I. Weitz, S. D. Berkowitz, E. M. Ohman, and R. M. Califf. “Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.” J Invasive Cardiol 12 Suppl F (December 2000): 14F – 149.
    Link to Item
  - Menon, V., J. S. Hochman, A. Stebbins, M. Pfisterer, J. Col, R. D. Anderson, D. Hasdai, et al. “Lack of progress in cardiogenic shock: lessons from the GUSTO trials.” Eur Heart J 21, no. 23 (December 2000): 1928–36. https://doi.org/10.1053/euhj.2000.2240.
    Full Text Link to Item
  - Wong, C. K., H. D. White, R. G. Wilcox, D. A. Criger, R. M. Califf, E. J. Topol, and E. M. Ohman. “New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.” Am Heart J 140, no. 6 (December 2000): 878–85. https://doi.org/10.1067/mhj.2000.111108.
    Full Text Link to Item
  - Herrmann, H. C., D. J. Moliterno, E. M. Ohman, A. L. Stebbins, C. Bode, A. Betriu, F. Forycki, et al. “Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.” J Am Coll Cardiol 36, no. 5 (November 1, 2000): 1489–96. https://doi.org/10.1016/s0735-1097(00)00923-2.
    Full Text Link to Item
  - McGuire, D. K., H. Emanuelsson, C. B. Granger, E. Magnus Ohman, D. J. Moliterno, H. D. White, D. Ardissino, J. W. Box, R. M. Califf, and E. J. Topol. “Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators.” Eur Heart J 21, no. 21 (November 2000): 1750–58. https://doi.org/10.1053/euhj.2000.2317.
    Full Text Link to Item
  - Topol, E. J., E. M. Ohman, P. W. Armstrong, R. Wilcox, A. M. Skene, P. Aylward, J. Simes, et al. “Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.” Circulation 102, no. 15 (October 10, 2000): 1761–65. https://doi.org/10.1161/01.cir.102.15.1761.
    Full Text Link to Item
  - Cantor, W. J., E. D. Peterson, J. J. Popma, J. P. Zidar, M. H. Sketch, J. E. Tcheng, and E. M. Ohman. “Provisional stenting strategies: systematic overview and implications for clinical decision-making.” J Am Coll Cardiol 36, no. 4 (October 2000): 1142–51. https://doi.org/10.1016/s0735-1097(00)00854-8.
    Full Text Link to Item
  - Chang, W. C., Y. Fu, E. M. Ohman, M. Gupta, A. Morris, S. N. Roth, C. B. Granger, et al. “Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.” Can J Cardiol 16, no. 10 (October 2000): 1231–39.
    Link to Item
  - Peter, K., B. Kohler, A. Straub, J. Ruef, M. Moser, T. Nordt, M. Olschewski, M. E. Ohman, W. Kübler, and C. Bode. “Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.” Circulation 102, no. 13 (September 26, 2000): 1490–96. https://doi.org/10.1161/01.cir.102.13.1490.
    Full Text Link to Item
  - Lincoff, A. M., R. A. Harrington, R. M. Califf, J. S. Hochman, A. D. Guerci, E. M. Ohman, C. J. Pepine, et al. “Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.” Circulation 102, no. 10 (September 5, 2000): 1093–1100. https://doi.org/10.1161/01.cir.102.10.1093.
    Full Text Link to Item
  - Roe, M. T., R. A. Harrington, D. M. Prosper, K. S. Pieper, D. L. Bhatt, A. M. Lincoff, M. L. Simoons, et al. “Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.” Circulation 102, no. 10 (September 5, 2000): 1101–6. https://doi.org/10.1161/01.cir.102.10.1101.
    Full Text Link to Item
  - Alpert, J. S., K. Thygesen, E. Antman, and J. P. Bassand. “Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.” J Am Coll Cardiol 36, no. 3 (September 2000): 959–69. https://doi.org/10.1016/s0735-1097(00)00804-4.
    Full Text Link to Item
  - “Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.” Eur Heart J 21, no. 18 (September 2000): 1502–13. https://doi.org/10.1053/euhj.2000.2305.
    Full Text Link to Item
  - Ohman, E. M., C. B. Granger, R. A. Harrington, and K. L. Lee. “Risk stratification and therapeutic decision making in acute coronary syndromes.” Jama 284, no. 7 (August 16, 2000): 876–78. https://doi.org/10.1001/jama.284.7.876.
    Full Text Link to Item
  - Barbagelata, A., R. M. Califf, E. B. Sgarbossa, S. G. Goodman, D. Knight, D. B. Mark, C. B. Granger, et al. “Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial).” Am J Cardiol 86, no. 1 (July 1, 2000): 24–29. https://doi.org/10.1016/s0002-9149(00)00823-7.
    Full Text Link to Item
  - “Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.” Circulation 101, no. 24 (June 20, 2000): 2788–94. https://doi.org/10.1161/01.cir.101.24.2788.
    Full Text Link to Item
  - Barsness, G. W., C. Buller, E. M. Ohman, E. Schechter, A. Pucillo, M. A. Taylor, M. J. Miller, et al. “Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.” Am Heart J 139, no. 5 (May 2000): 824–29. https://doi.org/10.1016/s0002-8703(00)90014-0.
    Full Text Link to Item
  - Newby, L. K., and E. M. Ohman. “Troponins in pericarditis: implications for diagnosis and management of chest pains patients.” Eur Heart J 21, no. 10 (May 2000): 798–800. https://doi.org/10.1053/euhj.1999.2056.
    Full Text Link to Item
  - Campbell, K. R., E. M. Ohman, W. Cantor, and A. M. Lincoff. “The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.” Am J Cardiol 85, no. 8A (April 27, 2000): 32C-38C. https://doi.org/10.1016/s0002-9149(00)00877-8.
    Full Text Link to Item
  - Tanguay, J. F., W. J. Cantor, M. W. Krucoff, B. Muhlestein, G. W. Barsness, J. P. Zidar, M. H. Sketch, et al. “Local delivery of heparin post-PTCA: a multicenter randomized pilot study.” Catheter Cardiovasc Interv 49, no. 4 (April 2000): 461–67. https://doi.org/10.1002/(sici)1522-726x(200004)49:4<461::aid-ccd26>3.0.co;2-7.
    Full Text Link to Item
  - Newby, L. K., A. L. Kaplan, B. B. Granger, F. Sedor, R. M. Califf, and E. M. Ohman. “Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit.” Am J Cardiol 85, no. 7 (April 1, 2000): 801–5. https://doi.org/10.1016/s0002-9149(99)00870-x.
    Full Text Link to Item
  - Christenson, R. H., R. T. Vollmer, E. M. Ohman, S. Peck, T. D. Thompson, S. H. Duh, S. G. Ellis, L. K. Newby, E. J. Topol, and R. M. Califf. “Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.” Am J Cardiol 85, no. 5 (March 1, 2000): 543–47. https://doi.org/10.1016/s0002-9149(99)00808-5.
    Full Text Link to Item
  - Alexander, J. H., R. A. Sparapani, K. W. Mahaffey, J. W. Deckers, L. K. Newby, E. M. Ohman, R. Corbalán, et al. “Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.” Jama 283, no. 3 (January 19, 2000): 347–53. https://doi.org/10.1001/jama.283.3.347.
    Full Text Link to Item
  - Goldmann, B. U., L. K. Newby, and E. M. Ohman. “Cardiac markers for decision making in acute ischemic syndromes.” Acc Current Journal Review 9, no. 1 (January 1, 2000): 43–45. https://doi.org/10.1016/S1062-1458(99)00048-3.
    Full Text
  - Nair, G. V., P. A. Gurbel, S. Y. Fuzaylov, C. J. Davis, E. M. Ohman, R. D. Bahr, R. H. Christensen, and V. L. Serebruany. “Combining necrosis and platelet markers for perfecting myocardial infarction rule out: how close are we?” Cardiology 93, no. 1–2 (2000): 50–55. https://doi.org/10.1159/000007002.
    Full Text Link to Item
  - Wagner, G. S., M. C. Bahit, D. Criger, A. B. de Luna, B. Chaitman, P. Clemmensen, P. Klootwijk, F. I. Marcus, O. Pahlm, and M. Ohman. “Moving toward a new definition of acute myocardial infarction for the 21st century: status of the ESC/ACC consensus conference. European Society of Cardiology and American College of Cardiology.” J Electrocardiol 33 Suppl (2000): 57–59. https://doi.org/10.1054/jelc.2000.20334.
    Full Text Link to Item
  - Hasdai, D., R. M. Califf, T. D. Thompson, J. S. Hochman, E. M. Ohman, M. Pfisterer, E. R. Bates, et al. “Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.” J Am Coll Cardiol 35, no. 1 (January 2000): 136–43. https://doi.org/10.1016/s0735-1097(99)00508-2.
    Full Text Link to Item
  - Kleiman, N. S., R. P. Tracy, J. D. Talley, K. Sigmon, D. Joseph, E. J. Topol, R. M. Califf, M. Kitt, and E. M. Ohman. “Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.” J Thromb Thrombolysis 9, no. 1 (January 2000): 5–12. https://doi.org/10.1023/a:1018650123272.
    Full Text Link to Item
  - Ohman, E. M., P. W. Armstrong, H. D. White, C. B. Granger, R. G. Wilcox, W. D. Weaver, W. B. Gibler, et al. “Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.” Am J Cardiol 84, no. 11 (December 1, 1999): 1281–86. https://doi.org/10.1016/s0002-9149(99)00558-5.
    Full Text Link to Item
  - Cohen, M. G., C. B. Granger, E. M. Ohman, A. L. Stebbins, L. R. Grinfeld, A. M. Cagide, M. V. Elizari, et al. “Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.” J Am Coll Cardiol 34, no. 6 (November 15, 1999): 1729–37. https://doi.org/10.1016/s0735-1097(99)00433-7.
    Full Text Link to Item
  - Miller, J. M., R. Smalling, E. M. Ohman, C. Bode, A. Betriu, N. S. Kleiman, J. S. Schildcrout, E. Bastos, E. J. Topol, and R. M. Califf. “Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.” Am J Cardiol 84, no. 7 (October 1, 1999): 779–84. https://doi.org/10.1016/s0002-9149(99)00437-3.
    Full Text Link to Item
  - Cantor, W. J., and E. M. Ohman. “Results of recent large myocardial infarction trials, adjunctive therapies, and acute myocardial infarction: improving outcomes.” Cardiol Rev 7, no. 4 (July 1999): 232–44. https://doi.org/10.1097/00045415-199907000-00015.
    Full Text Link to Item
  - Hudson, M. P., R. H. Christenson, L. K. Newby, A. L. Kaplan, and E. M. Ohman. “Cardiac markers: point of care testing.” Clin Chim Acta 284, no. 2 (June 30, 1999): 223–37. https://doi.org/10.1016/s0009-8981(99)00083-2.
    Full Text Link to Item
  - Hudson, M. P., A. B. Greenbaum, R. A. Harrington, and E. M. Ohman. “Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.” J Thromb Thrombolysis 7, no. 3 (June 1999): 241–45. https://doi.org/10.1023/a:1008974909124.
    Full Text Link to Item
  - Kern, M. J., F. V. Aguirre, E. A. Caracciolo, R. G. Bach, T. J. Donohue, D. Lasorda, E. M. Ohman, et al. “Hemodynamic effects of new intra-aortic balloon counterpulsation timing methods in patients: a multicenter evaluation.” Am Heart J 137, no. 6 (June 1999): 1129–36. https://doi.org/10.1016/s0002-8703(99)70373-x.
    Full Text Link to Item
  - Ohman, E. M. “Troponin and other cardiac markers: role in management of acute coronary syndromes.” Aust N Z J Med 29, no. 3 (June 1999): 436–43. https://doi.org/10.1111/j.1445-5994.1999.tb00740.x.
    Full Text Link to Item
  - Kaplan, A. L., B. Goldmann, and E. M. Ohman. “Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: an emerging solution for reperfusion.” J Emerg Med 17, no. 3 (May 1999): 589–95. https://doi.org/10.1016/s0736-4679(99)00024-4.
    Full Text Link to Item
  - French, P. A., and E. M. Ohman. “The abbreviated life of acronyms.” Am Heart J 137, no. 4 Pt 1 (April 1999): 577–78. https://doi.org/10.1016/s0002-8703(99)70203-6.
    Full Text Link to Item
  - Savonitto, S., D. Ardissino, C. B. Granger, G. Morando, M. D. Prando, A. Mafrici, C. Cavallini, et al. “Prognostic value of the admission electrocardiogram in acute coronary syndromes.” Jama 281, no. 8 (February 24, 1999): 707–13. https://doi.org/10.1001/jama.281.8.707.
    Full Text Link to Item
  - Hasdai, D., D. R. Holmes, E. J. Topol, P. B. Berger, D. A. Criger, J. S. Hochman, E. R. Bates, et al. “Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries.” Eur Heart J 20, no. 2 (January 1999): 128–35. https://doi.org/10.1053/euhj.1999.1282.
    Full Text Link to Item
  - Tardiff, B. E., R. M. Califf, J. E. Tcheng, A. M. Lincoff, K. N. Sigmon, R. A. Harrington, K. W. Mahaffey, et al. “Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.” J Am Coll Cardiol 33, no. 1 (January 1999): 88–96. https://doi.org/10.1016/s0735-1097(98)00551-8.
    Full Text Link to Item
  - Kristin Newby, L., R. H. Christenson, and E. Magnus Ohman. “The role of enzymatic markers in the new millennium: Point-of-care testing and beyond.” Journal of Thrombosis and Thrombolysis 5, no. SUPPL. 2 (December 1, 1998).
  - Newby, L. K., R. H. Christenson, E. M. Ohman, P. W. Armstrong, T. D. Thompson, K. L. Lee, C. W. Hamm, et al. “Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators.” Circulation 98, no. 18 (November 3, 1998): 1853–59. https://doi.org/10.1161/01.cir.98.18.1853.
    Full Text Link to Item
  - Hirsh, J., T. E. Warkentin, R. Raschke, C. Granger, E. M. Ohman, and J. E. Dalen. “Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.” Chest 114, no. 5 Suppl (November 1998): 489S-510S. https://doi.org/10.1378/chest.114.5_supplement.489s.
    Full Text Link to Item
  - Popma, J. J., J. Weitz, J. A. Bittl, E. M. Ohman, R. E. Kuntz, A. J. Lansky, and S. B. King. “Antithrombotic therapy in patients undergoing coronary angioplasty.” Chest 114, no. 5 Suppl (November 1998): 728S-741S. https://doi.org/10.1378/chest.114.5_supplement.728s.
    Full Text Link to Item
  - Harrington, R. A., N. S. Kleiman, C. B. Granger, E. M. Ohman, and S. D. Berkowitz. “Relation between inhibition of platelet aggregation and clinical outcomes.” Am Heart J 136, no. 4 Pt 2 Su (October 1998): S43–50. https://doi.org/10.1053/hj.1998.v136.93433.
    Full Text Link to Item
  - Kleiman, N. S., A. M. Lincoff, E. M. Ohman, and R. A. Harrington. “Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings.” Am Heart J 136, no. 4 Pt 2 Su (October 1998): S32–42. https://doi.org/10.1053/hj.1998.v136.93434.
    Full Text Link to Item
  - Anderson, R. D., E. M. Ohman, D. R. Holmes, R. A. Harrington, G. W. Barsness, N. M. Wildermann, H. R. Phillips, E. J. Topol, and R. M. Califf. “Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.” J Am Coll Cardiol 32, no. 4 (October 1998): 936–41. https://doi.org/10.1016/s0735-1097(98)00339-8.
    Full Text Link to Item
  - Serebruany, V. L., P. A. Gurbel, A. R. Shustov, E. M. Ohman, and E. J. Topol. “Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction.” Am Heart J 136, no. 3 (September 1998): 398–405. https://doi.org/10.1016/s0002-8703(98)70212-1.
    Full Text Link to Item
  - Gurbel, P. A., V. L. Serebruany, A. R. Shustov, R. D. Bahr, C. Carpo, E. M. Ohman, and E. J. Topol. “Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.” J Am Coll Cardiol 31, no. 7 (June 1998): 1466–73. https://doi.org/10.1016/s0735-1097(98)00172-7.
    Full Text Link to Item
  - Bates, E. R., R. J. Stomel, J. S. Hochman, and E. M. Ohman. “The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock.” Int J Cardiol 65 Suppl 1 (May 29, 1998): S37–42. https://doi.org/10.1016/s0167-5273(98)00049-7.
    Full Text Link to Item
  - Christenson, R. H., S. H. Duh, L. K. Newby, E. M. Ohman, R. M. Califf, C. B. Granger, S. Peck, et al. “Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators.” Clin Chem 44, no. 3 (March 1998): 494–501.
    Link to Item
  - Califf, R. M., A. E. Abdelmeguid, R. E. Kuntz, J. J. Popma, C. J. Davidson, E. A. Cohen, N. S. Kleiman, et al. “Myonecrosis after revascularization procedures.” J Am Coll Cardiol 31, no. 2 (February 1998): 241–51. https://doi.org/10.1016/s0735-1097(97)00506-8.
    Full Text Link to Item
  - Gurbel, P. A., V. L. Serebruany, A. R. Shustov, M. Dalesandro, C. I. Gumbs, L. B. Grablutz, R. D. Bahr, E. M. Ohman, and E. J. Topol. “Increased baseline levels of platelet P-selectin, and platelet-endothelial cell adhesion molecule-1 in patients with acute myocardial infarction as predictors of unsuccessful thrombolysis.” Coron Artery Dis 9, no. 7 (1998): 451–56. https://doi.org/10.1097/00019501-199809070-00008.
    Full Text Link to Item
  - Hirsh, J., T. E. Warkentin, R. Raschke, C. Granger, E. M. Ohman, and J. E. Dalen. “Heparin and low-molecular-weight heparin: Mechanisms of action, Pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.” Chest 114, no. 5 SUPPL. (January 1, 1998): 489S-510S.
  - Serebruany, V. L., P. A. Gurbel, A. R. Shustov, M. R. Dalesandro, C. I. Gumbs, L. B. Grabletz, R. D. Bahr, E. M. Ohman, and E. J. Topol. “Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators.” Stroke 29, no. 1 (January 1998): 235–38. https://doi.org/10.1161/01.str.29.1.235.
    Full Text Link to Item
  - Ohman, E. M., R. M. Califf, E. J. Topol, F. Catella-Lawson, and G. A. FitzGerald. “Trials in myocardial infarction [32] (multiple letters).” Circulation 96, no. 10 (December 12, 1997): 3814–16.
  - Ohman, E. M., R. M. Califf, and E. J. Topol. “Trials in myocardial infarction.” Circulation 96, no. 10 (November 18, 1997): 3814–16.
    Link to Item
  - Barsness, G. W., E. D. Peterson, E. M. Ohman, C. L. Nelson, E. R. DeLong, J. G. Reves, P. K. Smith, et al. “Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.” Circulation 96, no. 8 (October 21, 1997): 2551–56. https://doi.org/10.1161/01.cir.96.8.2551.
    Full Text Link to Item
  - Pomés Iparraguirre, H., C. Conti, H. Grancelli, E. M. Ohman, M. Calandrelli, S. Volman, and V. Garber. “Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy.” Am Heart J 134, no. 4 (October 1997): 631–38. https://doi.org/10.1016/s0002-8703(97)70045-0.
    Full Text Link to Item
  - Christenson, R. H., E. M. Ohman, E. J. Topol, S. Peck, L. K. Newby, S. H. Duh, D. J. Kereiakes, et al. “Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7.” Circulation 96, no. 6 (September 16, 1997): 1776–82. https://doi.org/10.1161/01.cir.96.6.1776.
    Full Text Link to Item
  - Anderson, R. D., E. M. Ohman, D. R. Holmes, I. Col, A. L. Stebbins, E. R. Bates, R. J. Stomel, C. B. Granger, E. J. Topol, and R. M. Califf. “Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.” J Am Coll Cardiol 30, no. 3 (September 1997): 708–15. https://doi.org/10.1016/s0735-1097(97)00227-1.
    Full Text Link to Item
  - Greenbaum, A. B., and E. M. Ohman. “An update on acute myocardial infarction from recent clinical trials.” Curr Opin Cardiol 12, no. 4 (July 1997): 418–26.
    Link to Item
  - Kovack, P. J., M. A. Rasak, E. R. Bates, E. M. Ohman, and R. J. Stomel. “Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock.” J Am Coll Cardiol 29, no. 7 (June 1997): 1454–58. https://doi.org/10.1016/s0735-1097(97)82537-5.
    Full Text Link to Item
  - Califf, R. M., K. L. Lee, C. B. Granger, and E. M. Ohman. “Predictors of outcome of reperfusion therapy.” Eur Heart J 18, no. 5 (May 1997): 728–35. https://doi.org/10.1093/oxfordjournals.eurheartj.a015338.
    Full Text Link to Item
  - Haft, J. I., and S. A. Saadeh. “Cardiac troponins in acute coronary syndromes.” N Engl J Med 336, no. 17 (April 24, 1997): 1257. https://doi.org/10.1056/NEJM199704243361714.
    Full Text Link to Item
  - Talley, J. D., E. M. Ohman, D. B. Mark, B. S. George, J. D. Leimberger, L. G. Berdan, L. Davidson-Ray, et al. “Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump.” Am J Cardiol 79, no. 5 (March 1, 1997): 590–94. https://doi.org/10.1016/0002-9149(96)00821-1.
    Full Text Link to Item
  - Ohman, E. M., N. S. Kleiman, G. Gacioch, S. J. Worley, F. I. Navetta, J. D. Talley, H. V. Anderson, et al. “Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.” Circulation 95, no. 4 (February 18, 1997): 846–54. https://doi.org/10.1161/01.cir.95.4.846.
    Full Text Link to Item
  - Ohman, E. M., and B. E. Tardiff. “Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization. Importance and implications.” Jama 277, no. 6 (February 12, 1997): 495–97. https://doi.org/10.1001/jama.277.6.495.
    Full Text Link to Item
  - Christenson, R. H., L. K. Newby, and E. M. Ohman. “Cardiac markers in the assessment of acute coronary syndromes.” Md Med J Suppl (1997): 18–24.
    Link to Item
  - O’Brien, J. E., E. D. Peterson, G. P. Keeler, L. G. Berdan, E. M. Ohman, D. P. Faxon, A. K. Jacobs, E. J. Topol, and R. M. Califf. “Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions.” J Am Coll Cardiol 28, no. 5 (November 1, 1996): 1111–18. https://doi.org/10.1016/S0735-1097(96)00306-3.
    Full Text Link to Item
  - Ohman, E. M., P. W. Armstrong, R. H. Christenson, C. B. Granger, H. A. Katus, C. W. Hamm, M. A. O’Hanesian, et al. “Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.” N Engl J Med 335, no. 18 (October 31, 1996): 1333–41. https://doi.org/10.1056/NEJM199610313351801.
    Full Text Link to Item
  - Overlie, P. A., F. A. Shawl, R. A. Vogel, M. R. Mooney, S. C. Smith, S. Stertzer, R. J. Freedman, et al. “Failed angioplasty with cardiac arrest: Survival characteristics and outcomes from the national registry for emergency cardiopulmonary bypass investigators.” Chest 110, no. 4 SUPPL. (October 1, 1996).
  - Granger, C. B., J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, et al. “Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.” Journal of Intravenous Nursing 19, no. 3 (May 1, 1996): 147–56.
  - Gurbel, P. A., F. I. Navetta, E. R. Bates, D. W. Muller, A. N. Tenaglia, M. J. Miller, B. Muhlstein, et al. “Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty.” Cathet Cardiovasc Diagn 37, no. 4 (April 1996): 382–91. https://doi.org/10.1002/(SICI)1097-0304(199604)37:4<382::AID-CCD8>3.0.CO;2-7.
    Full Text Link to Item
  - Mahaffey, K. W., C. B. Granger, R. Collins, C. M. O’Connor, E. M. Ohman, S. D. Bleich, J. J. Col, and R. M. Califf. “Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.” Am J Cardiol 77, no. 8 (March 15, 1996): 551–56. https://doi.org/10.1016/s0002-9149(97)89305-8.
    Full Text Link to Item
  - Weaver, W. D., H. D. White, R. G. Wilcox, P. E. Aylward, D. Morris, A. Guerci, E. M. Ohman, et al. “Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.” Jama 275, no. 10 (March 13, 1996): 777–82.
    Link to Item
  - Jurlander, B., P. Clemmensen, E. M. Ohman, R. Christenson, G. S. Wagner, and P. Grande. “Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction.” Eur Heart J 17, no. 3 (March 1996): 399–406. https://doi.org/10.1093/oxfordjournals.eurheartj.a014872.
    Full Text Link to Item
  - Anderson, R. D., and E. M. Ohman. “Succesful Identification and Management of High-Risk Patients with Acute Myocardial Infarction.” J Thromb Thrombolysis 3, no. 3 (1996): 271–78. https://doi.org/10.1007/BF00181672.
    Full Text Link to Item
  - Berger, P. B., D. R. Holmes, E. M. Ohman, M. A. O’Hanesian, J. G. Murphy, R. S. Schwartz, P. W. Serruys, and D. P. Faxon. “Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR).” J Am Coll Cardiol 27, no. 1 (January 1996): 1–7. https://doi.org/10.1016/0735-1097(95)00439-4.
    Full Text Link to Item
  - Barsness, G. W., E. M. Ohman, R. M. Califf, D. J. Kereiakes, B. S. George, and E. J. Topol. “The thrombolysis and angioplasty in myocardial infarction (TAMI) trials: A decade of reperfusion strategies.” Journal of Interventional Cardiology 9, no. 2 (January 1, 1996): 89–115. https://doi.org/10.1111/j.1540-8183.1996.tb00604.x.
    Full Text
  - Barbagelata, A., C. B. Granger, E. J. Topol, S. J. Worley, D. J. Kereiakes, B. S. George, E. M. Ohman, J. D. Leimberger, D. B. Mark, and R. M. Califf. “Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group.” Am J Cardiol 76, no. 14 (November 15, 1995): 1007–13. https://doi.org/10.1016/s0002-9149(99)80285-9.
    Full Text Link to Item
  - Ohman, E. M., R. A. Harrington, A. M. Lincoff, M. M. Kitt, N. S. Kleiman, and J. E. Tcheng. “Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor.” Eur Heart J 16 Suppl L (November 1995): 50–55. https://doi.org/10.1093/eurheartj/16.suppl_l.50.
    Full Text Link to Item
  - Popma, J. J., B. S. Coller, E. M. Ohman, J. A. Bittl, J. Weitz, R. E. Kuntz, and M. B. Leon. “Antithrombotic therapy in patients undergoing coronary angioplasty.” Chest 108, no. 4 Suppl (October 1995): 486S-501S. https://doi.org/10.1378/chest.108.4_supplement.486s.
    Full Text Link to Item
  - Newby, L. K., W. B. Gibler, E. M. Ohman, and R. H. Christenson. “Biochemical markers in suspected acute myocardial infarction: the need for early assessment.” Clin Chem 41, no. 9 (September 1995): 1263–65.
    Link to Item
  - Pilote, L., R. M. Califf, S. Sapp, D. P. Miller, D. B. Mark, W. D. Weaver, J. M. Gore, P. W. Armstrong, E. M. Ohman, and E. J. Topol. “Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” N Engl J Med 333, no. 9 (August 31, 1995): 565–72. https://doi.org/10.1056/NEJM199508313330907.
    Full Text Link to Item
  - Davenport, R. J., M. S. Dennis, P. A. Sandercock, C. P. Warlow, I. R. Starkey, C. V. Ruckley, J. M. Porter, G. Jackson, E. M. Ohman, and P. Hornick. “How should a patient presenting with unstable angina and a recent stroke be managed?” Bmj 310, no. 6992 (June 3, 1995): 1449–52. https://doi.org/10.1136/bmj.310.6992.1449a.
    Full Text Link to Item
  - Ohman, E. M. “A Difficult Case: Treat The most unstable vascular distribution identified by carotid and cardiac angiography.” Bmj 310, no. 6992 (June 3, 1995): 1450. https://doi.org/10.1136/bmj.310.6992.1450a.
    Full Text
  - Christenson, R. H., E. M. Ohman, E. J. Topol, M. A. O’Hanesian, K. N. Sigmon, S. H. Duh, D. Kereiakes, S. J. Worley, B. S. George, and C. K. Pizzo. “Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography. TAMI Study Group.” Clin Chem 41, no. 6 Pt 1 (June 1995): 844–52.
    Link to Item
  - Harrington, R. A., A. M. Lincoff, R. M. Califf, D. R. Holmes, L. G. Berdan, M. A. O’Hanesian, G. P. Keeler, K. N. Garratt, E. M. Ohman, and D. B. Mark. “Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).” J Am Coll Cardiol 25, no. 7 (June 1995): 1693–99. https://doi.org/10.1016/0735-1097(95)00091-h.
    Full Text Link to Item
  - Lincoff, A. M., E. J. Topol, R. M. Califf, K. N. Sigmon, K. L. Lee, E. M. Ohman, U. Rosenschein, and S. G. Ellis. “Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.” Am J Cardiol 75, no. 14 (May 1, 1995): 871–76. https://doi.org/10.1016/s0002-9149(99)80678-x.
    Full Text Link to Item
  - Armstrong, B., J. P. Zidar, and E. M. Ohman. “The use of intraaortic balloon counterpulsation in acute myocardial infarction and high risk coronary angioplasty.” J Interv Cardiol 8, no. 2 (April 1995): 185–91. https://doi.org/10.1111/j.1540-8183.1995.tb00530.x.
    Full Text Link to Item
  - Granger, C. B., J. M. Miller, E. G. Bovill, A. Gruber, R. P. Tracy, M. W. Krucoff, C. Green, E. Berrios, R. A. Harrington, and E. M. Ohman. “Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.” Circulation 91, no. 7 (April 1, 1995): 1929–35. https://doi.org/10.1161/01.cir.91.7.1929.
    Full Text Link to Item
  - Jurlander, B., P. M. Clemmensen, E. M. Ohman, G. S. Wagner, and P. Grande. “[Serum myoglobin as a non-invasive marker of coronary reperfusion after intravenous thrombolytic therapy in patients with acute myocardial infarction].” Ugeskr Laeger 157, no. 4 (January 23, 1995): 440–43.
    Link to Item
  - Kereiakes, D. J., M. H. Sketch, and E. M. Ohman. “Perfusion balloon angioplasty in patients with complex coronary lesion morphology.” J Invasive Cardiol 7 Suppl B (1995): 4B-9B.
    Link to Item
  - Phillips, H. R., E. M. Ohman, M. Labinaz, M. H. Sketch, and R. Stack. “Use of the perfusion balloon as a primary dilation device.” J Invasive Cardiol 7 Suppl B (1995): 17B-24B.
    Link to Item
  - Christenson, R. H., E. M. Ohman, E. J. Topol, M. A. O’Hanesian, K. N. Sigmon, S. H. Duh, D. Kereiakes, et al. “Creatine kinase MM and MB isoforms in patients receiving thrombolytic therapy and acute angiography.” Clinical Chemistry 41, no. 6 (January 1, 1995): 844–52. https://doi.org/10.1093/clinchem/41.6.844.
    Full Text
  - Granger, C. B., H. D. White, E. R. Bates, E. M. Ohman, and R. M. Califf. “A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction.” Am J Cardiol 74, no. 12 (December 15, 1994): 1220–28. https://doi.org/10.1016/0002-9149(94)90552-5.
    Full Text Link to Item
  - Kleiman, N. S., H. D. White, E. M. Ohman, A. M. Ross, L. H. Woodlief, R. M. Califf, D. R. Holmes, E. Bates, M. Pfisterer, and A. Vahanian. “Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.” Circulation 90, no. 6 (December 1994): 2658–65. https://doi.org/10.1161/01.cir.90.6.2658.
    Full Text Link to Item
  - Ohman, E. M. “Trials in acute myocardial infarction.” Journal of Myocardial Ischemia 6, no. 8 (October 4, 1994): 24–32.
  - Clemmensen, P., E. M. Ohman, D. C. Sevilla, T. Skelton, N. B. Wagner, P. S. Quigley, P. Grande, and G. S. Wagner. “Impact of infarct artery patency on the relationship between electrocardiographic and ventriculographic evidence of acute myocardial ischaemia.” Eur Heart J 15, no. 10 (October 1994): 1356–61. https://doi.org/10.1093/oxfordjournals.eurheartj.a060394.
    Full Text Link to Item
  - Ohman, E. M., B. S. George, C. J. White, M. J. Kern, P. A. Gurbel, R. J. Freedman, C. Lundergan, J. R. Hartmann, J. D. Talley, and M. J. Frey. “Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group.” Circulation 90, no. 2 (August 1994): 792–99. https://doi.org/10.1161/01.cir.90.2.792.
    Full Text Link to Item
  - Ellis, S. G., A. M. Lincoff, B. S. George, D. J. Kereiakes, E. M. Ohman, M. W. Krucoff, R. M. Califf, and E. J. Topol. “Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.” Coron Artery Dis 5, no. 7 (July 1994): 611–15. https://doi.org/10.1097/00019501-199407000-00009.
    Full Text Link to Item
  - Labinaz, M., S. G. Ellis, H. R. Phillips, and E. M. Ohman. “The role of angioplasty after successful thrombolysis for acute myocardial infarction.” Coron Artery Dis 5, no. 5 (May 1994): 399–406. https://doi.org/10.1097/00019501-199405000-00006.
    Full Text Link to Item
  - Hillegass, W. B., E. M. Ohman, J. D. Leimberger, and R. M. Califf. “A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.” Am J Cardiol 73, no. 12 (May 1, 1994): 835–39. https://doi.org/10.1016/0002-9149(94)90805-2.
    Full Text Link to Item
  - Hillegass, W. B., J. G. Jollis, C. B. Granger, E. M. Ohman, R. M. Califf, and D. B. Mark. “Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction.” Am J Cardiol 73, no. 7 (March 1, 1994): 444–49. https://doi.org/10.1016/0002-9149(94)90673-4.
    Full Text Link to Item
  - Ohman, E. M., J. F. Marquis, D. R. Ricci, R. I. Brown, M. L. Knudtson, D. J. Kereiakes, J. K. Samaha, J. R. Margolis, A. L. Niederman, and L. S. Dean. “A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial. Perfusion Balloon Catheter Study Group.” Circulation 89, no. 3 (March 1994): 1118–25. https://doi.org/10.1161/01.cir.89.3.1118.
    Full Text Link to Item
  - Ohman, E. M., E. J. Topol, R. M. Califf, E. R. Bates, S. G. Ellis, D. J. Kereiakes, B. S. George, J. K. Samaha, E. Kline, and K. N. Sigmon. “An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group.” Coron Artery Dis 4, no. 11 (November 1993): 957–64. https://doi.org/10.1097/00019501-199311000-00002.
    Full Text Link to Item
  - Ohman, E. M., R. H. Christenson, R. M. Califf, B. S. George, J. K. Samaha, D. J. Kereiakes, S. J. Worley, T. C. Wall, E. Berrios, and K. N. Sigmon. “Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.” Am Heart J 126, no. 4 (October 1993): 819–26. https://doi.org/10.1016/0002-8703(93)90694-5.
    Full Text Link to Item
  - Vollmer, R. T., R. H. Christenson, K. Reimer, and E. M. Ohman. “Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function.” Am J Clin Pathol 100, no. 3 (September 1993): 293–98. https://doi.org/10.1093/ajcp/100.3.293.
    Full Text Link to Item
  - Kleiman, N. S., E. M. Ohman, R. M. Califf, B. S. George, D. Kereiakes, F. V. Aguirre, H. Weisman, T. Schaible, and E. J. Topol. “Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study.” J Am Coll Cardiol 22, no. 2 (August 1993): 381–89. https://doi.org/10.1016/0735-1097(93)90041-x.
    Full Text Link to Item
  - Baskin, J. M., M. L. Wilkins, E. M. Ohman, P. Clemmensen, P. Grande, R. H. Christenson, D. C. Sevilla, N. B. Wagner, and G. S. Wagner. “Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction.” Am J Cardiol 71, no. 15 (June 1, 1993): 1362–65. https://doi.org/10.1016/0002-9149(93)90557-s.
    Full Text Link to Item
  - Chapman, G. D., E. M. Ohman, E. J. Topol, R. J. Candela, D. J. Kereiakes, J. Samaha, E. Berrios, K. S. Pieper, S. Y. Young, and R. M. Califf. “Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group).” Am J Cardiol 71, no. 10 (April 1, 1993): 783–87. https://doi.org/10.1016/0002-9149(93)90824-v.
    Full Text Link to Item
  - Clemmensen, P., E. M. Ohman, D. C. Sevilla, N. B. Wagner, P. S. Quigley, P. Grande, and G. S. Wagner. “Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction.” Am J Cardiol 70, no. 18 (December 1, 1992): 1391–96. https://doi.org/10.1016/0002-9149(92)90287-9.
    Full Text Link to Item
  - Jurlander, B., P. M. Clemmensen, E. M. Ohman, G. S. Wagner, and P. Grande. “[Serum creatine kinase isoenzyme MB and myoglobin in patients with acute myocardial infarction and coronary reperfusion].” Ugeskr Laeger 154, no. 39 (September 21, 1992): 2682–86.
    Link to Item
  - Muhlestein, J. B., P. J. Quigley, E. M. Ohman, R. P. Bauman, M. H. Sketch, J. E. Tcheng, C. J. Davidson, R. H. Peter, V. S. Behar, and M. W. Krucoff. “Prospective analysis of possible myocardial damage or hemolysis occurring as a result of prolonged autoperfusion angioplasty in humans.” J Am Coll Cardiol 20, no. 3 (September 1992): 594–98. https://doi.org/10.1016/0735-1097(92)90013-d.
    Full Text Link to Item
  - Tenaglia, A. N., P. J. Quigley, D. J. Kereiakes, C. W. Abbottsmith, H. R. Phillips, J. E. Tcheng, D. Rendall, and E. M. Ohman. “Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rate.” Am Heart J 124, no. 3 (September 1992): 585–89. https://doi.org/10.1016/0002-8703(92)90263-u.
    Full Text Link to Item
  - Califf, R. M., and E. M. Ohman. “The diagnosis of acute myocardial infarction.” Chest 101, no. 4 Suppl (April 1992): 106S-115S. https://doi.org/10.1378/chest.101.4_supplement.106s.
    Full Text Link to Item
  - Grande, P., P. Clemmensen, E. M. Ohman, and G. S. Wagner. “Biochemical markers of early reperfusion.” J Electrocardiol 25 Suppl (1992): 6–9. https://doi.org/10.1016/0022-0736(92)90049-6.
    Full Text Link to Item
  - Ohman, E. M. “Reply.” American Heart Journal 123, no. 6 (January 1, 1992): 1720. https://doi.org/10.1016/0002-8703(92)90837-L.
    Full Text
  - Ohman, E. M., R. Christenson, P. Clemmensen, and G. S. Wagner. “Myocardial salvage after reperfusion. Observations from analysis of serial electrocardiographic and biochemical indices.” J Electrocardiol 25 Suppl (1992): 10–14. https://doi.org/10.1016/0022-0736(92)90050-a.
    Full Text Link to Item
  - Silverman, A. J., R. W. Wetmore, and E. M. Ohman. “Intraaortic balloon pump and thrombolysis in AMI [1].” American Heart Journal 123, no. 6 (1992): 1720-.
  - Califf, R. M., and E. M. Ohman. “The diagnosis of acute myocardial infarction.” Chest 101, no. 4 SUPPL. (January 1, 1992). https://doi.org/10.1378/chest.101.4.106S.
    Full Text
  - Davidson, C. J., K. H. Sheikh, K. B. Kisslo, H. R. Phillips, R. H. Peter, V. S. Behar, Y. H. Kong, M. Krucoff, E. M. Ohman, and J. E. Tcheng. “Intracoronary ultrasound evaluation of interventional technologies.” Am J Cardiol 68, no. 13 (November 15, 1991): 1305–9. https://doi.org/10.1016/0002-9149(91)90236-e.
    Full Text Link to Item
  - Hellstrom, H. R. “Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction.” Circulation 84, no. 3 (September 1991): 1454–55. https://doi.org/10.1161/01.cir.84.3.1454.
    Full Text Link to Item
  - Christenson, R. H., E. M. Ohman, R. T. Vollmer, P. Clemmensen, P. Grande, and G. S. Wagner. “Serum release of the creatine kinase tissue-specific isoforms MM3 and MB2 is simultaneous during myocardial reperfusion.” Clin Chim Acta 200, no. 1 (August 15, 1991): 23–33. https://doi.org/10.1016/0009-8981(91)90330-f.
    Full Text Link to Item
  - Califf, R. M., D. F. Fortin, D. J. Frid, W. R. Harlan, E. M. Ohman, J. R. Bengtson, C. L. Nelson, J. E. Tcheng, D. B. Mark, and R. S. Stack. “Restenosis after coronary angioplasty: an overview.” J Am Coll Cardiol 17, no. 6 Suppl B (May 1991): 2B-13B. https://doi.org/10.1016/0735-1097(91)90933-z.
    Full Text Link to Item
  - Ohman, E. M., R. M. Califf, B. S. George, P. J. Quigley, D. J. Kereiakes, L. Harrelson-Woodlief, R. J. Candela, C. Flanagan, R. S. Stack, and E. J. Topol. “The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.” Am Heart J 121, no. 3 Pt 1 (March 1991): 895–901. https://doi.org/10.1016/0002-8703(91)90205-v.
    Full Text Link to Item
  - Ohman, E. M., R. M. Califf, E. J. Topol, R. S. Stack, and B. S. George. “Intra-aortic balloon pumping: Benefits after thrombolytic therapy.” Cardiology Board Review 8, no. 11 (January 1, 1991): 41–56.
  - Clemmensen, P., E. M. Ohman, D. C. Sevilla, S. Peck, N. B. Wagner, P. S. Quigley, P. Grande, K. L. Lee, and G. S. Wagner. “Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction.” Am J Cardiol 66, no. 20 (December 15, 1990): 1407–11. https://doi.org/10.1016/0002-9149(90)90524-5.
    Full Text Link to Item
  - Gurbel, P. A., C. J. Davidson, E. M. Ohman, J. E. Smith, and R. S. Stack. “Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty.” Am J Cardiol 66, no. 12 (October 15, 1990): 1021–23. https://doi.org/10.1016/0002-9149(90)90945-w.
    Full Text Link to Item
  - Ohman, E. M., K. N. Sigmon, and R. M. Califf. “Is diagnostic certainty essential for the use of thrombolytic therapy during myocardial infarction in the 1990s?” Circulation 82, no. 3 (September 1990): 1073–75. https://doi.org/10.1161/01.cir.82.3.1073.
    Full Text Link to Item
  - Ohman, E. M., R. M. Califf, E. J. Topol, R. Candela, C. Abbottsmith, S. Ellis, K. N. Sigmon, D. Kereiakes, B. George, and R. Stack. “Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.” Circulation 82, no. 3 (September 1990): 781–91. https://doi.org/10.1161/01.cir.82.3.781.
    Full Text Link to Item
  - Christenson, R. H., P. Clemmensen, E. M. Ohman, J. Toffaletti, L. M. Silverman, P. Grande, R. T. Vollmer, and G. S. Wagner. “Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent.” Clin Chem 36, no. 8 Pt 1 (August 1990): 1444–49.
    Link to Item
  - Ohman, E. M., C. Casey, J. R. Bengtson, D. Pryor, W. Tormey, and J. H. Horgan. “Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation.” Br Heart J 63, no. 6 (June 1990): 335–38. https://doi.org/10.1136/hrt.63.6.335.
    Full Text Link to Item
  - Ohman, E. M., S. Helmy, E. Shaughnessy, D. B. Adams, and J. Kisslo. “In vitro analysis of jets by Doppler colour flow imaging: the importance of time to maximum jet area.” Eur Heart J 11, no. 4 (April 1990): 361–67. https://doi.org/10.1093/oxfordjournals.eurheartj.a059711.
    Full Text Link to Item
  - Christenson, R. H., P. Clemmensen, E. M. Ohman, J. Toffaletti, L. M. Silverman, P. Grande, R. T. Vollmer, and G. S. Wagner. “Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent.” Clinical Chemistry 36, no. 8 I (January 1, 1990): 1444–49. https://doi.org/10.1093/clinchem/36.8.1444.
    Full Text
  - Sugarman, J., T. M. Bashore, E. M. Ohman, R. Jones, and W. P. Peters. “Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation.” Am J Med 88, no. 1N (January 1990): 52N-55N.
    Link to Item
  - Sugarman, J., T. M. Bashore, E. M. Ohman, R. Jones, and W. P. Peters. “Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation.” American Journal of Medicine 88, no. SUPPL. 1N (January 1, 1990).
  - Ohman, E. M., and R. M. Califf. “Thrombolytic therapy: overview of clinical trials.” Coronary Artery Disease 1, no. 1 (January 1, 1990): 23–33. https://doi.org/10.1097/00019501-199001000-00005.
    Full Text
  - Brady, H. R., M. Kinirons, T. Lynch, E. M. Ohman, W. Tormey, K. M. O’Malley, and J. H. Horgan. “Heart rate and metabolic response to competitive squash in veteran players: identification of risk factors for sudden cardiac death.” Eur Heart J 10, no. 11 (November 1989): 1029–35. https://doi.org/10.1093/oxfordjournals.eurheartj.a059415.
    Full Text Link to Item
  - Christenson, R. H., E. M. Ohman, P. Clemmensen, P. Grande, J. Toffaletti, L. M. Silverman, R. T. Vollmer, and G. S. Wagner. “Characteristics of creatine kinase-MB and MB isoforms in serum after reperfusion in acute myocardial infarction.” Clin Chem 35, no. 11 (November 1989): 2179–85.
    Link to Item
  - Wiseman, A., E. M. Ohman, and J. M. Wharton. “Transient reversal of bifascicular block during acute myocardial infarction with reperfusion therapy: a word of caution.” Am Heart J 117, no. 6 (June 1989): 1381–83. https://doi.org/10.1016/0002-8703(89)90422-5.
    Full Text Link to Item
  - Stoughton, R. B. “Adrenal suppression following low-dose topical clobetasol propionate.” J R Soc Med 81, no. 5 (May 1988): 308.
    Link to Item
  - Ohman, E. M., J. Butler, J. Kelly, J. Horgan, and K. O’Malley. “Beta-adrenoceptor adaptation to endurance training.” J Cardiovasc Pharmacol 10, no. 6 (December 1987): 728–31.
    Link to Item
  - Ohman, E. M., S. Rogers, F. O. Meenan, and T. J. McKenna. “Adrenal suppression following low-dose topical clobetasol propionate.” J R Soc Med 80, no. 7 (July 1987): 422–24. https://doi.org/10.1177/014107688708000709.
    Full Text Link to Item
  - Ohman, E. M., J. Butler, J. Kelly, J. Horgan, and K. O’Malley. “β-adrenoceptor adaptation to endurance training.” Journal of Cardiovascular Pharmacology 10, no. 6 (January 1, 1987): 728–31. https://doi.org/10.1097/00005344-198712000-00018.
    Full Text
  - Lucey, J., R. Gaffney, M. S. Laher, J. Comerford, P. Broe, J. Ennis, D. Bouchier-Hayes, et al. “Royal academy of medicine in Ireland section of medicine - Proceeding of registrar's prize meeting held on 22nd may.” Irish Journal of Medical Science 154, no. 12 (December 1, 1985): 477–82. https://doi.org/10.1007/BF02937202.
    Full Text
  - Ohman, E. M., P. Fitzsimons, F. Butler, and D. Bouchier-Hayes. “The value of ultrasonography in the screening for asymptomatic abdominal aortic aneurysm.” Ir Med J 78, no. 5 (May 1985): 127–29.
    Link to Item
  - Ohman, E. M., K. K. Teo, A. H. Johnson, P. B. Collins, D. P. Dowsett, J. T. Ennis, and J. H. Horgan. “Cardiospecific creatine kinase after strenuous exercise in female athletes.” J Sports Med Phys Fitness 24, no. 3 (September 1984): 270–72.
    Link to Item
  - O’Dwyer, R., G. Abrahamson, P. Ingram, T. H. Pierce, D. J. Murnaghan, G. Chadwick, B. Bradley, et al. “Royal academy of medicine Section of medicine/irish thoracic society - Spring meeting at regional hospital, Cork - 25th and 26th March, 1983.” Irish Journal of Medical Science 153, no. 8 (August 1, 1984): 288–96. https://doi.org/10.1007/BF02939905.
    Full Text
  - Ohman, E. M., K. K. Teo, A. H. Johnson, P. B. Collins, D. G. Dowsett, J. T. Ennis, and J. H. Horgan. “Abnormal cardiac enzyme responses after strenuous exercise: alternative diagnostic aids.” Br Med J (Clin Res Ed) 285, no. 6354 (November 27, 1982): 1523–26. https://doi.org/10.1136/bmj.285.6354.1523.
    Full Text Link to Item
  - Phillips, J., B. Horner, M. Ohman, and J. Horgan. “Increased brain-type creatine phosphokinase in marathon runners.” Lancet 1, no. 8284 (June 5, 1982): 1310. https://doi.org/10.1016/s0140-6736(82)92879-3.
    Full Text Link to Item
  - Phillips, J., B. Horner, M. Ohman, and J. Horgan. “Increased brain-type creatine phosphokinase in marathon runners.” Lancet 1, no. 8284 (1982): 1310-.
- Book Sections
  - Hinohara, T. T., and E. M. Ohman. “Heart disease in the elderly.” In Cardiology Secrets, 431–36, 2017. https://doi.org/10.1016/B978-0-323-47870-0.00050-7.
    Full Text
  - Cohen, M. G., and E. M. Ohman. “Therapeutic goals in patients with refractory angina.” In Coronary Artery Disease: New Approaches without Traditional Revascularization, 9781846287121:29–37, 2012. https://doi.org/10.1007/978-1-84628-712-1_4.
    Full Text
  - Kelly, R. V., M. G. Cohen, and E. Magnus Ohman. “Facilitating perfusion strategies in acute myocardial infarction.” In Clinical, Interventional and Investigational Thrombocardiology, 525–54, 2005.
  - Bragin-Sánchez, D., P. P. Chang, and E. M. Ohman. “Intraaortic balloon pumps in acute heart failure.” In Management of Acute Decompensated Heart Failure, 403–14, 2005.
- Conference Papers
  - Redfors, Björn, Matheus Simonato, Shmuel Chen, Flavien Vincent, Zixuan Zhang, Holger Thiele, Ingo Eitel, et al. “Ambient temperature and infarct size, microvascular obstruction, left ventricular function and clinical outcomes after ST-segment elevation myocardial infarction.” In Coron Artery Dis, 33:81–90, 2022. https://doi.org/10.1097/MCA.0000000000001099.
    Full Text Link to Item
  - Povsic, Thomas J., E Magnus Ohman, Matthew T. Roe, Jennifer White, Frank W. Rockhold, Gilles Montalescot, Jan H. Cornel, et al. “P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes.” In Jama Cardiol, 4:680–84, 2019. https://doi.org/10.1001/jamacardio.2019.1510.
    Full Text Open Access Copy Link to Item
  - Melloni, Chiara, Jan H. Cornel, Gail Hafley, Megan L. Neely, Peter Clemmensen, Dmitry Zamoryakhin, Dorairaj Prabhakaran, et al. “Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial.” In Eur Heart J Acute Cardiovasc Care, 5:443–54, 2016. https://doi.org/10.1177/2048872615598631.
    Full Text Link to Item
  - Cornel, Jan H., E Magnus Ohman, Benjamin Neely, Peter Clemmensen, Piyamitr Sritara, Dmitry Zamoryakhin, Paul W. Armstrong, et al. “Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial.” In Am Heart J, 168:76-87.e1, 2014. https://doi.org/10.1016/j.ahj.2014.04.011.
    Full Text Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

In the News

Selected Grants

External Relationships

Selected Publications

Academic Articles

Book Sections

Conference Papers